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Eclampsia is defined as de novo seizure in a woman with the hypertensive complication 
of pregnancy known as preeclampsia (PE), and is a leading cause of maternal and fetal 
morbidity and mortality worldwide. The pathogenesis of eclamptic seizure remains 
unknown, but is considered a form of hypertensive encephalopathy where an acute rise in 
blood pressure causes loss of cerebral blood flow (CBF) autoregulation and 
hyperperfusion of the brain that results in vasogenic edema formation and subsequent 
seizure. However, eclamptic seizure can occur during seemingly uncomplicated 
pregnancies, in the absence of hypertension and PE, suggesting that normal pregnancy 
may predispose the brain to hypertensive encephalopathy or seizure, independently of 
PE. The overall goal of this dissertation was to investigate the effect of pregnancy and PE 
on the cerebrovasculature and neurophysiological properties that may promote brain 
injury and eclamptic seizure. For this dissertation project, a rat model of PE was 
established that combined placental ischemia, induced by restricting blood flow to the 
uteroplacental unit, and maternal endothelial dysfunction that was induced by a 
prolonged high cholesterol diet. Rats with PE developed several PE-like symptoms, 
including elevated blood pressure, fetal growth restriction, placental dysfunction, and 
were in a state of oxidative stress and endothelial dysfunction. We found that pregnancy 
had an overall protective effect on the maintenance of CBF that was potentially due to a 
nitric-oxide dependent enhancement of the vasodilation of cerebral arteries to decreased 
intravascular pressure. Further, maintenance of CBF during acute hypertension was 
similar in pregnancy and PE. Thus, it does not appear that pregnancy and PE are states 
during which CBF autoregulation is compromised in a manner that would promote the 
development of hypertensive encephalopathy. However, the brain was found to be in a 
hyperexcitable state during normal pregnancy that was augmented in PE, and could 
contribute to onset of eclamptic seizure. Under chloral hydrate anesthesia, generalized 
seizure was induced by timed infusion of the convulsant pentylenetetrazole (PTZ), with 
simultaneous electroencephalography that was stopped at the first onset of spikewave 
discharge indicative of electrical seizure. Seizure threshold was determined as the amount 
of PTZ required to elicit seizure. Compared to the nonpregnant state, seizure threshold 
was ~44% lower in pregnant rats and ~80% lower in rats with PE. Further, pregnant rats 
were more susceptible to seizure-induced vasogenic edema formation than the 
nonpregnant state. Mechanisms by which pregnancy and PE lowered seizure threshold 
appeared to be through pregnancy-associated decreases in cortical γ-aminobutyric acid 
type A receptor (GABAAR) subunits and PE-induced disruption of the blood-brain 
barrier (BBB) and microglial activation, indicative of neuroinflammation. Magnesium 
sulfate (MgSO4), the leading treatment for seizure prophylaxis in women with PE, 
restored seizure threshold to control levels by reversing neuroinflammation in PE rats, 
without affecting BBB permeability. Overall, this dissertation provides evidence that 
pregnancy increases susceptibility of the brain to seizure and vasogenic edema formation 
that likely contribute to the onset of eclampsia during seemingly uncomplicated 
pregnancies. Further, the pathogenesis of eclampsia during PE likely involves breakdown 
of the BBB and subsequent neuroinflammation, resulting in a state of greater seizure 
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW 
1.1 Preeclampsia and Eclampsia 
Preeclampsia, defined as the new onset of hypertension with significant 
proteinuria after the 20th week of gestation, is a life-threatening complication that afflicts 
1-7% of all pregnancies (Roberts and Redman, 1993; Lisonkova and Joseph, 2013; 
Abalos et al., 2014; Rich-Edwards et al., 2014). Preeclampsia is a heterogeneous disease 
that exists on a spectrum from mild to severe and can affect many organs, including the 
kidney, liver, as well as the brain (Duley, 1992; Donaldson, 1994b; Aukes et al., 2007b; 
Aukes et al., 2009; Duley, 2009). Neurologic symptoms include severe and persistent 
headache, uncontrolled vomiting, visual disturbances, cortical blindness and seizure, or 
eclampsia. Eclampsia is the new appearance of unexplained seizure in a woman with 
preeclampsia, and is one of the most dangerous complications of pregnancy (Abalos et 
al., 2014). Eclampsia is a leading cause of maternal and fetal morbidity and mortality 
worldwide that accounts for greater than 50,000 maternal deaths each year with 1 in 50 
women dying and 1 in 14 offspring (Donaldson, 1989a; Duley, 1992, 2009). Although by 
definition eclampsia is restricted to women with preeclampsia, there does not appear to 
be a progression from mild to severe preeclampsia to eclampsia (Sibai, 1990a; Douglas 
and Redman, 1994; Katz et al., 2000). In fact, de novo seizure has been reported to occur 
in 38-60% of seemingly uncomplicated pregnancies, without hypertension or the 
diagnosis of preeclampsia (Douglas and Redman, 1994; Katz et al., 2000). The finding 
that de novo seizure occurs in the absence of preeclampsia suggests that pregnancy alone 
may be a state of increased seizure susceptibility. In addition, women who develop 
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preeclampsia are by definition normotensive and asymptomatic prior to pregnancy, with 
no known underlying conditions contributing to seizure onset, supporting the concept that 
pregnancy alone may predispose the brain to seizure, independently of preeclampsia. 
Thus, a portion of this dissertation investigated the contribution of normal pregnancy to 
eclampsia.  
A portion of women have de novo seizure during seemingly uncomplicated 
pregnancies, however, the majority of eclampsia occurs in the setting of preeclampsia. 
Further, by the growing use of magnesium sulfate (MgSO4) for seizure prophylaxis in 
women with preeclampsia, the incidence of eclamptic seizure has decreased ~ 50 % 
(Duley, 1995). That the incidence of eclampsia has decreased by treating preeclamptic 
women with a seizure prophylactic support that preeclampsia, too, contributes to de novo 
seizure during pregnancy. Therefore, the research completed for this thesis further 
investigated the pathogenesis of preeclampsia as it relates to the involvement of the brain, 
the effect of preeclampsia on seizure susceptibility, and mechanisms by which MgSO4 
effectively reduces seizure.  
1.2 Pathogenesis of Preeclampsia  
Currently there is no medical exam or test that can be performed to determine 
women that will develop preeclampsia, making this disease unpredictable and 
unpreventable. However, general risk factors have been identified including primiparity, 
multi-fetal gestations, body mass index > 34 kg/m2, ethnicity, with highest risk for black 
women, and underlying medical conditions such as pre-existing hypertension, renal 
disease or diabetes mellitus (Steegers et al., 2010; Trogstad et al., 2011; Abalos et al., 
2014). The only known cure for preeclampsia is delivery of the fetus, with preeclamptic 
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women improving nearly immediately upon discharge of the placenta. The finding that 
women improve after removal of the placenta has directly implicated the placenta in the 
etiology of preeclampsia (Myatt, 2002).  
The pathophysiology of preeclampsia was considered as a two-stage model: poor 
placental perfusion leads to release of pro-inflammatory cytokines and anti-angiogenic 
factors into the maternal circulation and development of maternal endothelial dysfunction 
and hypertension, resulting in the hallmark preeclamptic symptoms (Redman, 1991; de 
Groot and Taylor, 1993; Brown, 1995). Stage 1 describes placental disease and involves 
improper spiral artery adaptation and trophoblast invasion during implantation (Khong et 
al., 1986). In the nonpregnant state, spiral arteries are high resistance arteries, however 
during normal pregnancy these arteries remodel, with smooth muscle cells and 
endothelial cells being replaced by invading trophoblasts (Robertson et al., 1967). This 
invasion results in widely dilated, low resistance arteries that allow for increased blood 
flow to the placenta necessary for proper growth of the fetus (Brosens et al., 1967; 
Pijnenborg et al., 1983; Lyall, 2005). In stage 1 of the two-stage model of preeclampsia, 
improper trophoblast invasion leads to spiral arteries remaining in a state of high vascular 
resistance, decreasing blood perfusion to the placenta, resulting in placental ischemia and 
a state of oxidative stress (Redman, 1991; Roberts and Hubel, 1999). Oxidative stress 
causes the placenta to release substances into the maternal circulation that have 
deleterious effects. Increases in pro-inflammatory cytokines lead to an increase in the 
maternal systemic inflammatory response and increased circulating levels of soluble 
receptors for angiogenic factors (Kupferminc et al., 1994; Myatt and Webster, 2009). 
Overall, this cascade of events leads to generalized endothelial dysfunction and reversal 
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of cardiovascular adaptations to normal pregnancy (Stage 2). Consequentially, 
hypertension develops and glomerular endotheliosis in the kidneys and impaired renal 
function results in protein being excreted in the urine (proteinuria) (James et al., 2010). 
Significant proteinuria (> 300 mg/24 hours) was, until early 2014, considered a hallmark 
preeclamptic symptom necessary for diagnosis. However, due to the variability and 
unreliability of proteinuria in women with preeclampsia, the American College of 
Obstetricians and Gynecologists (ACOG) has now stressed that the diagnosis of 
preeclampsia can be made in the absence of proteinuria if de novo hypertension occurs in 
association with thrombocytopenia, renal insufficiency, impaired liver function, 
pulmonary edema, or visual disturbances (Lindheimer et al., 2014).  
The two-stage theory of preeclampsia has been adapted since first proposed in 
1991 as it has become clear that preeclampsia is far more heterogeneous of a disease, and 
that all cases do not fit into the two-stage model (Roberts and Hubel, 2009). Some 
women are diagnosed with the maternal syndrome of preeclampsia that have a healthy 
placenta and no fetal involvement, suggesting that preeclampsia can occur in a setting 
absent of placental ischemia (von Dadelszen et al., 2003; Egbor et al., 2006; Szarka et al., 
2010). Further, some women have placental involvement, indicated by fetal growth 
restriction that do not develop preeclamptic symptoms (Villar et al., 2006). Thus, the 
pathogenesis of preeclampsia does not necessarily appear to be a progression from Stage 
1 to Stage 2, and there appear to be subclassifications of preeclampsia, including 
separation of maternal and placental disease, making identifying the underlying 
mechanism(s) of the pathogenesis of preeclampsia more difficult.  
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Classification of preeclampsia is complicated, and how to differentiate mild forms 
of the disease from severe is still being debated (Lindheimer et al., 2008; Magee et al., 
2008; Lowe et al., 2009; Steegers et al., 2010). The current ACOG delineation of mild 
from severe preeclampsia is based largely upon the level of hypertension. Women with 
blood pressures of 140-159 mm Hg systolic and 90-109 mm Hg diastolic are considered 
to have a mild form of preeclampsia, where as > 160 mm Hg systolic and > 110 mm Hg 
diastolic is considered severe (Lindheimer et al., 2014). The presence of neurologic 
symptoms also advances a woman to severe preeclampsia. While the intent of 
classification is to separate women at high risk of eclampsia and maternal and fetal 
morbidity and mortality from those at low risk, some of the classification systems 
exclude, or neglect to include, criteria that appear to be key variables in prediction of 
maternal and fetal outcome (von Dadelszen et al., 2003). It is now accepted that the 
gestational timing of the onset of symptoms should be considered when assessing the 
severity of the disease. Development of hypertension and proteinuria prior to 34 weeks of 
gestation is considered early-onset preeclampsia whereas symptoms occurring after 34 
weeks of gestation, late-onset preeclampsia (von Dadelszen et al., 2003). The incidence 
of neurologic complications, including blurred vision and persistent headache, is greater 
in women with early-onset preeclampsia that is more often associated with maternal and 
fetal morbidity (Douglas and Redman, 1994; Odegard et al., 2000; Witlin et al., 2000; 
von Dadelszen et al., 2003; Lindheimer et al., 2008; Ogge et al., 2011). Further, early-
onset preeclampsia is more often associated with placental disease, with greater incidence 
of abnormal vascular morphology and intrauterine growth restriction than in late-onset 
preeclampsia (Xiong et al., 2002; Oudejans et al., 2007; Crispi et al., 2008; Raymond and 
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Peterson, 2011). In contrast, late-onset preeclampsia is, for the most part, considered to 
be maternal disease, with little involvement of the placenta, and preeclamptic symptoms 
arising due to underlying cardiovascular diseases that have been unmasked by the 
physiological stress of pregnancy (Ness and Roberts, 1996; Egbor et al., 2006; Raymond 
and Peterson, 2011). It has further been proposed that the most severe form of 
preeclampsia is early-onset of both placental and maternal disease (Staff et al., 2013). 
The combination of the effect of an ischemic placenta in a maternal setting of pre-
existing inflammation and/or endothelial dysfunction seems to amplify the disease 
process. Although eclampsia is most often nonfatal when occurring at term, maternal 
mortality due to eclampsia in women with severe early-onset preeclampsia is ~ 50 %, 
suggesting the combination of maternal and placental syndromes may adversely affect 
the brain to a greater degree than one of the syndromes alone (MacKay et al., 2001). 
Overall, there do not appear to be hard and fast rules that exist for the delineation of mild 
vs. severe preeclampsia; all women with preeclampsia are at some level of risk of 
eclampsia, and therefore increased risk for maternal and fetal morbidity and mortality. 
Strict demarcation of any one aspect of preeclampsia, whether it be the level of 
hypertension, or gestational age at which symptoms occur, could be misleading. Thus, 
seizure prophylaxis in the form of MgSO4 now tends to be administered to most women 
with preeclampsia, regardless of “severity”, as eclampsia can occur all along the 
spectrum of disease, including during seemingly uncomplicated pregnancies. 
1.3 Seizure during Pregnancy 
Based upon the timing of eclamptic seizure onset in regards to gestational age, 
three types of eclampsia exist. Antepartum eclampsia (occurring prior to labor) most 
7 
 
often occurs preterm (before 37 weeks of gestation), whereas intrapartum (during labor) 
and postpartum (after delivery of the fetus and placenta) occur more often at term 
(Douglas and Redman, 1994). Postpartum eclampsia, however, can occur several weeks 
after delivery (Douglas and Redman, 1994). Antepartum eclampsia accounts for 38-45% 
of eclampsia and is associated with greater maternal and fetal morbidity and mortality 
(Douglas and Redman, 1994; Knight, 2007). Commonly, severe headache and visual 
disturbances immediately precede eclamptic seizure onset, followed by confusion, then 
progression from focal seizure, frequently over the face, to generalized tonic-clonic 
convulsion (Thomas, 1998; Katz et al., 2000; Kaplan, 2001; Shah et al., 2008; Cooray et 
al., 2011). Eclamptic seizure seems to be self-limiting, typically lasting no more than 3-4 
minutes followed by a post-ictal period of confusion and agitation, and even coma 
(Norwitz et al., 2011). Seizure causes hypoxia and lactic acidosis due to cessation of 
respiration in the mother, and fetal bradycardia ensues for approximately 20 minutes 
(Donaldson, 1994b). Seizures can be recurrent, with the average frequency being three in 
12 hours (Thomas et al., 1995). Acute memory deficit is common in women with 
eclampsia, with either retrograde or anterograde amnesia lasting hours to days after 
seizure manifestation (Shah et al., 2008). Besides hypoxia, eclampsia can lead to 
intracerebral hemorrhage, cerebral edema, acute renal failure and pulmonary edema, 
which are leading causes of maternal death (Donaldson, 1994b; MacKay et al., 2001). 
The most common causes of fetal mortality are prematurity, abrupto placentae, and 
severe fetal growth restriction (Sibai, 1990a, 2005). Thus, eclamptic seizure poses an 
immediate and serious health risk for both the mother as well as the fetus, although long-
term effects remain unclear.  
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Eclampsia does not appear to be linked to the development of epilepsy and is not 
thought to have long-term neurological consequences (Zeeman et al., 2009). Thus, it 
remains, for the most part, an isolated event. However, it is difficult to assess whether the 
eclamptic seizure is simply benign. Studies using magnetic resonance imaging (MRI) 
showed that white matter lesions are present more often in women who had eclampsia 
than in healthy controls, however whether those white matter lesions were present prior 
to eclampsia remains unknown (Zeeman et al., 2004b; Aukes et al., 2009; Wiegman et 
al., 2014). A Cognitive Failures questionnaire that was administered to formerly 
eclamptic patients to assess the mental difficulty completing daily-life activities indicated 
impaired cognitive function later in life (Aukes et al., 2007b). Further, this self-report 
study revealed that women who had multiple eclamptic seizures reported greater 
cognitive impairment than those women who had a single seizure (Aukes et al., 2007b). 
However, neurocognitive function testing revealed no evidence for impaired executive 
functioning or sustained attention (Postma et al., 2010). Thus, it remains unclear if there 
are long-term neurological complications associated with eclampsia; however, the 
immediate risk for the mother and fetus remains high, making seizure prevention during 
pregnancy and preeclampsia critical. 
The incidence of eclampsia has declined in developed countries with the 
advancement of prenatal care, and the use of seizure prophylactics such as MgSO4 reduce 
the risk of eclampsia by ~ 50% (Duley et al., 2003). Incidence reports of eclampsia in the 
United States decreased by 22 % between 1987 and 2004 (Wallis et al., 2008), and in the 
United Kingdom declined from 4.9 cases per 10,000 pregnancies in 1992 to 2.7/10,000 
pregnancies in 2005-06 (Douglas and Redman, 1994; Knight, 2007). Similarly, in 
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Scandinavia the incidence was 5.0/10,000 pregnancies between 1998-2000 (Andersgaard 
et al., 2006), and in Canada (excluding Quebec) 5.9/10,000 cases between 2009-2010 
(Liu et al., 2011).  However, in developing countries the incidence of eclampsia is 
substantially higher. For example, in 1990 in South Africa the incidence of eclampsia 
was 60/10,000 pregnancies (Moodley and Daya, 1994), 144/10,000 in Muheza, Tanga 
region, Tanzania in 2007-2008 (Cooray et al., 2011) and 200/10,000 pregnancies at 
Muhimbili National Hospital in Dar es Salaam, Tanzania in 1999-2000 (Urassa et al., 
2006). Thus, despite rates of eclampsia declining in the developed world, eclampsia 
remains a worldwide problem.  
The complexity of the pathogenesis of eclampsia is augmented by the lack of 
predictability of women who are most at risk of seizure. In fact, despite the definition of 
eclampsia being in the context of a woman with preeclampsia, it does not appear to 
always be a progression from preeclampsia to eclamptic seizure. Several studies have 
reported a substantial percentage of women with eclamptic seizure did not have the 
hallmark preeclamptic symptoms of hypertension and/or proteinuria prior to seizure 
(Douglas and Redman, 1994; Katz et al., 2000; Knight, 2007), suggesting that de novo 
seizure occurs during seemingly uncomplicated pregnancies. A retrospective study that 
sought to investigate the percentage of eclampsia that was preventable, that is with a 
diagnosis of preeclampsia before seizure onset so that prophylaxis could be started with 
MgSO4, collected records of pregnancies complicated by eclampsia from The University 
of North Carolina Medical Center at Chapel Hill between January 1987 – December 1995 
and Sacred Heart Medical Center from January 1990 – March 1999 (Katz et al., 2000). In 
this study, 53 pregnancies were complicated by eclampsia, and seizure occurred without a 
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prior diagnosis of preeclampsia in 32 of the 53 eclamptic pregnancies (60%) (Katz et al., 
2000). A larger study investigated the incidence of eclampsia at all hospitals in the 
United Kingdom in 1992, and then again between February 2005 – February 2006 
(Douglas and Redman, 1994; Knight, 2007). Douglas & Redman (1994) reported that 
38% of eclampsia occurred prior to hypertension and proteinuria was documented in 
1992 (Douglas and Redman, 1994). Interestingly, the 2005-6 study by Knight et al. 
(2007) reported that only 38% of women who developed eclampsia had hypertension and 
proteinuria the week prior to seizure onset (Knight, 2007). Together these studies suggest 
that eclampsia does not only occur in women with pregnancies complicated by 
preeclampsia, and that seizure onset is not a progression from preeclampsia to eclampsia. 
Instead, these studies suggest that de novo seizure can occur in the absence of 
preeclampsia, and that pregnancy alone may predispose the brain to seizure, 
independently of preeclampsia. Thus, the term “preeclampsia” seems to be misleading, as 
eclampsia can occur in its absence. Further, the progression from normal pregnancy to 
preeclampsia to eclampsia should not be considered linear. Overall, understanding the 
cerebrovascular and neurophysiological changes associated with normal pregnancy may 
shed light into the pathogenesis of eclampsia, as normal pregnancy may contribute to de 
novo seizure in the absence of preeclampsia.  
1.4 The Cerebral Circulation during Pregnancy and Preeclampsia 
1.4.1 Introduction 
The brain is an organ of high metabolic demand that consumes ~ 20% of the 
body’s oxygen at rest, despite comprising only 2% of body weight (Siegel, 1999). 
Importantly, the brain has a relatively narrow capacity to tolerate changes in ion and 
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water balance, and blood flow (Siegel, 1999). The brain is also unique in that it is 
enclosed in a rigid skull and therefore increased vascular permeability or volume could 
result in detrimentally increased intracranial pressure that can cause serious neurological 
symptoms, brain herniation, and even death (Rosenberg, 1999; Marmarou, 2007). Thus, 
there is a need to maintain tight control of cerebral blood flow (CBF) and water flux in 
the face of a 40-50% increase in plasma volume and cardiac output during pregnancy and 
a decline in systemic vascular resistance necessary for the maintenance of a healthy blood 
pressure (Clapp and Capeless, 1997). In contrast to other organs outside the central 
nervous system that undergo substantial increases in both perfusion and transvascular 
filtration during pregnancy, including the uterus, kidney and heart, the cerebral 
circulation must resist these adaptations to counterbalance global hemodynamic changes 
in order to maintain the delicate microenvironment of the brain. Thus, the adaptation of 
the brain and cerebral circulation to pregnancy appears to be to maintain normalcy 
despite substantial hormonal and cardiovascular changes in almost every other organ. 
Pregnancy has the potential to affect several aspects of the cerebral circulation, including 
the cerebral endothelium and blood-brain barrier (BBB), the structure and function of the 
cerebrovasculature, hemodynamics, and CBF autoregulation. Further, in the context of 
these cerebrovascular adaptations, there is risk for neurological complications, such as 
eclampsia, when the cerebral circulation is compromised, as all of the parameters listed 
above have the potential to lead to seizure onset if disrupted or maladapted. In fact, the 
cerebral circulation is thought to have a central role in the pathogenesis of eclampsia. 
Further, the cerebrovasculature is directly involved in ~40 % of maternal deaths due to 
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eclampsia (MacKay et al., 2001). Thus, understanding how pregnancy and preeclampsia 
affect the cerebrovasculature is of interest. 
1.4.2 Vasomotor Responses to Circulating Factors 
One of the most important adaptations of the cerebral circulation during 
pregnancy is to counteract the effects of circulating vasoactive factors. During pregnancy, 
large amounts of hormones are secreted from the placenta, ovaries, and brain into the 
maternal circulation, including pro- and anti-inflammatory cytokines, chemokines, 
steroids and growth factors (Aagaard-Tillery et al., 2006; Szarka et al., 2010). These 
factors are critical for the development and survival of the fetus and adaptation of other 
organ systems needed for a successful pregnancy. Cerebral arteries uniquely adapt during 
pregnancy to oppose an increase in circulating vasoconstrictors present late in gestation. 
Exposure of plasma from pregnant women causes vasoconstriction of posterior cerebral 
arteries from nonpregnant rats, however, this vasoconstrictive effect is absent in arteries 
from pregnant rats (Amburgey et al., 2010a). This lack of effect in arteries from pregnant 
rats suggests the cerebral circulation adapts to combat vasoconstrictors present late in 
gestation. This adaptation may be due to either development of resistance to 
vasoconstrictors circulating during pregnancy, or increased sensitivity to vasodilators also 
circulating in pregnancy. Interestingly, this finding was specific to the cerebral 
vasculature, as the effect of pregnant plasma was not seen in mesenteric arteries 
(Amburgey et al., 2010a). Thus, the adaptation of the cerebral circulation during 
pregnancy is unique compared to the adaptation of other organ systems. The exact 
mechanism by which the cerebral vasculature resists the vasoconstrictive effect of 
circulating factors in pregnancy remains unclear, but may involve receptor 
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downregulation or changes in the influence of the endothelium on vascular tone in 
response to plasma (Duckles and Krause, 2007; Chan et al., 2010). Regardless, this 
adaptation of the cerebral circulation likely occurs to prevent the cerebrovasculature from 
constricting in response to circulating factors and may help maintain physiologic levels of 
cerebrovascular resistance and blood flow to the brain during pregnancy. 
1.4.3 The Cerebral Endothelium and BBB  
Vasomotor responses are not the only feature of the cerebral circulation that adapt 
to pregnancy. The cerebral endothelium that forms the BBB is a complex interface 
between systemically circulating factors and the delicate microenvironment of the brain. 
The endothelial cells of the BBB contain specialized high electrical-resistance tight 
junctions and lack fenestrations (Ueno, 2007; Zlokovic, 2008). BBB tight junctions limit 
the passage of blood constituents into the brain parenchyma by preventing paracellular 
transport and are highly protective of the brain milieu (Wahl et al., 1988; Rubin and 
Staddon, 1999). Cerebral endothelial cells also have a low rate of pinocytosis, which 
limits the amount of transcellular transport, reinforcing the overall function of the BBB 
(Reese and Karnovsky, 1967; Brightman and Reese, 1969; Fenstermacher et al., 1988). 
Pregnancy does not affect mRNA expression of the primary tight junction proteins of the 
BBB, including claudin-1, claudin-5, occludin and zona occludens-1, as these are similar 
to the nonpregnant state (Cipolla et al., 2011). In addition, paracellular and transcellular 
transport at the BBB remain unchanged during normal pregnancy, as BBB permeability 
to solutes does not increase (Cipolla et al., 2011). In addition, hydraulic conductivity, an 
important parameter that relates water movement through the vessel wall in response to 
hydrostatic pressure, is normally very low in cerebral endothelial cells due to the high 
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electrical resistance tight junctions and low pinocytotic activity (Rubin and Staddon, 
1999). Similar to paracellular and transcellular permeability, hydraulic conductivity is not 
changed during pregnancy (Cipolla et al., 2012b), but is increased in response to 
preeclamptic plasma (Amburgey et al., 2010b). Increased hydraulic conductivity during 
preeclampsia could promote neurologic symptoms as increased BBB permeability has 
been linked to several pathologic states including preeclampsia and eclampsia as well as 
epilepsy (Oby and Janigro, 2006; Marchi et al., 2007; Marchi et al., 2011).  
Pregnancy is a state marked by increased circulating permeability factors, 
including several that are known to promote BBB permeability (Brown et al., 1997; 
Evans et al., 1997), yet it is remarkable that no such changes in permeability have been 
measured (Cipolla et al., 2012b). For example, vascular endothelial growth factor 
(VEGF), a cytokine originally named vascular permeability factor, is secreted by the 
placenta and elevated during pregnancy in the uteroplacental unit and the maternal 
circulation (Brown et al., 1997; Evans et al., 1997; Charnock-Jones et al., 2004; 
Amburgey et al., 2010b). VEGF interacts with its receptors VEGFR1 (or FMS-like 
tyrosine kinase receptor 1, Flt-1) and VEGFR2 (or fetal liver kinase 1, Flk-1) located on 
vascular endothelium to initiate several critical physiological processes involved in 
angiogenesis, vascular growth, and endothelial cell survival (Dvorak, 2002; Shibuya, 
2013). In addition to VEGF, placental growth factor (PlGF), a member of the VEGF 
family, is also elevated during pregnancy and contributes to angiogenesis in the uterus 
and placenta (Krauss et al., 2004). Most notably, VEGF and PlGF are potent vasodilators 
and increase peripheral microvascular permeability to serum proteins and 
macromolecules, considered a primary step in preparation for angiogenesis (Feng et al., 
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1996; Dobrogowska et al., 1998; Dvorak, 2002; Oura et al., 2003), and increase BBB 
permeability (Schreurs et al., 2012). Interestingly, despite elevated circulating VEGF and 
PlGF during pregnancy, exposure of cerebral vessels to pregnant plasma or serum does 
not increase BBB permeability (Cipolla et al., 2012b; Schreurs et al., 2012). Further, 
VEGF receptor expression in cerebral arteries does not appear to change during 
pregnancy, suggesting the lack of effect of VEGF and PlGF is not due to downregulation 
of VEGFRI/II or neuropilin (Schreurs et al., 2012). In fact, plasma from late-pregnant 
rats prevents VEGF-induced increases in BBB permeability (Schreurs et al., 2012), likely 
due to increased levels of soluble Flt-1 (sFlt-1). The selective binding of VEGF and PlGF 
to sFlt-1 is important for regulating their bioavailability, thus limiting the permeability-
promoting effects at the BBB during pregnancy (Schreurs et al., 2012). The prevention of 
circulating permeability factors from increasing BBB permeability is an important 
adaptation during pregnancy to help maintain brain homeostasis. 
Although paracellular and transcellular permeability of the BBB appear to remain 
intact during pregnancy, efflux transporters present at the BBB are an important 
regulatory mechanism controlling passage of serum factors into the brain that appear to 
be gestationally regulated (Coles et al., 2009b; Chung et al., 2010). Specifically, p-
glycoprotein (Pgp) is a main efflux transporter at the BBB that extricates steroids, 
cytokines and chemokines as well as many pharmacologic agents that can pass through 
the BBB, essentially acting a gatekeeper to the central nervous system (Begley, 2004; 
Ueno, 2007). Pgp is an obstacle in administration of therapeutics to the brain, making it 
difficult for pharmacological interventions to be delivered in patients with epilepsy, brain 
tumors, HIV, etc. (Begley, 2004). The role of Pgp in restricting drug delivery to the brain 
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during pregnancy has been investigated in pregnant mice and nonhuman primates. Pgp 
protein expression is elevated at the BBB mid-gestation, but returns to pre-pregnancy 
levels by late-gestation in mice (Coles et al., 2009b). In the same study, the protein 
expression of another efflux transporter, multi-drug resistance-associated protein 1 
(Mrp1), was also elevated at the BBB mid-pregnancy that remained higher late in 
gestation (Coles et al., 2009b). A study using positron emission tomography scanning to 
investigate Pgp activity at the BBB across gestation in nonhuman primates reported that 
Pgp activity increases with gestational age (Chung et al., 2010). Thus, it appears that 
efflux transporters are gestationally regulated, potentially in response to the increase in 
circulating factors occurring during pregnancy (Bauer et al., 2007; Coles et al., 2009a). 
While it appears that Pgp expression increases at the BBB only in mid-gestation, its 
activity may increase late in pregnancy. This potential adaptation may play a key role in 
maintaining barrier function despite increases in circulating factors, some of which are 
hormones and steroids that can pass through the BBB due to their lipophilic nature. In 
fact, it is possible that during preeclampsia this adaptation fails or is overcome, resulting 
in eclamptic seizure (see below). Overall, increases in efflux transporter expression 
and/or activity across gestation are likely a critical adaptation of the BBB to prevent 
passage of circulating factors into the brain during pregnancy.  
Preservation of BBB properties and adaptation of efflux transporters in the face of 
elevated circulating permeability factors during pregnancy appears to be highly 
protective, and may be central to seizure prevention. Seizure-provoking serum 
constituents are also present late in gestation. Serum from late-pregnant, but not 
nonpregnant rats causes hyperexcitability of hippocampal neuronal networks in cultured 
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slices, measured by evoked field potentials (Cipolla et al., 2012b). The increase in 
excitability is due to serum factors causing neuroinflammation via activation of microglia 
and secretion of tumor necrosis factor α (TNFα) (Riazi et al., 2008; Cipolla et al., 2012b). 
However, under normal conditions the brain is not likely to come into contact with 
circulating serum factors due to the protective nature of the BBB, highlighting the 
importance of the BBB in seizure prevention during pregnancy (Ueno, 2007; Johnson et 
al., 2014).   
The adaptation of the BBB to normal pregnancy may play a critical role in seizure 
prevention, by protecting the brain from exposure to seizure-provoking constituents 
circulating late in gestation. However, during preeclampsia, maternal endothelial 
dysfunction appears to lead to BBB disruption and result in an increase in BBB 
permeability and edema formation (Kaplan, 2001; Demirtas et al., 2005). Under such 
conditions, seizure-provoking factors, or other deleterious proteins or pro-inflammatory 
cytokines that are increased in preeclampsia may cross into the brain and lead to seizure 
onset. In fact, plasma from women with preeclampsia caused increased BBB 
permeability when exposed to cerebral arteries of rats (Amburgey et al., 2010b). Further, 
when the effect of plasma from women with early-onset preeclampsia on BBB 
permeability was compared to that of late-onset preeclampsia, only plasma from early-
onset preeclamptic patients increased BBB permeability (Schreurs et al., 2013). This was 
due to a > 200% increase in circulating oxidized low-density lipoprotein (oxLDL) present 
in early-onset preeclampsia (Schreurs et al., 2013). Through interaction of oxLDL with 
its receptor, lectin-like oxLDL receptor 1 (LOX1), subsequent peroxynitrite formation 
leads to BBB disruption and an increase in BBB permeability (Schreurs et al., 2013). 
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This differential effect of plasma supports that early-onset preeclampsia is more severe 
than late-onset, and may explain the greater propensity of neurologic involvement during 
early-onset preeclampsia. Overall, increased BBB permeability during preeclampsia 
likely contributes to edema formation and/or passage of seizure-provoking factors into 
the brain, and may represent one mechanism by which eclamptic seizure occurs 
(Donaldson, 1994b; Cipolla, 2007).  
Cerebral edema formation is considered a leading cause of the neurological 
symptoms that occur in preeclampsia, including eclamptic seizure (Donaldson, 1994a; 
Hinchey et al., 1996; Zeeman et al., 2009). In fact, approximately 90 % of women with 
eclampsia have vasogenic cerebral edema formation, as indicated by diffusion-weighted 
MRI (Zeeman et al., 2004b; Brewer et al., 2013). Further, preeclampsia and eclampsia 
are commonly associated with hypertensive encephalopathy, and more specifically, 
posterior reversible encephalopathy syndrome (PRES) (Schwartz et al., 1992; Hinchey et 
al., 1996; Schwartz et al., 2000; Bartynski and Boardman, 2007). However, seizure itself 
leads to BBB disruption, making it difficult to determine if edema is the cause of or a 
consequence of eclamptic seizures (Oby and Janigro, 2006; Marchi et al., 2010). 
Regardless, the presence of vasogenic edema formation in women with preeclampsia that 
have not had seizures is definitive evidence of increased vascular permeability that leads 
to an accumulation of edematous fluid in the extracellular space within the brain (Klatzo, 
1987b, a). However, having the outcome of vasogenic edema in women with 
preeclampsia does not contribute to the understanding of what may be occurring at the 
cellular level at the BBB during preeclampsia in order to allow passage of solutes and 
water into the brain. Studies investigating changes in BBB permeability in the placental 
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ischemia rat model of preeclampsia have reported increased permeability of the BBB to 
albumin-bound Evans Blue (Porcello Marrone et al., 2014; Warrington et al., 2014). 
However, serum albumin levels change during pregnancy and preeclampsia (Honger, 
1968b, a; McCartney et al., 1971; Gojnic et al., 2004), suggesting conclusions from these 
studies about the integrity of the BBB should be made cautiously. Additionally, these 
studies using Evans Blue highlight the necessity for future studies using animal models of 
preeclampsia to investigate BBB permeability to other fluorescently tagged solutes. 
Overall, there is evidence that the BBB is compromised in both women with 
preeclampsia as well as in animal models of preeclampsia that likely plays a role in the 
pathogenesis of eclampsia. Further, it has been suggested that such BBB disruption and 
subsequent vasogenic edema formation may be a consequence of impaired CBF 
autoregulation.  
1.4.4 CBF Autoregulation and Hemodynamics 
The cerebral circulation ultimately functions to deliver oxygen, glucose and 
nutrient rich blood to, and remove metabolic waste from the central nervous system that 
is crucial to ensure proper brain function. It is therefore not surprising that blood flow 
autoregulation is well developed in the brain. CBF autoregulation is the intrinsic property 
of the brain to maintain relatively constant blood flow in the face of changes in blood 
pressure (Harper, 1966; Hayman et al., 1981). In normal healthy adults, CBF 
autoregulation operates between ~ 60 – 160 mmHg (Lassen, 1959; McHenry et al., 
1974). Although the effect of pregnancy on the lower limit of CBF autoregulation has yet 
to be investigated, pregnancy appears to shift the upper limit of the CBF autoregulatory 
curve. In normal pregnant rats, the upper limit of the CBF autoregulatory curve was 
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investigated by using a phenylephrine infusion to acutely raise blood pressure together 
with continuous CBF measurements using laser Doppler flowmetry (Cipolla et al., 
2012a). This study found that compared to the nonpregnant state, the upper limit of CBF 
autoregulation was shifted rightward to higher pressure (Cipolla et al., 2012a). Thus, the 
effect of pregnancy on CBF autoregulation appears to be protective, making the maternal 
brain better prepared to maintain blood flow in the face of acute hypertension. However, 
this study used an animal model of pregnancy, as such measurements in pregnant women 
are challenging and potentially dangerous. Studies in humans using non-invasive 
techniques to measure dynamic autoregulation during normal pregnancy have found 
improved or no change in CBF autoregulation in pregnant compared to nonpregnant 
women (Bergersen et al., 2006; Janzarik et al., 2014). To our knowledge, no study has 
determined the limits of CBF autoregulation during pregnancy but is important to 
understand because of the potential for acute hypotensive and hypertensive episodes that 
exist, especially during parturition. For example, hemorrhage can occur during parturition 
causing hypotension, or parturition can also lead to increased sympathetic discharge 
resulting in an acute elevation in blood pressure (Pickering, 2003).  
The cerebral circulation has a central role in neurologic complications associated 
with preeclampsia (MacKay et al., 2001). In fact, cerebrovascular events such as edema 
and hemorrhage account for ~ 40 % of maternal deaths (MacKay et al., 2001). An 
underlying feature of neurological complications, including seizure, in women with 
preeclampsia is the impairment of CBF autoregulation and subsequent edema formation 
(Engelter et al., 2000; Kaplan, 2001; Janzarik et al., 2014). Impaired CBF autoregulation 
is associated with decreased cerebrovascular resistance, hyperperfusion of the brain, BBB 
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disruption, and vasogenic edema formation (Schwartz et al., 2000; Janzarik et al., 2014). 
Studies that have assessed dynamic CBF autoregulation in women with preeclampsia 
using transcranial Doppler (TCD) to measure changes in CBF velocity in the middle 
cerebral artery (MCA) in response to hemodynamic fluctuations have found that CBF 
autoregulation appears to be intact in preeclampsia (Sherman et al., 2002; van Veen et al., 
2013; Janzarik et al., 2014). However, these studies did not delineate disease severity. A 
case report assessing cerebral autoregulation in women with severe preeclampsia 
experiencing neurologic symptoms reported impaired CBF autoregulation (Oehm et al., 
2006). Although small numbers of patients were assessed, this finding suggests that CBF 
autoregulation may be differentially affected in severe versus mild preeclampsia. Further, 
CBF autoregulation has been shown to be impaired in women with eclampsia (Oehm et 
al., 2003), however, whether loss of autoregulation is due to the convulsions themselves 
or whether it truly is an underlying mechanisms leading to seizure onset remains unclear, 
and difficult to determine. The use of animal models of preeclampsia has been employed 
to investigate the effect of preeclampsia on CBF autoregulation. A recent study 
investigating CBF autoregulation in the placental ischemia rat model of preeclampsia 
reported that autoregulation was impaired in the anterior brain region during stepwise 
increases in arterial blood pressure (Warrington et al., 2014). Interestingly, it is thought 
that CBF autoregulation in the posterior cerebral cortex is predominantly affected during 
preeclampsia, as the posterior cortex is a primary location of vasogenic edema formation 
(Schwartz et al., 2000). Further, most neurologic symptoms that occur in women with 
preeclampsia arise specifically from the posterior cerebral cortex, such as blurred vision 
and cortical blindness (Cunningham et al., 1995). Thus, while the effectiveness of CBF 
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autoregulation in preeclampsia has begun to be investigated using animal models, the 
need for more elaborate studies remains before a clear understanding of the role of 
impaired autoregulation in preeclampsia and eclampsia can be elucidated.   
Numerous recent studies have also investigated potential changes in basal CBF 
during pregnancy and preeclampsia, employing several techniques including 
ultrasonography and magnetic resonance (MR) studies. Early human studies using 
inhalation of a gaseous mixture of nitrous oxide, oxygen and nitrogen and the Fick 
principle to assess CBF, oxygen delivery and metabolism in the brain reported no 
differences in CBF between the nonpregnant, pregnant and preeclamptic states (McCall, 
1949, 1953). TCD studies have measured CBF velocity in cerebral arteries in pregnant 
women across gestation that revealed CBF velocity decreases during normal gestation 
(Williams and Wilson, 1994; Serra-Serra et al., 1997; Belfort et al., 2001), where as CBF 
velocity has been reported to be higher in preeclamptic than normotensive pregnant 
women (Williams and McLean, 1993; Williams and MacLean, 1994; Ohno et al., 1997).  
However, changes in vascular resistance and blood flow calculated from these 
measurements may not accurately reflect CBF due to the lack of information about vessel 
diameter (Kontos, 1989). In fact, despite reported increases in CBF velocity in women 
with preeclampsia, the majority of women with preeclampsia, regardless of severity, have 
normal CBF (Belfort et al., 2002; Belfort et al., 2006). Further, using dual-beam angle-
independent digital Doppler ultrasonography, diameter and blood flow volume of the 
internal carotid artery were measured during pregnancy. This study found that CBF 
increased ~ 20% across gestation based on these measurements (Nevo et al., 2010). In 
contrast, a study using MR reported ~ 20% decrease in CBF during pregnancy, however, 
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this was in comparison to post-partum and not pre-pregnancy values (Zeeman et al., 
2003). MR studies also report contradictory findings regarding CBF in women with 
severe preeclampsia. One study reported a significant increase in CBF in the MCAs and 
the posterior cerebral arteries (PCAs) of women with preeclampsia (Zeeman et al., 
2004a), while another study conducted similarly reported no difference in MCA or PCA 
blood flow between severe preeclamptic and normal pregnancies (Morriss et al., 1997). A 
possible explanation for this particular discrepancy could be the administration of 
medications. Zeeman et al. (2004), who reported an increase in CBF, excluded women 
with severe preeclampsia (blood pressure > 160 mm Hg systolic or with the presence of 
neurologic symptoms) and only took measurements in preeclamptic women not being 
treated with an antihypertensive medication and/or MgSO4 (Zeeman et al., 2004a). The 
study by Morriss et al. (1997) that reported no change in CBF was conducted in women 
with severe preeclampsia, many of which were being treated with either antihypertensive 
medications, MgSO4 or both (Morriss et al., 1997). Studies have used microspheres to 
measure absolute CBF in late-pregnant rats and found a nonsignificant 5-10% increase in 
CBF compared to the nonpregnant state (Buelke-Sam et al., 1982; Cipolla et al., 2011). 
Regardless, there appears to be conflicting evidence regarding the effect of both normal 
pregnancy, as well as preeclampsia on CBF, potentially due to variability in methodology 
and study populations. Overall, while studies reporting the effect of pregnancy and 
preeclampsia on CBF in women are contradictory, the use of animals that allowed 
invasive measurements suggest CBF remains similar in pregnancy to the nonpregnant 
state. However, animal models of preeclampsia have yet to be used to investigate the 
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effect of preeclampsia on absolute CBF, making it difficult to interpret the incongruous 
results that are currently reported from women with preeclampsia.  
1.4.5 Function and Structure of the Cerebrovasculature 
Understanding changes occurring in the structure and function of cerebral arteries 
and arterioles during pregnancy may shed some light on potential changes in vascular 
resistance that may drive changes in CBF and autoregulation. Cerebral arteries and 
arterioles exist in a state of partial constriction and thus have basal tone. A major 
contributor to basal tone in the cerebral circulation is the myogenic response of vascular 
smooth muscle cells (Bayliss, 1902; MacKenzie et al., 1979). Pregnancy does not appear 
to affect myogenic tone in cerebral pial arteries or penetrating brain arterioles (Chan et 
al., 2010; Cipolla et al., 2011). While myogenic tone refers to the degree of basal 
constriction of a vessel relative to its passive diameter at a constant pressure, the 
myogenic response refers to the dynamic response of cerebral arteries and arterioles to 
changes in intravascular pressure (Kontos et al., 1978). The myogenic response is a main 
contributor to CBF autoregulation through increasing and decreasing cerebrovascular 
resistance in response to changes in intravascular pressure and appears to be different in 
the pregnant versus nonpregnant state (Kontos et al., 1978; Faraci et al., 1987a; Faraci 
and Heistad, 1990; Cipolla et al., 2004; Chapman et al., 2013). In isolated cerebral 
arteries from pregnant rats, increased intravascular pressure caused forced dilatation at 
lower pressures than arteries from nonpregnant rats, suggesting a lower capacity to 
maintain cerebrovascular resistance in the face of increased pressure during pregnancy 
(Cipolla et al., 2004). However, the CBF autoregulatory curve is shifted to higher, not 
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lower pressures during pregnancy, suggesting other contributors to CBF autoregulation 
may act in a compensatory way during pregnancy.  
The vasculature of many organ systems, particularly within the uteroplacental 
circulation, changes structurally to accommodate the physiological adaptation of normal 
pregnancy (Osol and Mandala, 2009). There is evidence that the cerebrovasculature also 
structurally remodels during pregnancy in a selective manner. Structural remodeling 
describes changes in luminal diameter and vascular wall thickness in response to 
physiological or pathological stimuli (Martinez-Lemus et al., 2009). Remodeling can be 
directed outward or inward, depending upon whether the luminal diameter increases or 
decreases (Mulvany, 1999). Further, remodeling can be hypo-, hyper- or eutrophic, 
depending upon whether the vessel wall thickness decreases, increases or stays the same, 
respectively (Mulvany, 1999). During rat pregnancy, no changes in luminal diameter or 
wall thickness have been measured in cerebral pial arteries, suggesting pregnancy-
induced remodeling does not occur in the pial vasculature (Chan et al., 2010). However, 
brain parenchymal arterioles, precapillary resistance vessels that branch off pial vessels 
and perfuse the brain tissue, undergo outward hypotrophic remodeling during pregnancy, 
resulting in larger vascular lumens and thinner vessel walls than in the nonpregnant state 
(Cipolla et al., 2011). Although there is no change in myogenic tone in these vessels 
during pregnancy, the intravascular pressure vs. luminal diameter curve is shifted upward 
due to the structural changes (Cipolla et al., 2011). This selective remodeling of 
parenchymal arterioles during pregnancy is through arteriogenesis and driven by 
peroxisome proliferator-activated receptor gamma (PPARγ) activation by the hormone 
(ser)relaxin (Chan and Cipolla, 2011). Interestingly, the primary relaxin receptor is not 
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expressed in parenchymal arterioles (Chan and Cipolla, 2011). However, circulating 
relaxin appears to cross the BBB and is thought to activate PPARγ on astrocytes and 
neurons that in turn exert a paracrine effect on parenchymal arterioles to drive outward 
remodeling (Chan and Cipolla, 2011). In contrast to parenchymal arterioles, pial arteries 
are not intimately associated with brain parenchymal cell types such as astrocytes and 
neurons, and this may explain the selective effect of pregnancy-induced remodeling on 
parenchymal arterioles. This process of arteriogenesis is unique compared to 
angiogenesis, however, angiogenesis also occurs in the brain during pregnancy. In fact, 
capillary density increases during pregnancy in the posterior cerebral cortex, a finding 
that has also been linked to increased activation of PPARγ by relaxin (Chan and Cipolla, 
2011; Cipolla et al., 2011). Thus, while pregnancy does not affect the structure of the pial 
vasculature, it seems to have an outward hypotrophic remodeling effect on parenchymal 
arterioles that may contribute to the extension of the CBF autoregulatory curve.  
During pregnancy, outward remodeling of parenchymal arterioles and increased 
capillary density coupled with the approximate 10% hemodilution that occurs could 
decrease cerebrovascular resistance and increase CBF (Gordon, 2007). Despite these 
vascular and hemodynamic changes, pregnancy has little effect on cerebrovascular 
resistance when measured under normotensive conditions in the rat (Cipolla et al., 2011). 
The substantial contribution of large cerebral arteries to vascular resistance is unique to 
the cerebral circulation (Faraci and Heistad, 1990). In fact, large extracranial and 
intracranial cerebral arteries contribute ~50% of cerebrovascular resistance (Faraci et al., 
1987b; Faraci and Heistad, 1990). Although downstream arterioles undergo structural 
changes that may decrease small vessel resistance, the pial vasculature does not change 
27 
 
structurally during pregnancy and may compensate to maintain normal vascular 
resistance. The structural remodeling of the cerebral circulation may be important when 
considering hypertensive pathologies of pregnancy such as preeclampsia. Under 
experimental conditions of acute hypertension, cerebrovascular resistance of cerebral 
arteries was decreased in pregnant rats, leading to autoregulatory breakthrough and ~40% 
increase in CBF (Cipolla et al., 2011). The decrease in cerebrovascular resistance with 
autoregulatory breakthrough was further associated with increased BBB permeability due 
to greater hydrostatic pressure on the microcirculation (Cipolla et al., 2011). Thus, while 
the BBB seems to remain intact during normal pregnancy under physiological conditions, 
it also appears to be at greater risk of injury during pathologic states such as acute 
hypertension. Under conditions of elevated intravascular pressure when large arteries 
become ineffective in regulating CBF due to forced dilatation of myogenic tone, outward 
hypotrophic remodeling of parenchymal arterioles may predispose the microcirculation to 
injury by transmitting high hydrostatic pressure downstream. Outward hypotrophic 
remodeling of brain arterioles could also contribute to the maternal brain being more 
sensitive to vasogenic edema formation after acute hypertension (Euser and Cipolla, 
2007; Cipolla et al., 2012a). The increase in capillary density may further contribute to 
the susceptibility of the brain to hypertension-induced vasogenic edema during pregnancy 
by increasing the potential sites of BBB disruption. In addition, pregnancy both prevents 
and reverses remodeling of cerebral arteries that occurs in response to chronic 
hypertension (Cipolla et al., 2006; Aukes et al., 2007a; Cipolla et al., 2008). Chronic 
hypertension in the nonpregnant state leads to inward hypertrophic remodeling of 
cerebral arteries, resulting in smaller lumen diameters and thicker vascular walls 
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(Baumbach and Heistad, 1989; Cipolla et al., 2006). This is considered a protective 
adaptation by which cerebrovascular resistance is increased, thus protecting the 
microcirculation from elevated arterial blood pressure (Cipolla et al., 2006; Chan et al., 
2010). The prevention and/or reversal of this remodeling during pregnancy may be 
related to the downregulation of angiotensin type 1 receptor (AT1R) expression in the 
cerebral circulation that also occurs during pregnancy (Chan et al., 2010). While the 
reduction in AT1R expression may be a physiological adaptation to normal pregnancy, 
reversal and/or prevention of hypertensive remodeling may make the cerebral 
microcirculation even more susceptible to injury during states associated with 
hypertension. Again, this may be important during preeclampsia, where acute elevations 
in blood pressure are thought to lead to cerebral vasogenic edema formation and 
subsequent neurologic complications including eclamptic seizure (Cipolla, 2007). 
The adaptation of parenchymal arterioles during pregnancy may be further 
implicated in neurologic complications associated with preeclampsia and eclampsia. 
Parenchymal arterioles are the primary vessels involved in small vessel disease in the 
brain (Rincon and Wright, 2014). Women with eclampsia seem to be prone to white 
matter lesions later in life that may indicate the presence of small vessel disease in the 
brain (Aukes et al., 2009).  It is possible albeit speculative at this time, that failure of 
parenchymal arterioles to outward remodel during preeclampsia underlies the potential 
for white matter lesions later in life. Lack of spiral artery remodeling during pregnancy is 
a feature of some women with preeclampsia that may indicate a type of small vessel 
disease (Egbor et al., 2006). We further speculate that the lack of adaptation of small 
vessels in the uterine circulation may be similar to the lack of adaptation of the small 
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vessels in the brain, both of which may be occurring in women with severe preeclampsia 
and eclampsia. Further, if the lack of remodeling occurs in parenchymal arterioles in the 
brain, as it does in the uterine circulation in some eclamptic women, this may suggest a 
common pathology that leads to white matter lesions and cognitive impairment 
associated with eclampsia (Aukes et al., 2007b; Aukes et al., 2009). However, the 
association of small vessel disease of the brain later in life in formerly eclamptic women 
with impaired spiral artery remodeling during pregnancy is speculative and further 
studies are needed to understand these processes.  
In summary, pregnancy is associated with many adaptations of the cerebral 
circulation including changes in receptor and transporter activity, keeping increased 
permeability factors in balance in order to maintain brain homeostasis and protect against 
increases in BBB permeability. Further, structural and functional changes occur in certain 
segments of the cerebral vasculature; however, CBF and cerebrovascular resistance 
appear unchanged under normotensive conditions. The CBF autoregulation curve appears 
to extend to the right in the pregnant state, protecting the maternal brain against acute and 
drastic increases in blood pressure. It is remarkable that BBB permeability and CBF are 
affected so minimally during pregnancy, especially in the face of substantially increased 
factors that have direct effects on vascular filtration and flow in many other organ 
systems. However, this supports the principle that the adaptation of the cerebral 
circulation to normal pregnancy functions to maintain essential oxygen and nutrient 
delivery and waste removal similar to the nonpregnant state, especially in the face of 
tremendous systemic hemodynamic changes associated with pregnancy. There is 
evidence that the cerebral circulation may be compromised during preeclampsia, through 
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disruption of the BBB and/or effects on CBF autoregulation that may contribute to the 
onset of eclamptic seizure. However, a complete understanding of how preeclampsia 
affects the cerebrovasculature has yet to become clear and continued research efforts in 
this area would likely be fruitful.  
1.5 Changes in Neuronal Excitability during Normal Pregnancy 
1.5.1 Introduction 
 The majority of women do not seize during pregnancy; however, if there is 
greater susceptibility to seizure in the maternal brain, then under conditions where other 
protective mechanisms fail, such as at the BBB, seizure could ensue. Susceptibility to 
seizure during pregnancy has previously been investigated in the context of 
understanding epilepsy in pregnancy. However, the effect of pregnancy on seizure 
frequency in women with epilepsy is difficult to discern and appears variable (Pennell, 
2002; Battino and Tomson, 2007; Meador, 2014). A review of over 2000 pregnancies in 
epileptic patients found that ~ 25% of patients experienced an increase, ~25% a decrease, 
and ~50% experienced no change in the frequency of epileptic seizures (Schmidt, 1982). 
This variability in seizure frequency noted may be complicated by the absence or 
presence of anti-epileptic medications during pregnancy. One study investigating the 
effect of antiepileptic drugs on seizure in pregnant mice found that electroconvulsive 
seizure threshold was increased on day 18 of pregnancy compared to nonpregnant mice 
(Nau et al., 1984). Another study using amygdaloid kindled rats also reported increased 
threshold to electroconvulsive seizure in pregnant compared to nonpregnant animals (Kan 
et al., 1985). However, the latency to seizure onset using the chemoconvulsant 
pentylenentetrazole revealed no change in seizure threshold between nonpregnant and 
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pregnant rats in a study investigating seizure threshold in the lipopolysaccharide (LPS) 
model of preeclampsia (Huang et al., 2014). Thus, there are discrepancies in the effect of 
pregnancy on seizure threshold depending upon which seizure-induction method is used. 
Further, these few studies that have investigated seizure threshold in pregnancy used 
latency to physical convulsion as the threshold; however, the use of 
electroencephalography (EEG) may allow for a more sensitive means to detect seizure 
threshold differences. Despite these incongruities, there is evidence of central changes 
that occur during pregnancy that may increase the potential for seizure. If the brain 
during pregnancy is more susceptible to seizure, that could account for the 38-60% of 
women that experience de novo seizure during seemingly uncomplicated pregnancies. 
Understanding the neurophysiological changes occurring during normal pregnancy may 
lead to a greater understanding of the pathogenesis of de novo seizure in the absence of 
preeclampsia. 
1.5.2 Neuroactive Steroids 
 Pregnancy is a state during which there are tremendous elevations in estrogen and 
progesterone produced from several areas including the placenta. Estrogen and 
progesterone are precursors for neuroactive steroids that have been shown to affect 
neuronal excitability (Reddy, 2003). Neuroactive steroids, or neurosteroids, are 
synthesized from their precursor steroids de novo by neurons and glia throughout the 
brain and are capable of rapidly (within seconds) affecting neuronal excitability through 
non-genomic mechanisms (Baulieu and Robel, 1990; Mensah-Nyagan et al., 1999; Agis-
Balboa et al., 2006).  Neurosteroids affect neuronal excitability by interacting with ion 
channels and neurotransmitter receptors at the neuronal cell membrane (Reddy, 2003). 
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Specifically, estradiol exerts pro-convulsive effects by increasing neuronal excitability 
through increasing dendritic spine density and synapses on CA1 pyramidal cells of the 
hippocampus and facilitating N-methyl-D-aspartate (NMDA) receptor binding (Woolley 
et al., 1997; Pozzo-Miller et al., 1999). Further, estradiol increases excitatory responses 
of neurons by both enhancing inward sodium currents and attenuating outward potassium 
currents, independently of one another (Kow et al., 2006; Druzin et al., 2011). In contrast, 
many progesterone-derived neurosteroids have anti-convulsive effects through 
modulatory actions at gamma-aminobutyric acid type A receptors (GABAARs), the main 
inhibitory neurotransmitter receptors in the brain (Macdonald and Olsen, 1994; Herd et 
al., 2007). Specifically, the neurosteroid allopregnanolone has binding sites on the δ-
subunit of GABAARs, at which it acts as a positive allosteric modulator, exerting an 
overall sedative effect (Stell et al., 2003). GABAARs that contain the δ-subunit 
(GABAAR- δ) are located extrasynaptically and are involved in tonic inhibition 
throughout the brain (Stell et al., 2003). Studies investigating changes in GABAAR-δ 
expression during conditions of increased progesterone such as pregnancy have shown 
downregulation of GABAAR-δ (Maguire et al., 2009; Maguire and Mody, 2009). This 
downregulation has been associated with increased neuronal excitability of brain slices 
from pregnant mice that was normalized by the presence of allopregnanolone (Maguire et 
al., 2009). It is likely that the downregulation of GABAAR-δ is an adaptation that 
functions to maintain the steady state of excitability and avoid overinhibition in the face 
of increased neurosteroids present during pregnancy. Although these in vitro studies 
suggest that the brain may be hyperexcitable during pregnancy, it remains unclear as to 
whether pregnancy is a state of increased seizure susceptibility under physiological 
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conditions when neurosteroids are naturally circulating. Understanding the overall status 
of brain excitability during pregnancy, and whether pregnancy is a state of increased 
seizure susceptibility seems important as that could contribute to the potential for 
eclampsia. 
1.5.3 Neuroinflammation  
Neuronal excitability may also be affected during pregnancy by inflammation. 
Pregnancy is considered a state of mild peripheral inflammation, and peripheral 
inflammation has been shown to cause neuroinflammation through the activation of 
microglia, the resident immune cells in the brain (Sacks et al., 1998; Riazi et al., 2008). 
Active microglia may be in a reparative state that clean up cellular debris and promote 
restoration of the injury or insult that lead to their activation (Hu et al., 2014). These 
productive activated microglia are classified as M2 microglia (Hu et al., 2014). However, 
another role of active microglia has emerged. For unknown reasons, M2 microglia can 
transform to M1 microglia that have a cytotoxic effect on brain repair (Hu et al., 2014). 
Instead of promoting and facilitating healing, M1 microglia secrete pro-inflammatory 
cytokines and reactive oxygen species that act in a feed-forward system to promote 
detrimental neuroinflammation (Hu et al., 2014). Further, the secretion of pro-
inflammatory cytokines such as TNFα increase neuronal excitability through promoting 
the endocytosis of GABAARs and trafficking of α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors to the neuronal cell surface (Stellwagen et al., 
2005; Riazi et al., 2008). By shifting the excitatory/inhibitory balance, M1 microglia 
increase neuronal excitability that may potentiate seizure (Rodgers et al., 2009). Whether 
neuroinflammation is present during normal pregnancy is currently unknown, but is 
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possible as pregnancy is considered a state of mild peripheral inflammation that has been 
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Figure 1: Summary of potential mechanisms that may contribute to eclamptic seizure onset 
during normal pregnancy and preeclampsia. The pathogenesis of eclampsia remains unclear 
and the initiation of seizure onset may differ between preeclamptic patients. Further, eclampsia 
can occur during seemingly uncomplicated pregnancies, suggesting that the brain during normal 
pregnancy may be at greater risk of seizure that is augmented during preeclampsia. However, the 
majority of pregnant women do not seize, and not all women with preeclampsia become 
eclamptic, making it likely that additional insults are required to initiate seizure onset that are 
multifactoral and may exist in combination:  
1)  BBB disruption. Seizure-provoking factors are circulating late in gestation that do not 
gain access to the brain under healthy conditions due to the BBB (Cipolla et al., 2012b). 
However, under conditions of BBB disruption, increased BBB permeability could allow such 
hyperexcitable factors into the brain, potentially leading to seizure onset. Disruption of the BBB 
during normal pregnancy that could lead to seizure onset may be due to increased permeability 
factors such as VEGF, PlGF, vasopressin or histamine, or failure of efflux transporters located on 
the luminal surface of endothelial cells to extricate serum constituents back into the vascular 
lumen. During preeclampsia, maternal endothelial dysfunction is present that likely affects the 
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cerebral endothelium and may lead to increased BBB permeability and edema formation. Further, 
an acute rise in blood pressure during pregnancy or preeclampsia that leads to loss of 
cerebrovascular resistance and CBF autoregulatory breakthrough causes BBB disruption and 
cerebral vasogenic edema formation. Vasogenic edema formation may be another contributor to 
seizure onset during pregnancy and preeclampsia.  
2) Changes in neurosteroids. Neurosteroids, specifically progesterone metabolites such as 
allopreganolone are positive allosteric modulators of GABAARs that exert an overall sedative 
effect (Stell et al., 2003). For this reason, it is thought that GABAARs downregulate in response 
to elevated concentrations of neurosteroids to maintain a normal level of inhibition (Maguire et 
al., 2009). In fact, hyperexcitability of brain slices from pregnant mice is thought to be kept in 
balance by progesterone and progesterone metabolites; however, seizure can occur in response to 
changes in neurosteroids concentrations (Maguire et al., 2009). Thus, it is possible that an 
imbalance in neurosteroid levels that may be driven by rapid fluctuations of estrogen and 
progesterone concentrations could contribute to seizure onset during pregnancy and preeclampsia. 
It is further possible that the simultaneous and rapid decrease in progesterone and increase in 
GABAARs that occurs at parturition is out of balance, resulting in decreased inhibition and 
seizure onset (Maguire et al., 2009).   
3) Inflammation and infection. Peripheral inflammation and infection lead to 
neuroinflammation through activation of microglia. Microglia, the resident immune cells in the 
brain, secrete pro-inflammatory cytokines that increase neuronal excitability and potentiate 
seizure (Riazi et al., 2008). Pregnancy is considered a mild form of peripheral inflammation that 
is thought to be exaggerated during preeclampsia. Thus, activated microglia and 
neuroinflammation could contribute to seizure onset during pregnancy and preeclampsia through 
the secretion of pro-inflammatory cytokines and subsequent neuronal hyperexcitability. 
Overall, the particular insult(s) that initiate seizure in women during seemingly healthy 
pregnancies or women with pregnancies complicated by preeclampsia remain ambiguous. It is 
possible that physiological adaptations to normal pregnancy increase the potential for seizure that 
are exacerbated in the pathologic state of preeclampsia. This figure proposes several potential 
mechanisms of eclamptic seizure onset, yet seizure onset may involve a myriad of such 
contributors where several events such as those listed in this figure occur simultaneously. 
Additionally, the exact cause of seizure onset may be unique to each eclamptic patient, as 
convulsion can occur as a result of numerous pathologic processes, further complicating the 
determination of the pathogenesis of eclampsia. 
 
1.6 Magnesium Sulfate 
Eclampsia poses an immediate threat to both the mother and fetus and has been 
associated with white matter lesions in the brain and cognitive impairment later in life 
(Aukes et al., 2007b; Aukes et al., 2009; Duley, 2009).  Together the immediate and 
potential long-term risk of morbidity highlights the importance of seizure prevention 
during pregnancy and preeclampsia. MgSO4 is the leading therapeutic for seizure 
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prophylaxis in women with preeclampsia (Sibai, 1990b; Witlin and Sibai, 1998). MgSO4 
has a controversial history and its use as a seizure prophylactic has been scrutinized for 
decades (Kaplan et al., 1988). However, extensive studies have shown that MgSO4 
reduces the risk of eclampsia by > 50 %, and that it is more effective in prevention of 
recurrent eclamptic seizure than placebo and accepted anticonvulsant medications, 
including phenytoin and diazepam (Duley, 1995; Lucas et al., 1995; Altman et al., 2002; 
Duley et al., 2003; Duley and Henderson-Smart, 2003a, b). In fact, the incidence of 
recurrent eclamptic seizure in women treated with phenytoin or diazepam was 23.1% 
compared to 9.4% in women that received MgSO4 (Witlin and Sibai, 1998). Further, it 
was suggested that MgSO4 acted as a seizure prophylactic by lowering blood pressure 
through its vasodilatory properties; however, this blood pressure effect is transient, and 
MgSO4 is neither considered nor administered as an antihypertensive agent (Cotton et al., 
1984; Kaplan et al., 1988; Belfort et al., 2003; Lindheimer et al., 2008). Interestingly, the 
incidence of recurrent seizure in eclamptic women that received only antihypertensive 
agents was 2.8% and 0.9% in patients that received MgSO4 (Witlin and Sibai, 1998). 
Similarly, in a study comparing the effectiveness of nimodipine, a calcium-channel 
antagonist that has antihypertensive effects and inhibits cerebral vasospasm, to the 
effectiveness of MgSO4 in seizure prevention in women with severe preeclampsia 
reported that women who received nimodipine were more likely to become eclamptic 
(2.6% of patients) than those treated with MgSO4 (0.8% of patients) (Belfort et al., 2003). 
Together, these studies support that simply controlling hypertension during preeclampsia 
does not prevent development of eclamptic seizure, and that the actions specifically of 
MgSO4 are effective at preventing eclamptic seizure (Witlin and Sibai, 1998).  
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Eclampsia can occur antepartum, intrapartum or postpartum, with antepartum 
eclampsia occurring more often preterm and being associated with recurrent seizures and 
greater maternal and fetal morbidity and mortality (Douglas and Redman, 1994; Knight, 
2007). The largest and most recent study conducted by Knight et al. in 2005 investigated 
the incidence of eclampsia in the United Kingdom after the introduction of MgSO4 as a 
seizure prophylactic. This study reported that 45% of eclampsia occurred antepartum, 
19% intrapartum, and 36% postpartum (Knight, 2007). This was in agreement with a 
similar study conducted by Douglas & Redman in 1992, prior to MgSO4 being widely 
administered as an eclamptic seizure prophylactic (Douglas and Redman, 1994). Overall, 
it does not appear that the introduction of MgSO4 as a seizure prophylactic, at least in the 
United Kingdom, affected the distribution of eclamptic onset in regards to the timing of 
labor or the type (antepartum, etc.). This suggests that while MgSO4 effectively reduces 
the incidence of eclampsia, it does not suggest that one type of eclampsia is preferentially 
affected by MgSO4 treatment. However, it should be noted that eclamptic seizure still 
occurs in some preeclamptic patients, regardless of receiving appropriate MgSO4 
treatment (Katz et al., 2000). Overall, despite being widely administered to women with 
preeclampsia and eclampsia, and being remarkably effective in eclamptic seizure 
prophylaxis and cessation, the mechanism by which MgSO4 prevents seizure remains 
largely unknown, and may be multifaceted. 
The normal serum concentration of Mg2+ in humans is 1.8-3.0 mg/dL and the 
target therapeutic range of treatment of women with preeclampsia is to raise serum Mg2+ 
levels to 4.2-8.4 mg/dL (Pritchard, 1979; Sibai et al., 1984a). MgSO4 is typically 
dispensed intramuscularly, intravenously or a combination of the two. Despite being the 
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most widely administered drug for seizure prophylaxis in women with preeclampsia, its 
use is associated with potentially serious side effects including respiratory paralysis, 
cardiac arrest and death (Kelly et al., 1960; McCubbin et al., 1981; Donaldson, 1989b). 
Hypermagnesemia first leads to weakness of muscles, but can progress to full paralysis if 
severe enough (Donaldson, 1986; Fisher et al., 1988; Ramanathan et al., 1988). The 
effect of hypermagnesemia is due to the calcium antagonistic effects of Mg2+ blocking 
acetylcholine release at the neuromuscular junction (Ramanathan et al., 1988). 
Hyporeflexia begins to occur at serum Mg2+ levels greater than 5 mg/dL and areflexia at 
approximately 10 mg/dL making constant monitoring of serum concentrations of Mg2+ 
and deep patellar reflexes critical in preeclamptic and eclamptic patients receiving 
MgSO4 treatment (Donaldson, 1986). Due to MgSO4 impairing neuromuscular 
transmission, it was proposed in the argument against the use of MgSO4 treatment in the 
1980s that MgSO4 did not prevent seizure, but rather prevented the physical 
manifestation of convulsion due to its paralytic-like effects at high serum concentrations, 
and that MgSO4 simply masked the presence of the dangerous seizure activity that was 
still occurring in the brain (Donaldson, 1986; Fisher et al., 1988; Kaplan et al., 1988). In 
support of this theory, it was further argued that Mg2+ could not have central 
anticonvulsant effects because it could not cross the BBB, making its administration to 
preeclamptic women ineffective, dangerous and unnecessary (Kaplan et al., 1988). 
However, a study in the early 1990s investigating this controversy provided direct 
evidence that, not only does systemically administered MgSO4 correlate with increased 
Mg2+ concentrations throughout the brain, but also that it had direct anti-convulsant 
effects at NMDA receptors, likely due to the Mg2+-gated properties of these receptors 
39 
 
(Hallak et al., 1994). Since these early studies, substantial investigation has been done 
seeking to elucidate the mechanism by which MgSO4 acts as an eclamptic seizure 
prophylactic in women with preeclampsia.  
BBB disruption is a consequence of multiple pathologies and disease processes 
that may be central to eclamptic seizure onset, and is a potential therapeutic target of 
MgSO4. Studies have shown that MgSO4 treatment reduces BBB permeability under 
conditions of BBB disruption, including during dehydration of endothelial cells with 
hyperosmolar mannitol (Kaya et al., 2004), acute hypertension (Euser et al., 2008), 
hypoglycemia (Kaya et al., 2001), traumatic brain injury (Esen et al., 2003), and septic 
encephalopathy (Esen et al., 2005). This protective effect under pathologic conditions 
that increase permeability is likely due to the calcium antagonistic actions of Mg2+. The 
studies listed above measured BBB permeability to Evans Blue, a common tracer that 
binds to serum albumin. Serum albumin is a large protein (~ 70 kDa) and the use of 
Evans Blue specifically measures paracellular permeability due to disruption of tight 
junctions at the BBB. Tight junction proteins, including zona occludin-1, claudin-5 and 
occludin, are attached to the endothelial cell actin cytoskeleton. Through phosphorylation 
of myosin light chains by calcium-dependent myosin light chain kinase, endothelial cell 
contraction increases paracellular permeability, resulting in decreased barrier function 
(Bogatcheva and Verin, 2008). By inhibiting this calcium-dependent process, MgSO4 
seems to exert a “tightening” effect at the BBB that may be one mechanism by which 
MgSO4 treatment prevents seizure onset during preeclampsia.  
Treatment with MgSO4 has been shown to decrease the activity of NMDA 
receptors, likely through prolongation of the presence of the Mg2+ gate (Hallak et al., 
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1994). Removal of Mg2+ is necessary for the passage of cations to occur through the pore 
of these receptors to contribute to the depolarization of neurons, and propagation of 
action potentials. Thus, there seems to be a role for MgSO4 as a direct anti-convulsant. 
Treatment with MgSO4 increases Mg2+ concentrations within the central nervous system, 
having an antagonistic effect on NMDA receptor activity (Hallak et al., 1994). NMDA 
receptors are widely expressed in the hippocampus, a location considered central to 
seizure onset and propagation, as well as throughout the cerebral cortex. Interestingly, 
MgSO4 treatment does not appear to affect EEG patterns of women with preeclampsia, 
which one may suspect would occur with the reduction in NMDA receptor activity 
shown with MgSO4 treatment (Sibai et al., 1984b). The effect of MgSO4 on seizure 
threshold has been investigated in studies seeking to understand its role as a central 
anticonvulsant agent. MgSO4 treatment has been shown to increase the threshold for 
electrically-induced seizure in the hippocampus of awake rats (Cotton et al., 1992; Hallak 
et al., 1992), bupivicaine-induced seizure in awake pregnant rats (Okutomi et al., 2005), 
but shown to have no effect on lidocaine-induced seizures in rats anesthetized with 
nitrous oxide (Choi et al., 1991; Kim et al., 1996). It should be noted that the lack of 
effect of MgSO4 on lidocaine-induced seizures was attributed to the MgSO4 treatment 
regiment not increasing Mg2+ concentrations in the brain. More recently, MgSO4 was 
shown to increase the latency to seizure onset induced by pentylenetetrazol (PTZ) in a 
LPS model of preeclampsia (Huang et al., 2014), however the mechanisms by which 
MgSO4 affected seizure threshold in models of preeclampsia remain unclear. The 
pathogenesis of preeclampsia and eclampsia are likely heterogeneous and, like the actions 
of MgSO4, likely multifaceted. Thus, the multiple sites of action of MgSO4 may be why it 
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is more effective than a medication that functions solely as an anticonvulsant at 
preventing seizure during preeclampsia. Overall, understanding the mechanism(s) by 
which MgSO4 acts as a seizure prophylactic in preeclampsia may allow for more targeted 
therapies to be developed. Further, screening processes may be established to identify 
women who would most readily benefit from MgSO4 therapy, thereby targeting its use 
and avoiding unnecessary risk. 
1.7 Methodology 
1.7.1 Rat Model of Pregnancy 
 The rat is a useful and appropriate model of pregnancy because it has similar 
hemochorial implantation (Pijnenborg et al., 1981), undergoes similar cardiovascular 
changes (e.g. plasma volume increase) (Barron, 1987; Gilson et al., 1992), and has 
similar architecture of the cerebrovasculature (Edvinsson and MacKenzie, 2002) as 
humans. Further, the rat has a short gestation of approximately 22 days. All experiments 
were conducted using 12-14 week old female Sprague Dawley rats that were either 
virgin, nonpregnant animals or primiparous late-pregnant animals on day 20 of 
pregnancy, as late in pregnancy is when eclampsia occurs most often (Douglas and 
Redman, 1994). 
1.7.2 Rat Models of Preeclampsia 
  In order to investigate changes in cerebrovascular and neurophysiological 
properties during preeclampsia, an animal model of preeclampsia was used. Preeclampsia 
is a disease unique to humans, with only very few incidences being reported in primates 
(Stout and Lemmon, 1969; Van Wagenen, 1972). Many animal models of preeclampsia 
exist and have been used to investigate the pathogenesis of preeclampsia, and potential 
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treatment options; however, there is not a single model that is able to capture the full 
spectrum of symptoms of the human-specific disorder. Many models target a single 
pathway or organ system that is afflicted in preeclampsia to mimic hypertension, 
proteinuria, oxidative stress and endothelial dysfunction. For example, endothelial 
dysfunction and vasoconstriction that is associated with preeclampsia has been 
investigated by inhibiting production of nitric oxide synthase (Yallampalli and Garfield, 
1993; Molnar et al., 1994; Cadnapaphornchai et al., 2001). Further, the role of renal 
pathology associated with preeclampsia has been investigated by using the rat model of 
adriamycin nephropathy to induce hypertension and proteinuria in pregnant rats 
(Podjarny et al., 1992; Podjarny et al., 1995; Rathaus et al., 1995). Other models 
capitalize on the imbalance of angiogenic factors that is associated with preeclampsia by 
infusion of soluble receptors of the pro-angiogenic factors VEGF and PlGF, including 
infusion of or adenoviral administration of sFlt-1, soluble endoglin (sEng), or a 
combination of both (Venkatesha et al., 2006; Bridges et al., 2009; Murphy et al., 2010). 
There are inflammatory models of preeclampsia induced by infusion of TNFα (LaMarca 
et al., 2005a; LaMarca et al., 2005b), interleukin-6 (IL-6) (Gadonski et al., 2006; 
Lamarca et al., 2011), AT1R autoantibodies (LaMarca et al., 2009; Parrish et al., 2010), 
or a low-dose endotoxin such as LPS (Faas et al., 1994), as well as metabolic models of 
preeclampsia induced by nutritional selenium deficiency (Vanderlelie et al., 2004) and 
chronic insulin resistance (Podjarny et al., 2001).  
One of the most common models of preeclampsia is the Reduced Uteroplacental 
Perfusion Pressure (RUPP) rat model of preeclampsia. Adapted from original studies in 
pregnant dogs in the 1940s, placental ischemia is induced by limiting blood flow to the 
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uteroplacental unit by placing silver clips of specific diameters on the distal abdominal 
aorta and uterine arcades on day 14 of pregnancy, as seen in Figure 1. This method 
reduces uterine perfusion pressure by ~ 40 % and raises blood pressure by ~ 25 mm Hg 
(Crews et al., 2000; Alexander et al., 2001). Further, rats with RUPP have proteinuria, 
placental ischemia and fetal growth restriction, and are in a state of oxidative stress and 
endothelial dysfunction similar to that of women with preeclampsia (Alexander et al., 
2001; Granger et al., 2001; Sedeek et al., 2008; LaMarca et al., 2009). Rats that  
have RUPP have elevated circulating pro-inflammatory cytokines including TNFα and 
IL-6, as well as increased serum and placental concentrations of anti-angiogenic factors, 
including sFlt-1 (LaMarca et al., 2005a; Gadonski et al., 2006; Gilbert et al., 2007). Thus, 
the RUPP model of preeclampsia portrays many preeclamptic-like symptoms, as shown 
in Table 1. However, as with any animal model, there are limitations. The primary 
limitation of the RUPP model is that placental ischemia is induced. Therefore, this model 
does not incorporate the original disease process that causes lack of spiral artery 
remodeling, or any other small vessel disease pathology. Despite this, there is a broad 
spectrum of symptoms mimicked by this model, and the experimental model used in this 
dissertation was adapted from the RUPP model of preeclampsia. In addition to RUPP 
inducing placental disease, rats were also maintained on a high cholesterol diet (HC) days 
7-20 of gestation to further induce maternal disease. This diet regimen has been 
previously shown to cause hypercholesterolemia as well as endothelial and 
cerebrovascular dysfunction during pregnancy, indicative of maternal endothelial 
dysfunction (Schreurs and Cipolla, 2013). As mentioned previously, although the 
majority of eclampsia is nonfatal and occurs at term, when eclampsia occurs in women 
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with severe disease, maternal mortality is high (MacKay et al., 2001). Thus, RUPP+HC 
rats were used to focus on a more severe model of preeclampsia that incorporated both 










Figure 2: Illustration of the induction of placental ischemia. A silver clip 
0.203 mm in diameter is placed on the abdominal aorta, distal to the renal and 
superior mesenteric arteries, just proximal to the iliac bifurcation, and clips 0.10 mm 
in diameter placed on the uterine arcade, proximal to the first segmental branches to 






Characteristic Women with Preeclampsia Rats with RUPP 
New-onset hypertension Yes Yes 
Proteinuria  Yes Yes 
Abnormal placentation Yes No 
Fetal IUGR  Yes Yes 
Inflammation (TNFα, IL-6) Increased Increased 
Oxidative stress Increased Increased 
Endothelin-1 Increased Increased 
sFlt-1 and sEng Increased Increased 
VEGF and PlGF Decreased Decreased 
Placental HIF-1α Increased Increased 
AT1 autoantibodies Increased Increased 
Glomerular endotheliosis Yes No 
Glomerular filtration rate Decreased Decreased 
 
 
1.7.3 Measurement of Seizure Threshold 
 To investigate the effect of normal pregnancy and preeclampsia on seizure 
susceptibility in vivo, seizure threshold was measured in virgin, nonpregnant and normal 
pregnant rats, and rats with experimental preeclampsia. Under chloral hydrate anesthesia, 
seizure was induced by a timed intravenous infusion of pentylenetetrazole (PTZ) while 
recording electroencephalography (EEG) simultaneously. EEG measures the summated 
activity of many neurons by detecting the extracellular current flow that occurs during 
Table 1: Comparison of characteristics of women with preeclampsia and 
preeclamptic-like symptoms in the RUPP rat model. IUGR, intrauterine growth 
restriction; TNFα, tumor necrosis factor alpha; IL-6, interleukin-6; sFlt-1, soluble FMS-
like tyrosine kinase receptor 1; sEng, soluble endoglin; VEGF, vascular endothelial 
growth factor; PlGF, placental growth factor; HIF-1α, hypoxia-inducible factor 1alpha.  
Adapted from Li et al., Am J Physiol Heart CircPhysiol 303:H1-H8, 2012. 
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synaptic excitation of cortical neurons. PTZ infusion was stopped at the first onset of 
spikewave discharges, defined as a change in waveform when small amplitude, high 
frequency spikes that slowed and synchronized to large amplitude, rhythmic spikes, as 
detected by EEG (Sakamoto et al., 2008). Seizure threshold was then calculated as the 
amount of PTZ (mg/kg) required to elicit electrical seizure: Tinfusion * Rinfusion * [PTZ] / 
bw where Tinfusion is the time of infusion in min, Rinfusion is the rate of infusion in mL/min, 
[PTZ] is the concentration of PTZ in mg/mL, and bw is the body weight in kg (Riazi et 
al., 2008). Seizure susceptibility scores were also calculated: bw * 10/v where bw is body 
weight in grams and v is volume of PTZ infused in µL (Riazi et al., 2008). PTZ is a 
chemoconvulsant that quickly and reliably elicits seizure through antagonistic actions at 
GABAA receptors (Squires et al., 1984; Bough and Eagles, 2001). The use of this specific 
convulsant was chosen to directly investigate the role of pregnancy-induced changes in 
GABAA receptor subunit expression in whole-brain excitability during pregnancy and 
preeclampsia. EEG was recorded unipolarly using silver subdermal corkscrew electrodes 
placed over the parieto-occipital cortex to monitor generalized seizure. It has previously 
been determined that subcutaneous electrodes are a suitable alternative for cortical 
electrodes for less invasive EEG recordings (Ke-jian et al., 2001). Although some studies 
use a single intraperitoneal injection of PTZ and measure the latency to physical 
manifestation of seizure to avoid the use of an anesthetic, chloral hydrate was used 
because it is thought to not depress neural function, and is the preferred anesthetic for 
studies measuring EEG (Thoresen et al., 1997; Olson et al., 2001). Further, the use of 
EEG allowed for a more sensitive measure of electrical seizure activity that may be more 
precise than monitoring for physical convulsions only.  
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1.7.4 Blood-brain Barrier Permeability 
 In order to investigate the effect of experimental preeclampsia on basal BBB 
permeability in vivo, the integrity of the BBB was assessed in normal pregnant and 
preeclamptic rats using two different sized fluorescent tracers. Under chloral hydrate 
anesthesia, tracers were infused intravenously into the femoral vein and allowed to 
circulate for ten minutes, a sufficient amount of time to detect changes in BBB 
permeability (Euser et al., 2008; Cipolla et al., 2011). After ten minutes, a cardiac 
perfusion of lactated Ringer’s solution was performed through a thoracotomy to flush the 
circulation of all tracers and blood. Allowing the beating heart to flush the circulation 
avoided any pressure-induced artifact that can occur when the pressure at which the 
circulation is flushed exceeds the physiological pressure range, disrupting the BBB and 
pushing tracer into the brain. After the circulation was properly flushed, the brain was 
immediately removed, homogenized and centrifuged, and the amount of tracer that 
passed from the lumen of the cerebrovasculature into the brain parenchyma quantified 
using fluorescent spectroscopy. 
 Fluorescent tracers have been used to investigate the BBB for over a century, and 
are a common method of quantifying changes in BBB permeability (Belayev et al., 1996; 
Oztas et al., 2003; Esen et al., 2005; Euser et al., 2008; Cipolla et al., 2011). In fact, the 
presence of the BBB was originally discovered by the lack of passage of systemically 
administered water soluble dyes into the brain (Ehrlich, 1885; Goldmann, 1913). The 
smaller 470 Da sodium fluorescein is thought to pass both paracellularly and 
transcellulary, whereas the larger 70 kDa Texas Red dextran moves only via paracellular 
transport. Thus, the use of two fluorescent tracers of differing sizes allowed the 
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investigation of potential changes in size-selectivity of the BBB, as well as differential 
effects on the type of permeability (paracellular vs. transcellular) under basal conditions 
during experimental preeclampsia. 
1.7.5 Quantification of Cerebral Vasogenic Edema 
 Cerebral edema has been defined as “an abnormal accumulation of fluid within 
the brain parenchyma, producing a volumetric enlargement of the tissue” (Klatzo, 
1987b). Specifically, vasogenic edema is a type of cerebral edema that occurs in response 
to increased cerebrovascular permeability to proteins and solutes that disrupts the osmotic 
gradient and leads to passage and retention of water in the extracellular space in the brain 
(Klatzo, 1987b, a). Vasogenic edema is a consequence of many pathological states, 
including seizure, traumatic brain injury and stroke and has been shown to contribute to 
poor neurological outcome (Terry et al., 1990; Lin et al., 1993; Yang et al., 1994; 
Feldman et al., 1996; Unterberg et al., 2004). In fact, if extensive enough, vasogenic 
edema formation can lead to a drastic increase in intracranial pressure that exceeds the 
compensatory venous and cerebrospinal fluid space, and result in brain or brainstem 
herniation that can be fatal (Rosenberg, 1999; Marmarou, 2007).  
A common and accepted measure of vasogenic edema formation is through 
comparison of the wet and dry brain weights (Schwab et al., 1997). Studies in this 
dissertation investigated the susceptibility of the posterior cerebral cortex to seizure-
induced vasogenic edema during normal pregnancy and in experimental preeclampsia. To 
do so, after seizure threshold was measured, brains were removed and the posterior 
cerebral cortex isolated and immediately weighed (weightwet). The cortices were then 
dried for 24 hours in a laboratory oven at 90 oC then re-weighed (weightdry) and percent 
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water content calculated by the following formula: (weightwet - weightdry/weightwet) * 100. 
The posterior brain region was chosen as it is a primary location of edema in women with 
eclampsia (Sanders et al., 1991).  
1.7.6 MgSO4 Treatment 
 To investigate potential mechanisms by which MgSO4 acts as a seizure 
prophylactic during preeclampsia, including effects on seizure threshold and 
susceptibility, BBB permeability and neuroinflammation, RUPP+HC rats were treated for 
24 hours with MgSO4 prior to experimentation. A previous study from our laboratory 
investigated the effect of MgSO4 on BBB permeability during acute hypertension in 
pregnant rats using a dosing regimen of MgSO4 shown to raise serum Mg2+ 
concentrations into the therapeutic range given to preeclamptic women for seizure 
prophylaxis (e.g. 4.2 – 8.4 mg/dL) (Pritchard, 1979; Hallak et al., 1994; Euser et al., 
2008). This dosing regimen consisted of an intraperitoneal injection of 270 mg/kg 
MgSO4 every four hours for 24 hours (day 19 – 20 of pregnancy) (Euser et al., 2008). 
However, rats with experimental preeclampsia (RUPP+HC) had recently undergone an 
invasive abdominal surgery for induction of placental ischemia on day 14 of pregnancy, 
making repeated intraperitoneal injections unfavorable for this dissertation project. 
Another study used a subcutaneous osmotic minipump for continuous delivery of 60 
mg/kg/day of MgSO4, based on the solubility of MgSO4, however, this dose was not 
sufficient to raise serum Mg2+ above ~ 2 mg/dL (Standley et al., 2006). Thus, the dosing 
regimen of MgSO4 employed in this dissertation consisted of a combination of these 
methodologies to effectively raise serum Mg2+ into the therapeutic range in a less 
invasive manner to avoid additional stress on the animals. RUPP+HC rats received a 
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loading dose of 270 mg/kg of MgSO4 subcutaneously on the morning of the 19th day of 
gestation. Four hours later, under isoflurane anesthesia, three osmotic minipumps were 
implanted subcutaneously between the scapulae to continuously deliver ~ 180 mg/kg/day 
of MgSO4. Prior to implantation, minipumps were primed overnight at 37 oC in sterile 
saline to allow for immediate drug delivery once placed.  On day 20 of pregnancy, 
RUPP+HC rats received a second bolus of 270 mg/kg MgSO4 subcutaneously 
approximately 1 hour prior to beginning experimentation. This course of treatment 
assured RUPP+HC rats received MgSO4 continuously for approximately 24 hours. 
Further, after experimentation, serum was collected and Mg2+ concentrations determined 
using a colorimetric assay that uses the magnesium-dependent enzyme glycerol kinase to 
generate a kinetic red reaction that is proportional to the concentration of Mg2+ in serum 
(Wimmer et al., 1986). The dosing regimen of MgSO4 used in this dissertation was 
clinically relevant, raising serum Mg2+ concentrations to ~ 5.2 mg/dL that is within the 
target therapeutic range administered to women with preeclampsia for eclamptic seizure 
prophylaxis. 
1.7.7 Assessment of Microglial Activation 
To investigate the potential role of neuroinflammation in pregnancy- and 
preeclampsia-induced changes in seizure susceptibility, a method of quantifying the 
activation state of microglia was used. There are many established methods to quantify 
the activation state of microglia, the resident immune cells in the brain indicative of 
neuroinflammation, nearly all of which use the morphological changes associated 
microglial cell activation. Discovered and characterized by Pio del Rio-Hortega in the 
early 1900s, inactive microglia are highly ramified cells that typically have two to six 
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branches radiating from the soma, often with thin, finger-like protrusions extending from 
primary branches (Del Rio-Hortega, 1919). These inactive, or resting microglia are 
continuously surveying the brain parenchyma, monitoring for any pathological stimuli 
(Kreutzberg, 1996). As microglia respond to injury or disruption of the brain milieu, they 
transform morphologically as they activate and migrate to the site of injury, as illustrated 
in Figure 2. The primary branches retract, shortening and becoming thicker, and the cell 
bodies enlarge in preparation to phagocytose damaged cells, becoming amoeboid-like 
(Del Rio-Hortega, 1919; Kettenmann et al., 2011). Microglia are from 
mesodermal/mesenchymal origin and originate from bone marrow. In rodents, monocyte 
progenitor cells of future microglia migrate through the vasculature and immigrate into 
the brain during postnatal development, specifically until postnatal day 10 (Chan et al., 
2007). Once these cells have migrated into the brain parenchyma, they mature and 
transform into the ramified phenotype. 
 There are several 
antibodies that can be used to 
visualize microglial cells in the 
brain. One of the most 
commonly used antibodies to 
specifically visualize microglia 
with particular detail of their 
processes is ionized calcium-
binding adaptor molecule 1 
Figure 3: Illustration of the progression from left to 
right of inactive, resting microglia to active, 
phagocytotic microglia. Adapted from Kreutzberg, 
Trends Neurosci 19:312-318, 1996. 
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(Iba1), a protein involved in calcium homeostasis (Imai et al., 1996; Imai and Kohsaka, 
2002).  The morphological changes that occur when microglia become activated are well 
established and stereotypical, and commonly used to accurately determine the activation 
state of microglia (Kreutzberg, 1996; Stence et al., 2001). Thus, in this dissertation 
immunostaining with an antibody against Iba1 was used to assess the morphology of 
microglia in the cerebral cortex. A graded scale was established from 1 (relatively 
inactive) to 4 (relatively active) to allow each Iba1+ microglial cell to be ranked upon its 
morphology, similar to Figure 2 (Kreutzberg, 1996). Cells with highly ramified, long 
processes with a scattered, irregularly shaped cell body were ranked in state 1. Cells with 
an asymmetrical cell body and many long, defined processes were ranked in state 2. Cell 
bodies that were more rounded with several shorter, thicker processes were ranked 3, and 
large, round amoeboid-like cell bodies with few to no processes were ranked in state 4. 
By quantifying the activation state of microglia, the level of neuroinflammation present 
in the cerebral cortex during normal pregnancy and experimental preeclampsia was 
assessed as an underlying mechanism by which seizure susceptibility may be affected. 
1.7.8 CBF Measurement 
 To investigate the effect of pregnancy on the lower limit of CBF autoregulation, 
as well as the effect of experimental preeclampsia on CBF autoregulation, laser Doppler 
flowmetry was used to measure changes in relative CBF in response to manipulation of 
arterial pressure. Laser Doppler flowmetry measures CBF by detecting the disruption of 
light by moving red blood cells, producing a relative measurement of cerebral perfusion 
in arbitrary units (Stern, 1975). The use of laser Doppler is advantageous over more 
invasive and absolute measures such as with the use of radio-labeled microspheres, due to 
53 
 
the ability of laser Doppler to provide continuous and instantaneous measurements, 
allowing autoregulatory curves to be obtained (Tonnesen et al., 2005). Methods 
measuring absolute CBF typically require immediate euthanization of the animal, and are 
therefore limited in use when investigating CBF autoregulation across a wide pressure 
range. Further, laser Doppler flowmetry has been shown to accurately detect the lower 
limit of CBF autoregulation in rats when compared to absolute CBF measurements via 
the 133xenon injection technique (Tonnesen et al., 2005). As portions of this dissertation 
were focused on assessing CBF autoregulation across the physiological pressure range 
during normal pregnancy and experimental preeclampsia, laser Doppler flowmetry was 
an appropriate and ideal method.   
1.7.9 Isolated Vessel & Arteriograph Studies 
 A major contributor to CBF autoregulation is the myogenic function of cerebral 
arteries. In order to investigate the effect of pregnancy on the myogenic vasodilation of 
cerebral arteries in response to decreased intravascular pressure, pial arteries were 
isolated and studied using arteriograph. Arteries were dissected out of the brain, cleared 
of connective tissue and mounted and secured onto glass cannulas in an arteriograph 
chamber, shown in Figure 3. The proximal cannula is connected to an in-line pressure 
transducer and a servo-null pressure control system that allows for the controlled 
manipulation of intraluminal pressure. The distal cannula remained closed throughout the 
experiment to avoid flow-mediated responses. Luminal diameters and wall thicknesses 
were measured via video microscopy: the optical window in the bottom of the 
arteriograph allows for visualization of vessels mounted within the arteriograph chamber 
by an inverted microscope. The inverted microscope is attached to a video camera and 
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monitor that is connected to a video dimension analyzer. The pressure transducer and 
video dimension analyzer signals are recorded with a data acquisition system on a 
computer that allows for continuous recordings to be made of the pressure-diameter 
relationship of cerebral vessels. By using this arteriograph system to study isolated 
cerebral vessels in vitro, it was possible to investigate the myogenic response to 
fluctuations in intraluminal pressure independently of other factors that contribute to CBF 
autoregulation that are present in vivo, such as neuronal or metabolic influences.  
 
1.8 Project Goals and Hypotheses 
 The pathogenesis of the eclamptic seizure remains unclear, but is considered a 
form of hypertensive encephalopathy where an acute rise in blood pressure causes loss of 
cerebral blood flow autoregulation and hyperperfusion of the brain that result in 
Figure 4: A cerebral artery secured on glass cannulas in an arteriograph chamber. 
Image courtesy of Dr. Marilyn J. Cipolla  
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vasogenic edema formation and subsequent seizure (Schwartz et al., 2000). However, 
eclamptic seizure can occur during seemingly uncomplicated pregnancies in the absence 
of hypertension and preeclampsia (Douglas and Redman, 1994; Katz et al., 2000), 
suggesting that normal pregnancy may predispose the brain to hypertensive 
encephalopathy or seizure, independently of preeclampsia. The overarching goal of this 
dissertation was to investigate the effect of normal pregnancy and preeclampsia on the 
cerebrovasculature and neuronal excitability that may promote brain injury and eclamptic 
seizure. In addition, the pathologic processes by which preeclampsia may potentiate 
seizure onset that may be ameliorated by MgSO4 treatment were investigated. We 
hypothesized that normal pregnancy affects the function of the cerebrovasculature and 
CBF autoregulation by shifting the limits of CBF autoregulation, making the brain more 
susceptible to injury. In Chapter 2 of this dissertation the effect of pregnancy on the lower 
limit of CBF autoregulation and the vasodilatory response of cerebral arteries to 
decreased intravascular pressure was investigated. We further hypothesized that normal 
pregnancy increases seizure susceptibility that may potentiate eclamptic seizure, and this 
was investigated in Chapter 3 of this dissertation. Additionally, we hypothesized that 
preeclampsia is a state of greater seizure susceptibility due to compromised integrity of 
the BBB and neuroinflammation, and that MgSO4 treatment restores seizure susceptibility 
by protecting the BBB and reducing neuroinflammation. These hypotheses were 
investigated in Chapter 4 of this dissertation.    
56 
 
References for Comprehensive Literature Review 
Aagaard-Tillery KM, Silver R, Dalton J (2006) Immunology of normal pregnancy. Semin 
Fetal Neonatal Med 11:279-295. 
Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, Souza JP, Maternal 
WHOMSo, Newborn Health Research N (2014) Pre-eclampsia, eclampsia and 
adverse maternal and perinatal outcomes: a secondary analysis of the World 
Health Organization Multicountry Survey on Maternal and Newborn Health. 
BJOG 121 Suppl 1:14-24. 
Agis-Balboa RC, Pinna G, Zhubi A, Maloku E, Veldic M, Costa E, Guidotti A (2006) 
Characterization of brain neurons that express enzymes mediating neurosteroid 
biosynthesis. Proc Natl Acad Sci U S A 103:14602-14607. 
Alexander BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, Granger 
JP (2001) Reduced uterine perfusion pressure during pregnancy in the rat is 
associated with increases in arterial pressure and changes in renal nitric oxide. 
Hypertension 37:1191-1195. 
Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D (2002) Do 
women with pre-eclampsia, and their babies, benefit from magnesium sulphate? 
The Magpie Trial: a randomised placebo-controlled trial. Lancet 359:1877-1890. 
Amburgey OA, Reeves SA, Bernstein IM, Cipolla MJ (2010a) Resistance artery 
adaptation to pregnancy counteracts the vasoconstricting influence of plasma 
from normal pregnant women. Reprod Sci 17:29-39. 
57 
 
Amburgey OA, Chapman AC, May V, Bernstein IM, Cipolla MJ (2010b) Plasma from 
preeclamptic women increases blood-brain barrier permeability: role of vascular 
endothelial growth factor signaling. Hypertension 56:1003-1008. 
Andersgaard AB, Herbst A, Johansen M, Ivarsson A, Ingemarsson I, Langhoff-Roos J, 
Henriksen T, Straume B, Oian P (2006) Eclampsia in Scandinavia: incidence, 
substandard care, and potentially preventable cases. Acta obstetricia et 
gynecologica Scandinavica 85:929-936. 
Aukes AM, Vitullo L, Zeeman GG, Cipolla MJ (2007a) Pregnancy prevents hypertensive 
remodeling and decreases myogenic reactivity in posterior cerebral arteries from 
Dahl salt-sensitive rats: a role in eclampsia? Am J Physiol Heart Circ Physiol 
292:H1071-1076. 
Aukes AM, de Groot JC, Aarnoudse JG, Zeeman GG (2009) Brain lesions several years 
after eclampsia. Am J Obstet Gynecol 200:504 e501-505. 
Aukes AM, Wessel I, Dubois AM, Aarnoudse JG, Zeeman GG (2007b) Self-reported 
cognitive functioning in formerly eclamptic women. Am J Obstet Gynecol 
197:365 e361-366. 
Barron WM (1987) Volume homeostasis during pregnancy in the rat. Am J Kidney Dis 
9:296-302. 
Bartynski WS, Boardman JF (2007) Distinct imaging patterns and lesion distribution in 
posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 28:1320-
1327. 




Bauer B, Hartz AM, Miller DS (2007) Tumor necrosis factor alpha and endothelin-1 
increase P-glycoprotein expression and transport activity at the blood-brain 
barrier. Mol Pharmacol 71:667-675. 
Baulieu EE, Robel P (1990) Neurosteroids: a new brain function? The Journal of steroid 
biochemistry and molecular biology 37:395-403. 
Baumbach GL, Heistad DD (1989) Remodeling of cerebral arterioles in chronic 
hypertension. Hypertension 13:968-972. 
Bayliss WM (1902) On the local reactions of the arterial wall to changes of internal 
pressure. J Physiol 28:220-231. 
Begley DJ (2004) ABC transporters and the blood-brain barrier. Curr Pharm Des 
10:1295-1312. 
Belayev L, Busto R, Zhao W, Ginsberg MD (1996) Quantitative evaluation of blood-
brain barrier permeability following middle cerebral artery occlusion in rats. 
Brain Res 739:88-96. 
Belfort MA, Clark SL, Sibai B (2006) Cerebral hemodynamics in preeclampsia: cerebral 
perfusion and the rationale for an alternative to magnesium sulfate. Obstet 
Gynecol Surv 61:655-665. 
Belfort MA, Anthony J, Saade GR, Allen JC, Jr. (2003) A comparison of magnesium 
sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 348:304-
311. 
Belfort MA, Varner MW, Dizon-Townson DS, Grunewald C, Nisell H (2002) Cerebral 
perfusion pressure, and not cerebral blood flow, may be the critical determinant of 
59 
 
intracranial injury in preeclampsia: a new hypothesis. Am J Obstet Gynecol 
187:626-634. 
Belfort MA, Tooke-Miller C, Allen JC, Jr., Saade GR, Dildy GA, Grunewald C, Nisell H, 
Herd JA (2001) Changes in flow velocity, resistance indices, and cerebral 
perfusion pressure in the maternal middle cerebral artery distribution during 
normal pregnancy. Acta obstetricia et gynecologica Scandinavica 80:104-112. 
Bergersen TK, Hartgill TW, Pirhonen J (2006) Cerebrovascular response to normal 
pregnancy: a longitudinal study. Am J Physiol Heart Circ Physiol 290:H1856-
1861. 
Bogatcheva NV, Verin AD (2008) The role of cytoskeleton in the regulation of vascular 
endothelial barrier function. Microvascular research 76:202-207. 
Bough KJ, Eagles DA (2001) Comparison of the anticonvulsant efficacies and neurotoxic 
effects of valproic acid, phenytoin, and the ketogenic diet. Epilepsia 42:1345-
1353. 
Brewer J, Owens MY, Wallace K, Reeves AA, Morris R, Khan M, LaMarca B, Martin 
JN, Jr. (2013) Posterior reversible encephalopathy syndrome in 46 of 47 patients 
with eclampsia. Am J Obstet Gynecol 208:468 e461-466. 
Bridges JP, Gilbert JS, Colson D, Gilbert SA, Dukes MP, Ryan MJ, Granger JP (2009) 
Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular 
dysfunction in pregnant rats. Am J Hypertens 22:564-568. 
Brightman MW, Reese TS (1969) Junctions between intimately apposed cell membranes 
in the vertebrate brain. J Cell Biol 40:648-677. 
60 
 
Brosens I, Robertson WB, Dixon HG (1967) The physiological response of the vessels of 
the placental bed to normal pregnancy. J Pathol Bacteriol 93:569-579. 
Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM, Dvorak HF (1997) 
Vascular permeability factor/vascular endothelial growth factor: a multifunctional 
angiogenic cytokine. Exs 79:233-269. 
Brown MA (1995) The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 
22:781-791. 
Buelke-Sam J, Nelson CJ, Byrd RA, Holson JF (1982) Blood flow during pregnancy in 
the rat: I. Flow patterns to maternal organs. Teratology 26:269-277. 
Cadnapaphornchai MA, Ohara M, Morris KG, Jr., Knotek M, Rogachev B, Ladtkow T, 
Carter EP, Schrier RW (2001) Chronic NOS inhibition reverses systemic 
vasodilation and glomerular hyperfiltration in pregnancy. Am J Physiol Renal 
Physiol 280:F592-598. 
Chan SL, Cipolla MJ (2011) Relaxin causes selective outward remodeling of brain 
parenchymal arterioles via activation of peroxisome proliferator-activated 
receptor-gamma. FASEB J 25:3229-3239. 
Chan SL, Chapman AC, Sweet JG, Gokina NI, Cipolla MJ (2010) Effect of PPARgamma 
inhibition during pregnancy on posterior cerebral artery function and structure. 
Front Physiol 1:130. 
Chan WY, Kohsaka S, Rezaie P (2007) The origin and cell lineage of microglia: new 
concepts. Brain research reviews 53:344-354. 
61 
 
Chapman AC, Cipolla MJ, Chan SL (2013) Effect of pregnancy and nitric oxide on the 
myogenic vasodilation of posterior cerebral arteries and the lower limit of 
cerebral blood flow autoregulation. Reprod Sci 20:1046-1054. 
Charnock-Jones DS, Kaufmann P, Mayhew TM (2004) Aspects of human fetoplacental 
vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 25:103-113. 
Choi WW, Warner DS, Monahan DJ, Todd MM (1991) Effects of acute 
hypermagnesemia on the threshold for lidocaine-induced seizures in the rat. Am J 
Obstet Gynecol 164:693-697. 
Chung FS, Eyal S, Muzi M, Link JM, Mankoff DA, Kaddoumi A, O'Sullivan F, Hsiao P, 
Unadkat JD (2010) Positron emission tomography imaging of tissue P-
glycoprotein activity during pregnancy in the non-human primate. Br J Pharmacol 
159:394-404. 
Cipolla MJ (2007) Cerebrovascular function in pregnancy and eclampsia. Hypertension 
50:14-24. 
Cipolla MJ, Vitullo L, McKinnon J (2004) Cerebral artery reactivity changes during 
pregnancy and the postpartum period: a role in eclampsia? Am J Physiol Heart 
Circ Physiol 286:H2127-2132. 
Cipolla MJ, DeLance N, Vitullo L (2006) Pregnancy prevents hypertensive remodeling 
of cerebral arteries: a potential role in the development of eclampsia. 
Hypertension 47:619-626. 
Cipolla MJ, Sweet JG, Chan SL (2011) Cerebral vascular adaptation to pregnancy and its 
role in the neurological complications of eclampsia. J Appl Physiol 110:329-339. 
62 
 
Cipolla MJ, Bishop N, Chan SL (2012a) Effect of pregnancy on autoregulation of 
cerebral blood flow in anterior versus posterior cerebrum. Hypertension 60:705-
711. 
Cipolla MJ, Smith J, Bishop N, Bullinger LV, Godfrey JA (2008) Pregnancy reverses 
hypertensive remodeling of cerebral arteries. Hypertension 51:1052-1057. 
Cipolla MJ, Pusic AD, Grinberg YY, Chapman AC, Poynter ME, Kraig RP (2012b) 
Pregnant serum induces neuroinflammation and seizure activity via TNFalpha. 
Exp Neurol 234:398-404. 
Clapp JF, 3rd, Capeless E (1997) Cardiovascular function before, during, and after the 
first and subsequent pregnancies. Am J Cardiol 80:1469-1473. 
Coles LD, Lee IJ, Voulalas PJ, Eddington ND (2009a) Estradiol and progesterone-
mediated regulation of P-gp in P-gp overexpressing cells (NCI-ADR-RES) and 
placental cells (JAR). Molecular pharmaceutics 6:1816-1825. 
Coles LD, Lee IJ, Hassan HE, Eddington ND (2009b) Distribution of saquinavir, 
methadone, and buprenorphine in maternal brain, placenta, and fetus during two 
different gestational stages of pregnancy in mice. Journal of pharmaceutical 
sciences 98:2832-2846. 
Cooray SD, Edmonds SM, Tong S, Samarasekera SP, Whitehead CL (2011) 
Characterization of symptoms immediately preceding eclampsia. Obstet Gynecol 
118:995-999. 
Cotton DB, Gonik B, Dorman KF (1984) Cardiovascular alterations in severe pregnancy-
induced hypertension: acute effects of intravenous magnesium sulfate. Am J 
Obstet Gynecol 148:162-165. 
63 
 
Cotton DB, Janusz CA, Berman RF (1992) Anticonvulsant effects of magnesium sulfate 
on hippocampal seizures: therapeutic implications in preeclampsia-eclampsia. Am 
J Obstet Gynecol 166:1127-1134; discussion 1134-1126. 
Crews JK, Herrington JN, Granger JP, Khalil RA (2000) Decreased endothelium-
dependent vascular relaxation during reduction of uterine perfusion pressure in 
pregnant rat. Hypertension 35:367-372. 
Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E (2008) 
Predictive value of angiogenic factors and uterine artery Doppler for early- versus 
late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet 
Gynecol 31:303-309. 
Cunningham FG, Fernandez CO, Hernandez C (1995) Blindness associated with 
preeclampsia and eclampsia. Am J Obstet Gynecol 172:1291-1298. 
de Groot CJ, Taylor RN (1993) New insights into the etiology of pre-eclampsia. Ann 
Med 25:243-249. 
Del Rio-Hortega P (1919) El tercer elemento de los centros nerviosos I La microglia en 
estado normal II Intervencion de la microglia en los procesos patologicos III 
Naturaleza pprobable de la microglia. Bol de la Soc esp de biol 9:69-120. 
Demirtas O, Gelal F, Vidinli BD, Demirtas LO, Uluc E, Baloglu A (2005) Cranial MR 
imaging with clinical correlation in preeclampsia and eclampsia. Diagn Interv 
Radiol 11:189-194. 
Dobrogowska DH, Lossinsky AS, Tarnawski M, Vorbrodt AW (1998) Increased blood-
brain barrier permeability and endothelial abnormalities induced by vascular 
endothelial growth factor. J Neurocytol 27:163-173. 
64 
 
Donaldson J (1994a) The brain in eclampsia. hypertens Pregnancy 13:115-133. 
Donaldson JO (1986) Does magnesium sulfate treat eclamptic convulsions? Clinical 
neuropharmacology 9:37-45. 
Donaldson JO (1989a) Eclampsia. In: Neurology of Pregnancy, pp 269-310. 
Philadelphia: W.B. Saunders. 
Donaldson JO (1989b) Magnesium sulfate and eclampsia. Arch Neurol 46:945-946. 
Donaldson JO (1994b) Eclampsia. Adv Neurol 64:25-33. 
Douglas KA, Redman CW (1994) Eclampsia in the United Kingdom. BMJ 309:1395-
1400. 
Druzin M, Malinina E, Grimsholm O, Johansson S (2011) Mechanism of estradiol-
induced block of voltage-gated K+ currents in rat medial preoptic neurons. PloS 
one 6:e20213. 
Duckles SP, Krause DN (2007) Cerebrovascular effects of oestrogen: multiplicity of 
action. Clin Exp Pharmacol Physiol 34:801-808. 
Duley L (1992) Maternal mortality associated with hypertensive disorders of pregnancy 
in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 99:547-
553. 
Duley L (1995) Which anticonvulsant for women with eclampsia? Evidence from the 
collaborative eclampsia trial. Lancet:1455-1463. 
Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 
33:130-137. 
Duley L, Henderson-Smart D (2003a) Magnesium sulphate versus diazepam for 
eclampsia. Cochrane Database Syst Rev:CD000127. 
65 
 
Duley L, Henderson-Smart D (2003b) Magnesium sulphate versus phenytoin for 
eclampsia. Cochrane Database Syst Rev:CD000128. 
Duley L, Gulmezoglu AM, Henderson-Smart DJ (2003) Magnesium sulphate and other 
anticonvulsants for women with pre-eclampsia. Cochrane Database Syst 
Rev:CD000025. 
Dvorak HF (2002) Vascular permeability factor/vascular endothelial growth factor: a 
critical cytokine in tumor angiogenesis and a potential target for diagnosis and 
therapy. Journal of clinical oncology : official journal of the American Society of 
Clinical Oncology 20:4368-4380. 
Edvinsson L, MacKenzie ET (2002) General and comparative anatomy of the cerebral 
circulation. In: Cerebral Blood Flow and Metabolism (Edvinsson L, Krause DN, 
eds). Philadelphia, PA: Lippincott and Williams & Wilkins. 
Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD (2006) Morphometric placental 
villous and vascular abnormalities in early- and late-onset pre-eclampsia with and 
without fetal growth restriction. BJOG 113:580-589. 
Ehrlich P (1885) Sauerstoff-Bed des Organismus. Eine farbenanalytische Studie. In. 
Berlin: Hirschwald. 
Engelter ST, Provenzale JM, Petrella JR (2000) Assessment of vasogenic edema in 
eclampsia using diffusion imaging. Neuroradiology 42:818-820. 
Esen F, Erdem T, Aktan D, Kalayci R, Cakar N, Kaya M, Telci L (2003) Effects of 
magnesium administration on brain edema and blood-brain barrier breakdown 




Esen F, Erdem T, Aktan D, Orhan M, Kaya M, Eraksoy H, Cakar N, Telci L (2005) 
Effect of magnesium sulfate administration on blood-brain barrier in a rat model 
of intraperitoneal sepsis: a randomized controlled experimental study. Crit Care 
9:R18-23. 
Euser AG, Cipolla MJ (2007) Cerebral blood flow autoregulation and edema formation 
during pregnancy in anesthetized rats. Hypertension 49:334-340. 
Euser AG, Bullinger L, Cipolla MJ (2008) Magnesium sulphate treatment decreases 
blood-brain barrier permeability during acute hypertension in pregnant rats. Exp 
Physiol 93:254-261. 
Evans P, Wheeler T, Anthony F, Osmond C (1997) Maternal serum vascular endothelial 
growth factor during early pregnancy. Clinical science 92:567-571. 
Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW (1994) A new animal 
model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant 
rats. Am J Obstet Gynecol 171:158-164. 
Faraci FM, Heistad DD (1990) Regulation of large cerebral arteries and cerebral 
microvascular pressure. Circ Res 66:8-17. 
Faraci FM, Heistad DD, Mayhan WG (1987a) Role of large arteries in regulation of 
blood flow to brain stem in cats. J Physiol 387:115-123. 
Faraci FM, Mayhan WG, Heistad DD (1987b) Segmental vascular responses to acute 
hypertension in cerebrum and brain stem. Am J Physiol 252:H738-742. 
Feldman Z, Gurevitch B, Artru AA, Oppenheim A, Shohami E, Reichenthal E, Shapira Y 
(1996) Effect of magnesium given 1 hour after head trauma on brain edema and 
neurological outcome. J Neurosurg 85:131-137. 
67 
 
Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM (1996) Vesiculo-vacuolar organelles 
and the regulation of venule permeability to macromolecules by vascular 
permeability factor, histamine, and serotonin. The Journal of experimental 
medicine 183:1981-1986. 
Fenstermacher J, Gross P, Sposito N, Acuff V, Pettersen S, Gruber K (1988) Structural 
and functional variations in capillary systems within the brain. Ann N Y Acad Sci 
529:21-30. 
Fisher RS, Kaplan PW, Krumholz A, Lesser RP, Rosen SA, Wolff MR (1988) Failure of 
high-dose intravenous magnesium sulfate to control myoclonic status epilepticus. 
Clinical neuropharmacology 11:537-544. 
Gadonski G, LaMarca BB, Sullivan E, Bennett W, Chandler D, Granger JP (2006) 
Hypertension produced by reductions in uterine perfusion in the pregnant rat: role 
of interleukin 6. Hypertension 48:711-716. 
Gilbert JS, Babcock SA, Granger JP (2007) Hypertension produced by reduced uterine 
perfusion in pregnant rats is associated with increased soluble fms-like tyrosine 
kinase-1 expression. Hypertension 50:1142-1147. 
Gilson GJ, Mosher MD, Conrad KP (1992) Systemic hemodynamics and oxygen 
transport during pregnancy in chronically instrumented, conscious rats. Am J 
Physiol 263:H1911-1918. 
Gojnic M, Petkovic S, Papic M, Mostic T, Jeremic K, Vilendecic Z, Djordjevic S (2004) 




Goldmann E (1913) Vitalfarbung am Zentralnervensystem. Beitrag zur Physio-
Pathologie des Plexus chorioideus und der Hirnhaute. Berlin: Abhandl Konigl 
Preuss Akad Wiss. 
Gordon MC (2007) Maternal Physiology. In: Obstetrics: Normal and Problem 
Pregnancies, 5 Edition (Gabbe SG, Niebyl JR, Simpson JL, eds): Churchill 
Liverstone. 
Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA (2001) Pathophysiology 
of hypertension during preeclampsia linking placental ischemia with endothelial 
dysfunction. Hypertension 38:718-722. 
Hallak M, Berman RF, Irtenkauf SM, Evans MI, Cotton DB (1992) Peripheral 
magnesium sulfate enters the brain and increases the threshold for hippocampal 
seizures in rats. Am J Obstet Gynecol 167:1605-1610. 
Hallak M, Berman RF, Irtenkauf SM, Janusz CA, Cotton DB (1994) Magnesium sulfate 
treatment decreases N-methyl-D-aspartate receptor binding in the rat brain: an 
autoradiographic study. J Soc Gynecol Investig 1:25-30. 
Harper AM (1966) Autoregulation of cerebral blood flow: influence of the arterial blood 
pressure on the blood flow through the cerebral cortex. J Neurol Neurosurg 
Psychiatry 29:398-403. 
Hayman LA, Berman SA, Hinck VC (1981) Correlation of CT cerebral vascular 
territories with function: II. Posterior cerebral artery. AJR Am J Roentgenol 
137:13-19. 
Herd MB, Belelli D, Lambert JJ (2007) Neurosteroid modulation of synaptic and 
extrasynaptic GABA(A) receptors. Pharmacol Ther 116:20-34. 
69 
 
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas 
JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N 
Engl J Med 334:494-500. 
Honger PE (1968a) Albumin metabolism in preeclampsia. Scandinavian journal of 
clinical and laboratory investigation 22:177-184. 
Honger PE (1968b) Albumin metabolism in normal pregnancy. Scandinavian journal of 
clinical and laboratory investigation 21:3-9. 
Hu X, Leak RK, Shi Y, Suenaga J, Gao Y, Zheng P, Chen J (2014) Microglial and 
macrophage polarization-new prospects for brain repair. Nature reviews 
Neurology. 
Huang Q, Liu L, Hu B, Di X, Brennecke SP, Liu H (2014) Decreased seizure threshold in 
an eclampsia-like model induced in pregnant rats with lipopolysaccharide and 
pentylenetetrazol treatments. PloS one 9:e89333. 
Imai Y, Kohsaka S (2002) Intracellular signaling in M-CSF-induced microglia activation: 
role of Iba1. Glia 40:164-174. 
Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S (1996) A novel gene iba1 in the major 
histocompatibility complex class III region encoding an EF hand protein 
expressed in a monocytic lineage. Biochemical and biophysical research 
communications 224:855-862. 
James JL, Whitley GS, Cartwright JE (2010) Pre-eclampsia: fitting together the placental, 
immune and cardiovascular pieces. J Pathol 221:363-378. 
70 
 
Janzarik WG, Ehlers E, Ehmann R, Gerds TA, Schork J, Mayer S, Gabriel B, Weiller C, 
Prompeler H, Reinhard M (2014) Dynamic cerebral autoregulation in pregnancy 
and the risk of preeclampsia. Hypertension 63:161-166. 
Johnson A, Tremble S, Cipolla M (2014) Decreased seizure threshold during pregnancy 
and experimental preeclampsia: Roles for GABAA receptors and microglial 
activation. Reprod Sci 21:100A. 
Kan R, Ono T, Takano T, Yoshijima T, Masubuchi Y, Endo M, Kumashiro H (1985) 
Generalized seizure triggering threshold and serum phenobarbital levels during 
pregnancy in rats. Epilepsia 26:682-688. 
Kaplan PW (2001) The neurologic consequences of eclampsia. The neurologist 7:357-
363. 
Kaplan PW, Lesser RP, Fisher RS, Repke JT, Hanley DF (1988) No, magnesium sulfate 
should not be used in treating eclamptic seizures. Arch Neurol 45:1361-1364. 
Katz VL, Farmer R, Kuller JA (2000) Preeclampsia into eclampsia: toward a new 
paradigm. Am J Obstet Gynecol 182:1389-1396. 
Kaya M, Kucuk M, Kalayci RB, Cimen V, Gurses C, Elmas I, Arican N (2001) 
Magnesium sulfate attenuates increased blood-brain barrier permeability during 
insulin-induced hypoglycemia in rats. Canadian journal of physiology and 
pharmacology 79:793-798. 
Kaya M, Gulturk S, Elmas I, Kalayci R, Arican N, Kocyildiz ZC, Kucuk M, Yorulmaz H, 
Sivas A (2004) The effects of magnesium sulfate on blood-brain barrier 




Ke-jian W, Fang H, Jing-ling S (2001) Use of quantitative EEG in models of whole 
cerebral ischemia in rats. Acta Academiae Medicinae Xuzhou 21:326-329. 
Kelly HG, Cross HC, Turton MR, Hatcher JD (1960) Renal and cardiovascular effects 
induced by intravenous infusion of magnesium sulphate. Canadian Medical 
Association journal 82:866-871. 
Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. 
Physiol Rev 91:461-553. 
Khong TY, De Wolf F, Robertson WB, Brosens I (1986) Inadequate maternal vascular 
response to placentation in pregnancies complicated by pre-eclampsia and by 
small-for-gestational age infants. Br J Obstet Gynaecol 93:1049-1059. 
Kim YJ, McFarlane C, Warner DS, Baker MT, Choi WW, Dexter F (1996) The effects of 
plasma and brain magnesium concentrations on lidocaine-induced seizures in the 
rat. Anesth Analg 83:1223-1228. 
Klatzo I (1987a) Blood-brain barrier and ischaemic brain oedema. Z Kardiol 76 Suppl 
4:67-69. 
Klatzo I (1987b) Pathophysiological aspects of brain edema. Acta Neuropathol 72:236-
239. 
Knight M (2007) Eclampsia in the United Kingdom 2005. BJOG 114:1072-1078. 
Kontos HA (1989) Validity of cerebral arterial blood flow calculations from velocity 
measurements. Stroke 20:1-3. 
Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, Patterson JL, Jr. (1978) 
Responses of cerebral arteries and arterioles to acute hypotension and 
hypertension. Am J Physiol 234:H371-383. 
72 
 
Kow LM, Devidze N, Pataky S, Shibuya I, Pfaff DW (2006) Acute estradiol application 
increases inward and decreases outward whole-cell currents of neurons in rat 
hypothalamic ventromedial nucleus. Brain Res 1116:1-11. 
Krauss T, Pauer HU, Augustin HG (2004) Prospective analysis of placenta growth factor 
(PlGF) concentrations in the plasma of women with normal pregnancy and 
pregnancies complicated by preeclampsia. Hypertens Pregnancy 23:101-111. 
Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends 
Neurosci 19:312-318. 
Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML (1994) Tumor 
necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with 
severe preeclampsia. Am J Obstet Gynecol 170:1752-1757; discussion 1757-
1759. 
Lamarca B, Speed J, Ray LF, Cockrell K, Wallukat G, Dechend R, Granger J (2011) 
Hypertension in response to IL-6 during pregnancy: role of AT1-receptor 
activation. International journal of interferon, cytokine and mediator research : 
IJIM 2011:65-70. 
LaMarca B, Parrish M, Ray LF, Murphy SR, Roberts L, Glover P, Wallukat G, Wenzel 
K, Cockrell K, Martin JN, Jr., Ryan MJ, Dechend R (2009) Hypertension in 
response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in 
pregnant rats: role of endothelin-1. Hypertension 54:905-909. 
LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP (2005a) Hypertension 
produced by reductions in uterine perfusion in the pregnant rat: role of tumor 
necrosis factor-alpha. Hypertension 46:1022-1025. 
73 
 
LaMarca BB, Cockrell K, Sullivan E, Bennett W, Granger JP (2005b) Role of endothelin 
in mediating tumor necrosis factor-induced hypertension in pregnant rats. 
Hypertension 46:82-86. 
Lassen NA (1959) Cerebral blood flow and oxygen consumption in man. Physiol Rev 
39:183-238. 
Lin TN, He YY, Wu G, Khan M, Hsu CY (1993) Effect of brain edema on infarct 
volume in a focal cerebral ischemia model in rats. Stroke 24:117-121. 
Lindheimer MD, Taler SJ, Cunningham FG (2008) Hypertension in pregnancy. J Am Soc 
Hypertens 2:484-494. 
Lindheimer MD, Taylor RN, Roberts JM, Cunningham FG, Chesley LC (2014) 
Introduction, History, Controversies, and Definitions. In: Chesley's Hypertensive 
Disorders in Pregnancy, 4th Edition (Taylor RN, Roberts JM, Cunningham FG, 
Lindheimer MD, eds). Boston: Academic Press/Elsevier. 
Lisonkova S, Joseph KS (2013) Incidence of preeclampsia: risk factors and outcomes 
associated with early- versus late-onset disease. Am J Obstet Gynecol 209:544 
e541-544 e512. 
Liu S, Joseph KS, Liston RM, Bartholomew S, Walker M, Leon JA, Kirby RS, Sauve R, 
Kramer MS, Maternal Health Study Group of Canadian Perinatal Surveillance S 
(2011) Incidence, risk factors, and associated complications of eclampsia. Obstet 
Gynecol 118:987-994. 
Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK, McMahon LP, Mangos G, 
Moore MP, Muller P, Paech M, Walters B (2009) Guidelines for the management 
74 
 
of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 
49:242-246. 
Lucas MJ, Leveno KJ, Cunningham FG (1995) A comparison of magnesium sulfate with 
phenytoin for the prevention of eclampsia. N Engl J Med 333:201-205. 
Lyall F (2005) Priming and remodelling of human placental bed spiral arteries during 
pregnancy--a review. Placenta 26 Suppl A:S31-36. 
Macdonald RL, Olsen RW (1994) GABAA receptor channels. Annu Rev Neurosci 
17:569-602. 
MacKay AP, Berg CJ, Atrash HK (2001) Pregnancy-related mortality from preeclampsia 
and eclampsia. Obstet Gynecol 97:533-538. 
MacKenzie ET, Farrar JK, Fitch W, Graham DI, Gregory PC, Harper AM (1979) Effects 
of hemorrhagic hypotension on the cerebral circulation. I. Cerebral blood flow 
and pial arteriolar caliber. Stroke 10:711-718. 
Magee LA, Helewa M, Moutquin JM, von Dadelszen P (2008) Diagnosis, evaluation, and 
management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 
30:S1-48. 
Maguire J, Mody I (2009) Steroid hormone fluctuations and GABA(A)R plasticity. 
Psychoneuroendocrinology 34 Suppl 1:S84-90. 
Maguire J, Ferando I, Simonsen C, Mody I (2009) Excitability changes related to 
GABAA receptor plasticity during pregnancy. J Neurosci 29:9592-9601. 
Marchi N, Tierney W, Alexopoulos AV, Puvenna V, Granata T, Janigro D (2011) The 
etiological role of blood-brain barrier dysfunction in seizure disorders. Cardiovasc 
Psychiatry Neurol 2011:482415. 
75 
 
Marchi N, Teng Q, Ghosh C, Fan Q, Nguyen MT, Desai NK, Bawa H, Rasmussen P, 
Masaryk TK, Janigro D (2010) Blood-brain barrier damage, but not parenchymal 
white blood cells, is a hallmark of seizure activity. Brain Res 1353:176-186. 
Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, Hernandez N, Hallene K, Diglaw 
T, Franic L, Najm I, Janigro D (2007) Seizure-promoting effect of blood-brain 
barrier disruption. Epilepsia 48:732-742. 
Marmarou A (2007) A review of progress in understanding the pathophysiology and 
treatment of brain edema. Neurosurg Focus 22:E1. 
Martinez-Lemus LA, Hill MA, Meininger GA (2009) The plastic nature of the vascular 
wall: a continuum of remodeling events contributing to control of arteriolar 
diameter and structure. Physiology 24:45-57. 
McCall M (1949) Cerebral blood flow and metabolism in toxemias of pregnancy. Surg 
Gynecol Obstet 89:715-721, illust. 
McCall M (1953) Cerebral circulation and metabolism in toxemia of pregnancy; 
observations on the effects of veratrum viride and apresoline (1-
hydrazinophthalazine). Am J Obstet Gynecol 66:1015-1030. 
McCartney CP, Schumacher GF, Spargo BH (1971) Serum proteins in patients with 
toxemic glomerular lesion. Am J Obstet Gynecol 111:580-590. 
McCubbin JM, Sibai BM, Ardella TN, Anderson GD (1981) Cardiopulmonary arrest due 
to acute maternal hypermagnesaemia. Lancet 1:1058. 
McHenry LC, Jr., West JW, Cooper ES, Goldberg HI, Jaffe ME (1974) Cerebral 
autoregulation in man. Stroke 5:695-706. 
76 
 
Meador KJ (2014) Epilepsy: Pregnancy in women with epilepsy--risks and management. 
Nature reviews Neurology 10:614-616. 
Mensah-Nyagan AG, Do-Rego JL, Beaujean D, Luu-The V, Pelletier G, Vaudry H 
(1999) Neurosteroids: expression of steroidogenic enzymes and regulation of 
steroid biosynthesis in the central nervous system. Pharmacological reviews 
51:63-81. 
Molnar M, Suto T, Toth T, Hertelendy F (1994) Prolonged blockade of nitric oxide 
synthesis in gravid rats produces sustained hypertension, proteinuria, 
thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 
170:1458-1466. 
Moodley J, Daya P (1994) Eclampsia: a continuing problem in developing countries. 
International journal of gynaecology and obstetrics: the official organ of the 
International Federation of Gynaecology and Obstetrics 44:9-14. 
Morriss MC, Twickler DM, Hatab MR, Clarke GD, Peshock RM, Cunningham FG 
(1997) Cerebral blood flow and cranial magnetic resonance imaging in eclampsia 
and severe preeclampsia. Obstet Gynecol 89:561-568. 
Mulvany MJ (1999) Vascular remodelling of resistance vessels: can we define this? 
Cardiovascular research 41:9-13. 
Murphy SR, LaMarca BB, Cockrell K, Granger JP (2010) Role of endothelin in 
mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant 
rats. Hypertension 55:394-398. 
Myatt L (2002) Role of placenta in preeclampsia. Endocrine 19:103-111. 
77 
 
Myatt L, Webster RP (2009) Vascular biology of preeclampsia. J Thromb Haemost 
7:375-384. 
Nau H, Kuhnz W, Loscher W (1984) Effects of pregnancy on seizure threshold and the 
disposition and efficacy of antiepileptic drugs in the mouse. Life Sciences 36:663-
669. 
Ness RB, Roberts JM (1996) Heterogeneous causes constituting the single syndrome of 
preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175:1365-
1370. 
Nevo O, Soustiel JF, Thaler I (2010) Maternal cerebral blood flow during normal 
pregnancy: a cross-sectional study. Am J Obstet Gynecol 203:475 e471-476. 
Norwitz ER, Belfort MA, Saade G, Miller H (2011) Eclampsia. In: Obstetric Clinical 
Algorithms: Management and Evidence: John Wiley & Sons. 
Oby E, Janigro D (2006) The blood-brain barrier and epilepsy. Epilepsia 47:1761-1774. 
Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R (2000) Preeclampsia and 
fetal growth. Obstet Gynecol 96:950-955. 
Oehm E, Reinhard M, Keck C, Els T, Spreer J, Hetzel A (2003) Impaired dynamic 
cerebral autoregulation in eclampsia. Ultrasound Obstet Gynecol 22:395-398. 
Oehm E, Hetzel A, Els T, Berlis A, Keck C, Will HG, Reinhard M (2006) Cerebral 
hemodynamics and autoregulation in reversible posterior leukoencephalopathy 
syndrome caused by pre-/eclampsia. Cerebrovasc Dis 22:204-208. 
Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, Kim CJ, 
Hassan SS (2011) Placental lesions associated with maternal underperfusion are 
78 
 
more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 
39:641-652. 
Ohno Y, Kawai M, Wakahara Y, Kitagawa T, Kakihara M, Arii Y (1997) Transcranial 
assessment of maternal cerebral blood flow velocity in patients with pre-
eclampsia. Acta obstetricia et gynecologica Scandinavica 76:928-932. 
Okutomi T, Zhang Y, Cooper TB, Morishima HO (2005) Magnesium and bupivacaine-
induced convulsions in awake pregnant rats. International journal of obstetric 
anesthesia 14:32-36. 
Olson DM, Sheehan MG, Thompson W, Hall PT, Hahn J (2001) Sedation of children for 
electroencephalograms. Pediatrics 108:163-165. 
Osol G, Mandala M (2009) Maternal uterine vascular remodeling during pregnancy. 
Physiology 24:58-71. 
Oudejans CB, van Dijk M, Oosterkamp M, Lachmeijer A, Blankenstein MA (2007) 
Genetics of preeclampsia: paradigm shifts. Human genetics 120:607-612. 
Oura H, Bertoncini J, Velasco P, Brown LF, Carmeliet P, Detmar M (2003) A critical 
role of placental growth factor in the induction of inflammation and edema 
formation. Blood 101:560-567. 
Oztas B, Kaya M, Kucuk M, Tugran N (2003) Influence of hypoosmolality on the blood-
brain barrier permeability during epileptic seizures. Prog Neuropsychopharmacol 
Biol Psychiatry 27:701-704. 
Parrish MR, Murphy SR, Rutland S, Wallace K, Wenzel K, Wallukat G, Keiser S, Ray 
LF, Dechend R, Martin JN, Granger JP, LaMarca B (2010) The effect of immune 
factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the 
79 
 
angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin 
production in response to hypertension during pregnancy. Am J Hypertens 
23:911-916. 
Pennell PB (2002) Pregnancy in the woman with epilepsy: maternal and fetal outcomes. 
Semin Neurol 22:299-308. 
Pickering TG (2003) Effects of stress and behavioral interventions in hypertension. Pain 
and blood pressure. Journal of clinical hypertension 5:359-361. 
Pijnenborg R, Robertson WB, Brosens I, Dixon G (1981) Review article: trophoblast 
invasion and the establishment of haemochorial placentation in man and 
laboratory animals. Placenta 2:71-91. 
Pijnenborg R, Bland JM, Robertson WB, Brosens I (1983) Uteroplacental arterial 
changes related to interstitial trophoblast migration in early human pregnancy. 
Placenta 4:397-413. 
Podjarny E, Bernheim J, Rathaus M, Pomeranz A, Tovbin D, Shapira J, Bernheim J 
(1992) Adriamycin nephropathy: a model to study effects of pregnancy on renal 
disease in rats. Am J Physiol 263:F711-715. 
Podjarny E, Haskiah A, Pomeranz A, Bernheim J, Green J, Rathaus M, Bernheim J 
(1995) Effect of diltiazem and methyldopa on gestation-related renal 
complications in rats with adriamycin nephrosis. Relationship to glomerular 
prostanoid synthesis. Nephrol Dial Transplant 10:1598-1602. 
Podjarny E, Bursztyn M, Rashed G, Benchetrit S, Katz B, Green J, Karmeli F, Peleg E, 
Bernheim J (2001) Chronic exogenous hyperinsulinaemia-induced hypertension 
80 
 
in pregnant rats: effect of chronic treatment with l-arginine. Clinical science 
100:667-671. 
Porcello Marrone LC, Gadonski G, de Oliveira Laguna G, Poli-de-Figueiredo CE, 
Pinheiro da Costa BE, Lopes MF, Brunelli JP, Diogo LP, Huf Marrone AC, Da 
Costa JC (2014) Blood-brain barrier breakdown in reduced uterine perfusion 
pressure: a possible model of posterior reversible encephalopathy syndrome. 
Journal of stroke and cerebrovascular diseases : the official journal of National 
Stroke Association 23:2075-2079. 
Postma IR, Wessel I, Aarnoudse JG, Zeeman GG (2010) Neurocognitive functioning in 
women with a history of eclampsia: executive functioning and sustained attention. 
Am J Perinatol 27:685-690. 
Pozzo-Miller LD, Inoue T, Murphy DD (1999) Estradiol increases spine density and 
NMDA-dependent Ca2+ transients in spines of CA1 pyramidal neurons from 
hippocampal slices. Journal of neurophysiology 81:1404-1411. 
Pritchard JA (1979) The use of magnesium sulfate in preeclampsia-eclampsia. J Reprod 
Med 23:107-114. 
Ramanathan J, Sibai BM, Pillai R, Angel JJ (1988) Neuromuscular transmission studies 
in preeclamptic women receiving magnesium sulfate. Am J Obstet Gynecol 
158:40-46. 
Rathaus M, Podjarny E, Pomeranz A, Green J, Bernheim J (1995) Adriamycin-related 
hypertension in pregnant rats: response to a thromboxane receptor antagonist. 
Clinical science 88:623-627. 
81 
 
Raymond D, Peterson E (2011) A critical review of early-onset and late-onset 
preeclampsia. Obstet Gynecol Surv 66:497-506. 
Reddy DS (2003) Pharmacology of endogenous neuroactive steroids. Critical reviews in 
neurobiology 15:197-234. 
Redman CW (1991) Current topic: pre-eclampsia and the placenta. Placenta 12:301-308. 
Reese TS, Karnovsky MJ (1967) Fine structural localization of a blood-brain barrier to 
exogenous peroxidase. J Cell Biol 34:207-217. 
Riazi K, Galic MA, Kuzmiski JB, Ho W, Sharkey KA, Pittman QJ (2008) Microglial 
activation and TNFalpha production mediate altered CNS excitability following 
peripheral inflammation. Proc Natl Acad Sci U S A 105:17151-17156. 
Rich-Edwards JW, Ness RB, Roberts JM (2014) Epidemiology of Pregnancy-Related 
Hypertension. In: Chesley's Hypertensive Disorders in Pregnancy, Fourth Edition 
(Taylor RN, Roberts JM, Cunningham FG, Lindheimer MD, eds): Academic 
Press/Elsevier. 
Rincon F, Wright CB (2014) Current pathophysiological concepts in cerebral small 
vessel disease. Front Aging Neurosci 6:24. 
Roberts J, Hubel C (1999) Is oxidative stress the link in the two stage model of pre-
eclampsia? Lancet 354:788-789. 
Roberts JM, Redman CW (1993) Pre-eclampsia: more than pregnancy-induced 
hypertension. Lancet 341:1447-1451. 
Roberts JM, Hubel CA (2009) The two stage model of preeclampsia: variations on the 
theme. Placenta 30 Suppl A:S32-37. 
82 
 
Robertson WB, Brosens I, Dixon HG (1967) The pathological response of the vessels of 
the placental bed to hypertensive pregnancy. J Pathol Bacteriol 93:581-592. 
Rodgers KM, Hutchinson MR, Northcutt A, Maier SF, Watkins LR, Barth DS (2009) The 
cortical innate immune response increases local neuronal excitability leading to 
seizures. Brain 132:2478-2486. 
Rosenberg GA (1999) Ischemic brain edema. Progress in cardiovascular diseases 42:209-
216. 
Rubin LL, Staddon JM (1999) The cell biology of the blood-brain barrier. Annu Rev 
Neurosci 22:11-28. 
Sacks GP, Studena K, Sargent K, Redman CW (1998) Normal pregnancy and 
preeclampsia both produce inflammatory changes in peripheral blood leukocytes 
akin to those of sepsis. Am J Obstet Gynecol 179:80-86. 
Sakamoto K, Saito T, Orman R, Koizumi K, Lazar J, Salciccioli L, Stewart M (2008) 
Autonomic consequences of kainic acid-induced limbic cortical seizures in rats: 
peripheral autonomic nerve activity, acute cardiovascular changes, and death. 
Epilepsia 49:982-996. 
Sanders TG, Clayman DA, Sanchez-Ramos L, Vines FS, Russo L (1991) Brain in 
eclampsia: MR imaging with clinical correlation. Radiology 180:475-478. 
Schmidt D (1982) The effect of pregnancy on the natural history of epilepsy: review of 
the literature. In: Epilepsy, Pregnancy, and the Child (Janz D, Dam M, Richens A, 
Bossi L, Helge H, Schmidt D, eds), pp 3-14. New York, NY: Raven Press. 
Schreurs MP, Cipolla MJ (2013) Pregnancy enhances the effects of hypercholesterolemia 
on posterior cerebral arteries. Reprod Sci 20:391-399. 
83 
 
Schreurs MP, Houston EM, May V, Cipolla MJ (2012) The adaptation of the blood-brain 
barrier to vascular endothelial growth factor and placental growth factor during 
pregnancy. FASEB J 26:355-362. 
Schreurs MP, Hubel CA, Bernstein IM, Jeyabalan A, Cipolla MJ (2013) Increased 
oxidized low-density lipoprotein causes blood-brain barrier disruption in early-
onset preeclampsia through LOX-1. FASEB J 27:1254-1263. 
Schwab M, Bauer R, Zwiener U (1997) The distribution of normal brain water content in 
Wistar rats and its increase due to ischemia. Brain Res 749:82-87. 
Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, Garada B, Holman BL 
(1992) Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT 
imaging in 14 cases. AJR Am J Roentgenol 159:379-383. 
Schwartz RB, Feske SK, Polak JF, DeGirolami U, Iaia A, Beckner KM, Bravo SM, 
Klufas RA, Chai RY, Repke JT (2000) Preeclampsia-eclampsia: clinical and 
neuroradiographic correlates and insights into the pathogenesis of hypertensive 
encephalopathy. Radiology 217:371-376. 
Sedeek M, Gilbert JS, LaMarca BB, Sholook M, Chandler DL, Wang Y, Granger JP 
(2008) Role of reactive oxygen species in hypertension produced by reduced 
uterine perfusion in pregnant rats. Am J Hypertens 21:1152-1156. 
Serra-Serra V, Kyle PM, Chandran R, Redman CW (1997) Maternal middle cerebral 
artery velocimetry in normal pregnancy and postpartum. Br J Obstet Gynaecol 
104:904-909. 




Sherman RW, Bowie RA, Henfrey MM, Mahajan RP, Bogod D (2002) Cerebral 
haemodynamics in pregnancy and pre-eclampsia as assessed by transcranial 
Doppler ultrasonography. British journal of anaesthesia 89:687-692. 
Shibuya M (2013) Vascular endothelial growth factor and its receptor system: 
physiological functions in angiogenesis and pathological roles in various diseases. 
J Biochem 153:13-19. 
Sibai BM (1990a) Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. 
Am J Obstet Gynecol 163:1049-1054; discussion 1054-1045. 
Sibai BM (1990b) Magnesium sulfate is the ideal anticonvulsant in preeclampsia-
eclampsia. Am J Obstet Gynecol 162:1141-1145. 
Sibai BM (2005) Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 
105:402-410. 
Sibai BM, Graham JM, McCubbin JH (1984a) A comparison of intravenous and 
intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol 
150:728-733. 
Sibai BM, Spinnato JA, Watson DL, Lewis JA, Anderson GD (1984b) Effect of 
magnesium sulfate on electroencephalographic findings in preeclampsia-
eclampsia. Obstet Gynecol 64:261-266. 
Siegel GJ (1999) Basic neurochemistry : molecular, cellular, and medical aspects, 6th 
Edition. Philadelphia: Lippincott Williams & Wilkins. 
Squires RF, Saederup E, Crawley JN, Skolnick P, Paul SM (1984) Convulsant potencies 
of tetrazoles are highly correlated with actions on 
85 
 
GABA/benzodiazepine/picrotoxin receptor complexes in brain. Life Sci 35:1439-
1444. 
Staff AC, Benton SJ, von Dadelszen P, Roberts JM, Taylor RN, Powers RW, Charnock-
Jones DS, Redman CW (2013) Redefining preeclampsia using placenta-derived 
biomarkers. Hypertension 61:932-942. 
Standley CA, Batia L, Yueh G (2006) Magnesium sulfate effectively reduces blood 
pressure in an animal model of preeclampsia. J Matern Fetal Neonatal Med 
19:171-176. 
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 
376:631-644. 
Stell BM, Brickley SG, Tang CY, Farrant M, Mody I (2003) Neuroactive steroids reduce 
neuronal excitability by selectively enhancing tonic inhibition mediated by delta 
subunit-containing GABAA receptors. Proc Natl Acad Sci U S A 100:14439-
14444. 
Stellwagen D, Beattie EC, Seo JY, Malenka RC (2005) Differential regulation of AMPA 
receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J 
Neurosci 25:3219-3228. 
Stence N, Waite M, Dailey ME (2001) Dynamics of microglial activation: a confocal 
time-lapse analysis in hippocampal slices. Glia 33:256-266. 
Stern MD (1975) In vivo evaluation of microcirculation by coherent light scattering. 
Nature 254:56-58. 
Stout C, Lemmon WB (1969) Glomerular capillary endothelial swelling in a pregnant 
chimpanzee. Am J Obstet Gynecol 105:212-215. 
86 
 
Szarka A, Rigo J, Jr., Lazar L, Beko G, Molvarec A (2010) Circulating cytokines, 
chemokines and adhesion molecules in normal pregnancy and preeclampsia 
determined by multiplex suspension array. BMC Immunol 11:59. 
Terry JB, Padzernik TL, Nelson SR (1990) Effect of LiCl pretreatment on 
cholinomimetic-induced seizures and seizure-induced brain edema in rats. 
Neuroscience letters 114:123-127. 
Thomas SV (1998) Neurological aspects of eclampsia. J Neurol Sci 155:37-43. 
Thomas SV, Somanathan N, Radhakumari R (1995) Interictal EEG changes in eclampsia. 
Electroencephalogr Clin Neurophysiol 94:271-275. 
Thoresen M, Henriksen O, Wannag E, Laegreid L (1997) Does a sedative dose of chloral 
hydrate modify the EEG of children with epilepsy? Electroencephalogr Clin 
Neurophysiol 102:152-157. 
Tonnesen J, Pryds A, Larsen EH, Paulson OB, Hauerberg J, Knudsen GM (2005) Laser 
Doppler flowmetry is valid for measurement of cerebral blood flow 
autoregulation lower limit in rats. Exp Physiol 90:349-355. 
Trogstad L, Magnus P, Stoltenberg C (2011) Pre-eclampsia: Risk factors and causal 
models. Best practice & research Clinical obstetrics & gynaecology 25:329-342. 
Ueno M (2007) Molecular anatomy of the brain endothelial barrier: an overview of the 
distributional features. Curr Med Chem 14:1199-1206. 




Urassa DP, Carlstedt A, Nystrom L, Massawe SN, Lindmark G (2006) Eclampsia in Dar 
es Salaam, Tanzania -- incidence, outcome, and the role of antenatal care. Acta 
obstetricia et gynecologica Scandinavica 85:571-578. 
van Veen TR, Panerai RB, Haeri S, Griffioen AC, Zeeman GG, Belfort MA (2013) 
Cerebral autoregulation in normal pregnancy and preeclampsia. Obstet Gynecol 
122:1064-1069. 
Van Wagenen G (1972) Vital statistics from a breeding colony. Reproduction and 
pregnancy outcome in Macaca mulatta. Journal of medical primatology 1:2-28. 
Vanderlelie J, Venardos K, Perkins AV (2004) Selenium deficiency as a model of 
experimental pre-eclampsia in rats. Reproduction 128:635-641. 
Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim 
KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, 
Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA (2006) Soluble 
endoglin contributes to the pathogenesis of preeclampsia. Nature medicine 
12:642-649. 
Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H, Farnot U, Bergsjo P, 
Bakketeig L, Lumbiganon P, Campodonico L, Al-Mazrou Y, Lindheimer M, 
Kramer M, World Health Organization Antenatal Care Trial Research G (2006) 
Preeclampsia, gestational hypertension and intrauterine growth restriction, related 
or independent conditions? Am J Obstet Gynecol 194:921-931. 
von Dadelszen P, Magee LA, Roberts JM (2003) Subclassification of preeclampsia. 
Hypertens Pregnancy 22:143-148. 
88 
 
Wahl M, Unterberg A, Baethmann A, Schilling L (1988) Mediators of blood-brain barrier 
dysfunction and formation of vasogenic brain edema. J Cereb Blood Flow Metab 
8:621-634. 
Wallis AB, Saftlas AF, Hsia J, Atrash HK (2008) Secular trends in the rates of 
preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. 
Am J Hypertens 21:521-526. 
Warrington JP, Fan F, Murphy SR, Roman RJ, Drummond HA, Granger JP, Ryan MJ 
(2014) Placental ischemia in pregnant rats impairs cerebral blood flow 
autoregulation and increases blood-brain barrier permeability. Physiological 
reports 2. 
Wiegman MJ, Zeeman GG, Aukes AM, Bolte AC, Faas MM, Aarnoudse JG, de Groot JC 
(2014) Regional distribution of cerebral white matter lesions years after 
preeclampsia and eclampsia. Obstet Gynecol 123:790-795. 
Williams K, Wilson S (1994) Maternal middle cerebral artery blood flow velocity 
variation with gestational age. Obstet Gynecol 84:445-448. 
Williams K, MacLean C (1994) Transcranial assessment of maternal cerebral blood flow 
velocity in normal vs. hypertensive states. Variations with maternal posture. J 
Reprod Med 39:685-688. 
Williams KP, McLean C (1993) Peripartum changes in maternal cerebral blood flow 
velocity in normotensive and preeclamptic patients. Obstet Gynecol 82:334-337. 
Wimmer MC, Artiss JD, Zak B (1986) A kinetic colorimetric procedure for quantifying 
magnesium in serum. Clinical chemistry 32:629-632. 
89 
 
Witlin AG, Sibai BM (1998) Magnesium sulfate therapy in preeclampsia and eclampsia. 
Obstet Gynecol 92:883-889. 
Witlin AG, Saade GR, Mattar F, Sibai BM (2000) Predictors of neonatal outcome in 
women with severe preeclampsia or eclampsia between 24 and 33 weeks' 
gestation. Am J Obstet Gynecol 182:607-611. 
Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA (1997) Estradiol increases 
the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated 
synaptic input: correlation with dendritic spine density. J Neurosci 17:1848-1859. 
Xiong X, Demianczuk NN, Saunders LD, Wang FL, Fraser WD (2002) Impact of 
preeclampsia and gestational hypertension on birth weight by gestational age. Am 
J Epidemiol 155:203-209. 
Yallampalli C, Garfield RE (1993) Inhibition of nitric oxide synthesis in rats during 
pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 
169:1316-1320. 
Yang GY, Betz AL, Chenevert TL, Brunberg JA, Hoff JT (1994) Experimental 
intracerebral hemorrhage: relationship between brain edema, blood flow, and 
blood-brain barrier permeability in rats. J Neurosurg 81:93-102. 
Zeeman G, Cipolla M, Cunningham G (2009) Cerebrovascular (patho) physiology in 
preeclampsia/eclampsia. Chesley's Hypertensive Disorders in Pregnancy, edited 
by Lindhiemer M, Roberts J, Cunningham G San Diego, CA: Elsevier:227-248. 
Zeeman GG, Hatab M, Twickler DM (2003) Maternal cerebral blood flow changes in 
pregnancy. Am J Obstet Gynecol 189:968-972. 
90 
 
Zeeman GG, Hatab MR, Twickler DM (2004a) Increased cerebral blood flow in 
preeclampsia with magnetic resonance imaging. Am J Obstet Gynecol 191:1425-
1429. 
Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG (2004b) Cerebral 
infarction in eclampsia. Am J Obstet Gynecol 190:714-720. 
Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative 








CHAPTER 2: EFFECT OF PREGNANCY AND NITRIC OXIDE ON 
THE MYOGENIC VASODILATION OF POSTERIOR CEREBRAL 












Abbie C. Chapman, Marilyn J. Cipolla, and Siu-Lung Chan 




Hemorrhage during parturition can lower blood pressure beyond the lower limit 
of cerebral blood flow (CBF) autoregulation that can cause ischemic brain injury. 
However, the impact of pregnancy on the lower limit of CBF autoregulation is unknown. 
We measured myogenic vasodilation, a major contributor of CBF autoregulation, in 
isolated posterior cerebral arteries (PCA) from nonpregnant and late-pregnant rats 
(n=10/group) while the effect of pregnancy on the lower limit of CBF autoregulation was 
studied in the posterior cerebral cortex during controlled hemorrhage (n=8). Pregnancy 
enhanced myogenic vasodilation in PCA and shifted the lower limit of CBF 
autoregulation to lower pressures. Inhibition of nitric oxide synthase (NOS) prevented the 
enhanced myogenic vasodilation during pregnancy but did not affect the lower limit of 
CBF autoregulation. The shift in the autoregulatory curve to lower pressures during 
pregnancy is likely protective of ischemic injury during hemorrhage and appears to be 











Cerebral blood flow (CBF) autoregulation is an intrinsic property of the brain that 
maintains relatively constant blood flow despite fluctuations in blood pressure (BP).1, 2 In 
normotensive adults, CBF autoregulation operates within the arterial pressure range of ~ 
60 to 160 mmHg, outside of which autoregulation is lost and CBF becomes dependent on 
pressure in a linear fashion.2-5 A drop in BP within this autoregulatory range results in 
insignificant clinical symptoms as brain perfusion is maintained by autoregulatory 
mechanisms.2 However, when BP falls below the lower limit of CBF autoregulation, 
CBF decreases with pressure, potentially causing loss of consciousness and hypoxic-
ischemic brain injury.6-8 During pregnancy, hemorrhage occurs with parturition. In some 
pregnancies, hemorrhage may be severe (> 1500 mL blood loss) and cause an acute drop 
in maternal BP potentially below the lower limit of CBF autoregulation.9-11 However, 
whether pregnancy alters the lower limit of CBF autoregulation is not known, but is 
important to understand. For example, a shift in CBF autoregulation to lower pressures 
during pregnancy may be protective of the brain, allowing maintenance of blood flow in 
the face of acute hypotension. Alternatively, a shift of the lower limit of CBF 
autoregulation to higher pressures could increase the susceptibility of the brain to injury 
during parturition. 
The myogenic response of cerebral arteries and arterioles is a major contributor to 
CBF autoregulation.12 Myogenic vasodilation occurs as BP decreases, contributing to the 
maintenance of blood flow to the brain.5 If BP decreases below the lower limit of CBF 
autoregulation, maximal dilation of cerebral vessels occurs and this vascular contributor 
to CBF autoregulation becomes insufficient to maintain brain perfusion.8 Several 
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mechanisms may be involved in the relaxation of vascular smooth muscle (VSM) to 
decreased intravascular pressure, including endothelial vasodilators such as nitric oxide 
(NO).13, 14 Pregnancy has been shown to increase expression of endothelial-NO synthase 
(eNOS) in several vascular beds.15, 16 However, the involvement of NO in the myogenic 
vasodilatory response of cerebral arteries and CBF autoregulation during pregnancy has 
yet to be investigated. 
In the present study, in-vitro methodology was used to investigate the myogenic 
vasodilatory response to decreased intravascular pressure of posterior cerebral arteries 
(PCA) from nonpregnant (NP) and late-pregnant (LP) rats. The contribution of NO to 
myogenic vasodilation during pregnancy was also assessed. We found that pregnancy 
enhanced myogenic vasodilation in response to decreased pressure that was NO-
dependent. To test if this enhanced myogenic vasodilation translates to a shift of CBF 
autoregulation, the effect of pregnancy on the lower limit of CBF autoregulation was 
measured using an in-vivo model of hemorrhagic hypotension and measuring changes of 
CBF in the posterior cerebral cortex. We further investigated the role of NO on CBF 
autoregulation during acute hypotension by infusing a NOS inhibitor. 
 
Materials and Methods 
Animal model. All experiments were conducted using virgin NP female (14-16 
weeks) or timed-pregnant Sprague Dawley rats (Charles River, Canada). Rats were 
housed individually in the University of Vermont Animal Care Facility. NP females were 
chosen randomly and timed-pregnant rats were studied during LP on days 19 - 21 of a 22 
day gestation. All procedures were approved by the Institutional Animal Care and Use 
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Committee and conducted in accordance with the National Institute of Health Guide for 
the Care and Use of Laboratory Animals. 
Isolated Vessel Preparation and Pressurized Arteriograph System. NP and LP 
animals were anesthetized with isoflurane (3 % in oxygen) and decapitated. Brains were 
promptly removed and placed in cold, oxygenated physiological saline solution (PSS). 
PCA were carefully dissected and cleared of connective tissue. Third-order PCA were 
mounted and secured onto glass cannulas in an arteriograph chamber as previously 
described.17 Briefly, the proximal cannula was connected to an in-line pressure transducer 
and a servo-null pressure control system (Living Systems Instrumentation, Inc., 
Burlington, VT).  The distal cannula remained closed throughout the experiment to avoid 
flow-mediated responses. Vessel diameters were measured via video microscopy. PSS 
was aerated with 5 % CO2, 10 % O2, and 85 % N2 to maintain pH at 7.40 ± 0.05. 
Temperature within the arteriograph chamber was maintained at 37.0 ± 0.1 o C 
throughout the experiments.  
 Determination of myogenic vasodilation in isolated PCA. Vessels were 
equilibrated at 50 mmHg for 1 hour, after which pressure was increased to 125 mmHg in 
25 mmHg increments to allow for tone development. Myogenic vasodilation was 
measured by decreasing pressure from 125 to 5 mmHg in a step-wise manner and 
recording active luminal diameter at each pressure once stable. Myogenic vasodilation 
was measured in PCA from NP and LP rats in PSS alone (n=10/group) and in the 
presence of the NOS inhibitor Nω –nitro-L-arginine (L-NNA, 0.1 mM, n=7/group). 




In-vivo measurement of CBF during hemorrhagic hypotension in the posterior 
cerebral cortex. A separate set of NP and LP rats (n=8/group) were anesthetized initially 
with isoflurane (3% in O2), which was then lowered to 1.5 – 2.0 % in O2 for 
instrumentation and tracheostomy. Anesthesia was then shifted to intravenous injections 
of chloral hydrate (200 mg/kg, left femoral vein). Animals were mechanically ventilated 
to maintain blood gases and pH within normal physiological ranges (Table 1). Body 
temperature was monitored and maintained with a heating pad at 37 o C throughout the 
experiment. CBF was measured and recorded transcranially using laser Doppler 
flowmetry as previously described.18 The left side of the medioposterior skull was 
exposed and a laser Doppler probe was affixed over a thinned area 2 mm lateral to the 
sagittal suture and 1 mm anterior to the lambdoid suture to measure CBF in the PCA 
territory. Both femoral arteries were cannulated to measure arterial blood pressure via a 
pressure transducer (Living Systems Instrumentation, Inc., Burlington, VT), and to obtain 
blood samples for blood gas measurements and controlled blood withdrawal. Blood was 
slowly withdrawn through the femoral catheter at a steady rate (0.67 - 0.69 ml/min) to 
gradually decrease arterial blood pressure from 100 mmHg to 30 mmHg. The lower limit 
of CBF autoregulation was defined as the arterial pressure at which CBF decreased by 20 
% from baseline.19, 20  
 A separate set of LP animals (n=7) underwent the same instrumentation as 
described above, with the addition of cannulation of the right femoral vein for the 
infusion of  the NOS inhibitor Nω –nitro-L-arginine methyl ester hydrochloride (L-
NAME, 10 mg/kg/min, 3 min). After drug infusion, controlled blood withdrawal was 
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performed in the same manner as described above and the lower limit of CBF 
autoregulation was determined as stated above. 
Real-time quantitative PCR of eNOS in pial arteries. A separate group of NP 
(n=5) and LP (n=4) rats were used for the isolation of arteries for real-time qPCR for 
eNOS. PCA segments from both right and left sides of the brain were pooled from each 
animal. RNA was extracted using Trizol reagent (Life Technologies) followed by 
purification using an RNeasy Micro Kit (Qiagen) per manufacturers’ protocols. RNA 
concentrations and quality were determined using an Agilent Bioanalyzer (Agilent). Real 
time qPCR was performed in a two step process. Total RNA was reverse transcribed 
using a mix of oligo dTs and random primers using the iScript cDNA Synthesis Kit 
(Biorad).  For each sample, cDNA was used to amplify the target gene eNOS and two 
housekeeping genes: Hprt1 and Ywhaz.  One microliter of cDNA was used per reaction 
with 150 nM of the forward and reverse primers (eNOS: forward 
CCTGAGCAGCACAAGAGTTACAA, reverse GGAGCCCAGCCCAAACACA; Hprt1: 
forward CTCATGGACTGATTATGGACAGGAC, reverse 
GCAGGTCAGCAAAGAACTTATAGCC; and ywhaz: forward 
GATGAAGCCATTGCTGAACTTG, reverse GTCTCCTTGGGTATCCGATGTC) and 
12.5 µl of Power Sybrgreen Master mix (Life Technologies) in a 25 µl reaction. Primers 
were designed by the Obstetrics and Gynecology Departmental Molecular Core Facility 
at the University of Vermont using PrimerSelect (DNASTAR). The reactions were 
performed using an initial denaturation of 3 minutes at 95 ° C, 40 cycles of 15 seconds at 
95 ° C and 60 seconds at 60 ° C followed by a melt curve analysis to ensure only the 
correct product was amplified. One set of PCR products for each gene were checked for 
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correct size on a 2 % agarose gel. Each sample was run in triplicate on the ABI 7000 
Sequence Detection System (ABI). Negative water controls were run for each primer set 
in the real time PCR reaction to ensure no contamination in the reagents as well as no 
secondary primer structures were amplified. Primers were designed over an exon-exon 
junction or the amplicon was designed to span an exon-exon junction to ensure genomic 
DNAwas not amplified. Relative expression was calculated using the 2 -ΔΔCT method.21   
Drugs and Solutions. All experiments were conducted using a bicarbonate-based 
PSS containing (mmol/L): NaCl 119.0, NaHCO3 24.0, KCl 4.7, KH2PO4 1.18, MgSO4 · 
7H2O 1.17, CaCl2 1.6, and EDTA 0.026. PSS was made and stored without glucose at 4 o 
C; glucose (5.5 mmol/L) was added to the PSS prior to each experiment. Zero calcium 
PSS was made similarly, omitting the addition of CaCl2. L-NNA and L-NAME were 
purchased from Sigma-Aldrich (St. Louis, MO). L-NNA was made weekly in a 0.01 mM 
stock solution and stored at 4 o C. L-NAME was made fresh daily at 40 mg/ml in sterile 
lactated ringers solution. 
Data Calculations and Statistical Analysis. Results are presented as mean ± SEM. 
Percent tone of isolated arteries was calculated at 100 mmHg and after addition of L-
NNA as the percent decrease in active luminal diameter from the passive diameter by the 
equation: [ 1 – (diameteractive / diameterpassive)] x 100 %, where diameteractive is luminal 
diameter in PSS with or without L-NNA and diameterpassive is maximum luminal diameter 
in zero calcium PSS. To determine the pressure at which diameters of PCA from NP and 
LP rats differed from baseline of 125 mmHg, repeated measures ANOVA with a post-hoc 
Bonferroni test was used. Differences in diameters between the presence and absence of 
L-NNA were determined using Student’s unpaired t-test. The lower limit of CBF 
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autoregulation, defined as when CBF decreased 20 % from baseline, was determined 
from the laser Doppler traces for each animal. Differences in the percent change in CBF 
during hemorrhagic hypotension and between the pressure at which the lower limit of 
CBF autoregulation was reached between NP and LP, and LP and LP+L-NAME animals 
were determined using Student’s unpaired t-test. Differences were considered significant 
at p < 0.05. 
 
Results 
Myogenic vasodilation in response to decreased intravascular pressure in PCA 
from NP and LP rats. We sought to determine the effect of pregnancy on the myogenic 
vasodilatory response of PCA to decreased intraluminal pressure. We used PCA because 
they are the main blood supply to the posterior cortex.22 PCA from NP and LP animals 
developed similar myogenic tone at 100 mmHg (33.8 ± 2.3 % and 33.7 ± 1.5 %; ns). 
When intravascular pressure was decreased, luminal diameter of PCA from NP and LP 
rats remained relatively unchanged until ~ 60 mmHg (Figure 1A). As intravascular 
pressure was lowered below 60 mmHg, myogenic vasodilation occurred in PCA from 
both NP and LP animals. However, PCA from LP rats had significantly greater dilation 
compared to NP rats when pressure was lowered between 50 – 30 mmHg. The diameter 
of PCA from LP rats was significantly greater than baseline diameter (183 ± 8 µm at 50 
mmHg vs. 147 ± 5 µm at 125 mmHg; p < 0.05). In contrast, arteries from NP rats dilated 
less in response to decreased intravascular pressure, with luminal diameter never 
becoming statistically significantly different compared to baseline at any pressure (Figure 
1A). Below 30 mmHg, the diameter of PCA from both NP and LP animals passively 
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decreased with pressure. Figure 1B shows that there was no difference in passive 
diameters of PCA from either group at any pressure studied, suggesting the difference in 
the magnitude of myogenic vasodilation between the groups was due to a difference in 
active vasodilation and not structural remodeling. Thus, the magnitude of the myogenic 
vasodilation in response to decreased pressure was greater in PCA from LP compared to 
NP rats.  
Effect of NOS inhibition on myogenic vasodilation to decreased pressure. As 
greater myogenic vasodilation occurred in PCA from LP compared to NP rats, we 
investigated NO as an underlying mechanism by which pregnancy increases myogenic 
vasodilation in PCA by inhibiting NOS with L-NNA and measuring myogenic 
vasodilation. Addition of L-NNA caused similar constriction of PCA from both groups of 
animals and the percent tone with NOS inhibition at 100 mmHg was similar between 
PCA from NP and LP animals (52.1 ± 3.4 % and 51.8 ± 3.2 %; ns). In PCA from NP rats 
treated with L-NNA, vasodilation occurred and diameters were similar to PCA in PSS 
alone when pressure was decreased, becoming significantly greater than baseline at 60 
mmHg (176 ± 20 µm at 60 mmHg vs. 105 ± 7 µm at 125 mmHg; p < 0.05; Figure 2A). In 
contrast, vasodilation of PCA from LP rats was markedly reduced with NOS inhibition 
(Figure 2B). The diameters of L-NNA treated vessels from LP animals were smaller than 
those in PSS alone (p < 0.01; Figure 2B). Despite this, luminal diameter of L-NNA 
treated PCA from LP rats still became significantly greater than baseline at 50 mmHg 
(140 ± 20 µm at 50 mmHg vs. 93 ± 8 µm at 125 mmHg; p < 0.05; Figure 2B).  
Figure 2C compares vasodilation of PCA with L-NNA treatment from NP and LP 
rats. Vessels from both groups of animals underwent similar vasodilation with NOS 
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inhibition as pressure was decreased. However, the dilation was shifted to lower pressure 
in PCA from LP compared to NP rats. When pressure was lowered to 70 mmHg the 
diameter of PCA from LP rats was significantly smaller than the diameter of PCA from 
NP rats (88 ± 8 µm vs. 148 ± 22 µm, respectively; p < 0.05; Figure 2C). Thus, NOS 
inhibition prevented the greater myogenic vasodilation of PCA from LP compared to NP 
rats from occurring without eliminating myogenic vasodilation all together, and it shifted 
the dilation of PCA from LP rats leftward compared to PCA from NP rats. 
The results above suggest that enhanced vasodilation of PCA from LP rats was 
NO-dependent. To determine if this was due to an affect of pregnancy on eNOS 
expression, real time qPCR was performed on PCA from both groups of animals. There 
were no differences in relative quantity (RQ) of mRNA expression of eNOS between 
PCA from NP and LP rats (0.86 ± 0.25 vs. 1.02 ± 0.27; ns; Figure 2D). These results 
suggest that greater vasodilation of PCA from LP compared to NP rats via NO was not 
due to changes in mRNA expression of eNOS during pregnancy.  
CBF autoregulation during acute hypotension in NP and LP rats. The myogenic 
response of cerebral arteries is a main contributor to CBF autoregulation.12 Since we 
found that enhanced myogenic vasodilation in response to decreased pressure during 
pregnancy was NO-dependent, we sought to determine the effect of pregnancy on the 
lower limit of CBF autoregulation and investigate the role of NOS in CBF autoregulation 
during acute hypotension. Table 1 shows the physiological parameters of all groups of 
animals used. Importantly, arterial pH and arterial gasses that can affect CBF were within 
physiological ranges and were not different between groups.  
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Figures 3A & B show the effect of pregnancy on CBF autoregulation during 
hemorrhagic hypotension in the posterior cortex. Baseline BPs were similar between LP 
and NP rats (100.1 ± 0.2 mmHg vs. 100.0 ± 0.3 mmHg; ns) prior to controlled blood 
withdrawal. The autoregulatory curve was shifted leftward to lower pressures in LP 
compared to NP animals during hemorrhagic hypotension (Figure 3A). The lower limit of 
CBF autoregulation was significantly lower in LP vs. NP rats (Figure 3B). To determine 
the role of NO in the pregnancy-specific leftward shift in CBF autoregulation, L-NAME 
was infused into LP rats and the autoregulatory curve determined. Figures 3C & D show 
the effect of acute NOS inhibition during pregnancy on CBF autoregulation and its lower 
limit during hemorrhagic hypotension, respectively. NOS inhibition caused a rise in BP, 
which has been previously shown,23, 24 with the BP of LP rats infused with L-NAME 
being 115.1 ± 2.0 mmHg prior to blood withdrawal. Despite this baseline increase in BP 
with L-NAME infusion, CBF was maintained similarly between LP rats with and without 
NOS inhibition during hemorrhagic hypotension (Figure 3C). The lower limit of CBF 
autoregulation was also unaffected by acute NOS inhibition during pregnancy (Figure 
3D). Thus, it appears that pregnancy shifts the autoregulatory curve leftward to lower 
pressures, and that this is unaffected by acute NOS inhibition.  
 
Discussion 
In the present study, we investigated the effect of pregnancy and NOS inhibition 
on the myogenic vasodilatory response of PCA to decreased intravascular pressure and 
the lower limit of CBF autoregulation. PCA from LP rats dilated to a greater extent in 
response to decreased pressure compared to PCA from NP rats that was NO-dependent. 
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However, L-NNA did not prevent myogenic vasodilation from occurring in PCA from 
either NP or LP rats, but it eliminated the pregnancy-specific enhancement of 
vasodilation, causing the magnitude of dilation of PCA from NP and LP rats to be 
similar. Using an animal model of controlled hemorrhage, we found that pregnancy 
caused a leftward shift in the CBF autoregulatory curve during acute hypotension, with 
the lower limit being reached at significantly lower pressures compared to the NP state. 
We hypothesized this was due to the enhanced vasodilatory response to decreased 
pressure seen in PCA of LP rats, however, acute NOS inhibition in pregnancy did not 
affect the lower limit of CBF autoregulation. These results suggest that CBF 
autoregulation is more effective in pregnancy during hemorrhagic hypotension, but that 
this shift in the lower limit of the CBF autoregulatory curve to lower pressure is not due 
to NO.  
NO appears to be responsible for the enhanced vasodilation of PCA from LP 
compared to NP rats. There are at least three possibilities by which NO may be affecting 
vasodilation during pregnancy. First, expression of eNOS could be increased in PCA 
during pregnancy, although this is unlikely as no difference in mRNA expression was 
seen in PCA from NP and LP rats. Second, pregnancy could enhance the sensitivity of 
VSM to NO. However, a previous study showed no differences in VSM sensitivity to the 
NO donor sodium nitroprusside between PCA from NP and LP rats.17 Finally, the activity 
of eNOS could be increased in endothelium from pregnant animals as intravascular 
pressure was lowered. Changes in phosphorylation of eNOS during pregnancy could 
change the activity of NO and increase NO production.25 In addition, the role of NO in 
myogenic vasodilation appeared to be pressure-dependent because there was no 
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difference in the magnitude of constriction of PCA with NOS inhibition between NP and 
LP rats at a constant pressure, as has also been shown previously.26 Pregnancy increases 
flow-mediated vasodilation in an NO-dependent manner in mesenteric arteries from rats 
27, 28 and subcutaneous arteries from humans.29 Thus, it is possible that changes in 
response to shear stress during decreased intravascular pressure are responsible for 
increasing NO in PCA from LP rats.  
To our knowledge, this is the first study investigating the effect of pregnancy on 
CBF autoregulation during acute hypotension and the involvement of NOS in the 
pregnant state. NOS inhibition did not alter the lower limit of CBF autoregulation 
although it inhibited pregnancy-specific enhancement of myogenic vasodilation in 
response to decreased pressure. Thus, the response of an isolated cerebral artery may not 
be indicative of what is occurring during hemorrhagic hypotension that encompasses the 
entire brain. Our previous study showed that, in pregnancy, brain parenchymal arterioles 
are significantly larger than in the NP state, an effect that may also contribute to more 
effective CBF autoregulation when upstream pial vessels are dilated.44 Thus, it is possible 
that even when the NO-dependent enhancement of myogenic vasodilation of PCA in 
pregnancy was inhibited, CBF was better maintained in pregnancy during acute 
hypotension due to the vasodilation that was occurring in upstream vessels, coupled with 
structurally larger downstream arterioles. 
Our findings of NOS inhibition having no effect on the lower limit of the 
autoregulatory curve are in accordance with other studies utilizing systemic NOS 
inhibition in the investigation of the role of NO in the lower limit of CBF 
autoregulation.30-33 In fact, the involvement of NO in CBF autoregulation is controversial, 
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with several studies showing contrasting findings.23, 24, 30-36 It is possible that differences 
in methodology, such as the method that hypotension is induced, may play a role in the 
outcome of a study. Our result agrees with others when hypotension was induced by 
hemorrhage, but not by ganglionic blockade or administration of a potassium channel 
activator.24 Another previous study used similar methodology as the present study and 
found intravenous infusion of a NOS inhibitor shifted the lower limit of CBF 
autoregulation to higher pressure.23 However, NOS inhibition raised BP in the present 
study to 115 mmHg, compared to over 150 mmHg in the previous study.23 Therefore, it is 
possible that the difference between the two findings is due to the greater acute increase 
in BP upon NOS inhibition. It should be noted that the rise in BP in our study confirmed 
that eNOS was indeed inhibited by L-NAME infusion. However, it is possible that a 
greater degree of inhibition would have produced a shift in the autoregulatory curve seen 
in other studies. 
Despite evidence for NO having no role in the low end of CBF autoregulation 
with i.v. infusion of a NOS inhibitor,24, 30-33 including our findings in the present study, 
other studies have identified a role of NO in the lower limit of CBF autoregulation when 
the NOS inhibitor was suffused over the cortex.35, 36 L-NAME suffusion over a cranial 
window both raised the lower limit of CBF autoregulation and depressed the height of the 
CBF autoregulatory curve.35, 36 In addition to eNOS, neuronal NOS (nNOS) contributes 
to CBF autoregulation and increases NO production during hypotension-induced 
hypoxia, effectively dilating cerebral vessels.37, 38 nNOS mRNA and protein levels are 
increased in the hypothalamus of pregnant rats15 suggesting that pregnancy increases 
nNOS in some brain regions. Although our recent study determined there were no 
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changes in nNOS mRNA expression in the posterior cortex between NP and LP rats, 
activity of nNOS was not measured and may be increased during pregnancy.39 These data 
support the idea that changes in NO production by increased activation of nNOS during 
acute hypotension in pregnancy could contribute to the leftward shift of the CBF 
autoregulatory curve seen in LP rats. As inhibition of nNOS appears to take substantially 
longer time to achieve than that of eNOS,35 it is possible that nNOS was not inhibited in 
the present study due to the acute nature of the L-NAME infusion. Therefore, it is 
possible that NO derived from nNOS was still maintaining CBF in the face of acute 
hypotension. 
In this study, we investigated the myogenic component of CBF autoregulation. 
However, there are other contributors to CBF autoregulation, including metabolic and 
neuronal influences in addition to myogenic responses of VSM of cerebral arteries and 
arterioles.2, 8 Oxygen metabolism of the pregnant brain has been found to be similar to 
that of NP brain, thus this is unlikely to be contributing to the shift in the autoregulatory 
curve.40 Pregnancy-induced changes in neuronal contributors, such as nNOS as 
previously discussed, may be contributing to the leftward shift of the autoregulatory 
curve. The baroreceptor reflex also influences CBF autoregulation during increases in 
BP, with its disruption extending the autoregulatory curve surpassing the pressure at 
which autoregulatory breakthrough would normally occur.41 The baroreflex stimulates 
sympathetic fibers which have been shown to affect CBF autoregulation during acute 
hypotension as well.42 Both alpha-adrenergic blockade as well as sympathectomy shifts 
the lower limit of CBF autoregulation leftward to lower pressures.6, 42, 43 A recent study 
by our group measured perivascular sympathetic fiber density of PCA of NP and LP rats 
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and found that pregnancy did not affect innervation of PCA; however, nerve activity was 
not measured.39 Thus, pregnancy-induced attenuation of the baroreflex44, 45 may be partly 
responsible for the left-ward shift of the lower limit of CBF autoregulation seen in LP 
rats by decreasing activity of sympathetic nerves that innervate PCA.  
In summary, investigation of the myogenic vasodilation to decreased intravascular 
pressure of PCA revealed greater dilation in vessels from pregnant rats that was NO-
dependent. Pregnancy improved CBF autoregulation during hemorrhagic hypotension by 
shifting the lower limit of CBF autoregulation leftward in the posterior cortex, which 
remained unaffected by acute NOS inhibition. This leftward shift in CBF autoregulation 
in the posterior cortex during pregnancy may be a protective mechanism by which the 
maternal brain is better prepared to maintain CBF in the face of acute hypotension that 
can occur during parturition.  
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Table 1: Physiological parameters of nonpregnant (NP), late-pregnant (LP) and LP 
rats infused with L-NAME during hemorrhagic hypotension to assess the lower 
limit of CBF autoregulation. 
 
 
   NP  (n=8)          LP (n=8)     LP+L-NAME (n=7)
Weight (g) 342 ± 6 442 ± 11 389 ± 12 
Arterial pH 7.40 ± 0.01 7.33 ± 0.01 7.42 ± 0.01 
Arterial pCO2 40.1 ± 1.6 40.3 ± 1.5 40.2 ± 1.4 










Figure 1.  Impact of pregnancy on myogenic vasodilation to decreased pressure in 
posterior cerebral arteries (PCA). (A) Graph showing active pressure-diameter 
relationship in PCA from nonpregnant (NP) and late-pregnant (LP) rats.  Note that 
greater myogenic vasodilation was seen in PCA from LP animals, with diameters 
becoming statistically greater than baseline at 50, 40 and 30 mmHg. (B) Graph showing 
passive pressure-diameter relationship in PCA from NP and LP rats. There was no 
difference in passive diameters between PCA from NP and LP rats at any pressure 






Figure 2. Role of nitric oxide synthase (NOS) inhibition on myogenic vasodilation of 
posterior cerebral arteries (PCA) during pregnancy. Graphs showing active pressure-
diameter relationships of  PCA from (A) nonpregnant (NP) and (B) late-pregnant (LP) 
animals in the presence or absence of the NOS inhibitor L-NNA. (C) Graph comparing 
the effect of NOS inhibition on myogenic vasodilation in PCA from NP and LP rats. 
Despite NOS inhibition, PCA from NP and LP rats had substantial myogenic vasodilation 
in response to decreased pressure. (D) Relative eNOS mRNA expression in PCA from 
NP and LP rats. There was no difference between eNOS expression in cerebral arteries 
from NP and LP rats.  * p < 0.05 vs. baseline by repeated measures ANOVA; HH p < 





Figure 3. Effect of pregnancy on the lower limit of cerebral blood flow 
autoregulation. (A) Graph showing changes of CBF during hemorrhagic hypotension in 
the posterior cerebral cortex of nonpregnant (NP) and late-pregnant (LP) rats, and (B) the 
lower limit of CBF autoregulation in NP and LP rats during hypotension.  (C) Graph 
showing the effect of acute NOS inhibition on changes in CBF during hemorrhagic 
hypotension in the posterior cerebral cortex in LP rats only, and (D) the lower limit of 
CBF autoregulation in LP rats with and without NOS inhibition. The lower limit is 
indicated by the dotted line and defined as the pressure at which CBF decreased to 20% 
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Eclampsia, clinically defined as unexplained seizure in a woman with preeclampsia, is a 
life threatening complication unique to the pregnant state. However, a subpopulation of 
women with seemingly uncomplicated pregnancies experience de novo seizure without 
preeclamptic signs or symptoms, suggesting pregnancy alone may predispose the brain to 
seizure. Here, we hypothesized that normal pregnancy lowers seizure threshold and 
investigated mechanisms by which pregnancy may affect seizure susceptibility, including 
neuroinflammation and plasticity of gamma-aminobutyric acid type A receptor 
(GABAAR) subunit expression. Seizure threshold was determined by quantifying the 
amount of pentylenetetrazole (PTZ) required to elicit electrical seizure in Sprague 
Dawley rats that were either nonpregnant (Nonpreg, n=7) or pregnant (Preg; d20, n=6). 
Seizure-induced vasogenic edema was also measured. Further, the basal activation state 
of microglia, a measure of neuroinflammation (n=6-8/group), and GABAAR δ-subunit 
(GABAAR-δ) protein expression (n=3/group) in the cerebral cortex were determined as 
underlying contributors to changes in seizure threshold. Seizure threshold was lower in 
Preg compared to Nonpreg rats (36.7±9.6 vs. 65.0±14.5 mg/kg PTZ; p<0.01) that was 
associated with greater vasogenic edema formation (78.55±0.11 vs. 78.04±0.19 % water; 
p<0.05). The % of active microglia was similar between groups; however, pregnancy was 
associated with downregulation of GABAAR-δ in the cerebral cortex. Overall, pregnancy 
appears to be a state of increased seizure susceptibility that is not due to 
neuroinflammation, but rather is associated with reduced expression of GABAAR-δ and 
greater edema. Understanding neurophysiological changes occurring in normal 
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pregnancy could allow for better prevention and management of de novo seizure, 




 Preeclampsia, defined as the new onset of hypertension and proteinuria after the 
20th week of gestation, is a life-threatening complication of pregnancy that afflicts 1-7% 
of all pregnancies [1-4]. Numerous organs are affected by preeclampsia, including the 
brain in the form of eclampsia [5-9]. Eclampsia is the appearance of unexplained seizure 
in a woman with preeclampsia and is one of the most dangerous complications of 
pregnancy [4]. Eclampsia is a leading cause of maternal and fetal morbidity and mortality 
worldwide that accounts for greater than 50,000 maternal deaths each year [6,7,10]. 
While eclampsia by definition is restricted to women with preeclampsia, seizure during 
pregnancy does not appear to be a progression from severe preeclampsia to eclampsia 
[11-13]. In fact, de novo seizure has been reported to occur in 38-60% of seemingly 
uncomplicated pregnancies, without hypertension and proteinuria, or the diagnosis of 
preeclampsia [11]. The finding that de novo seizure occurs in the absence of 
preeclampsia suggests that pregnancy alone may be a state of increased seizure 
susceptibility. In addition, women who develop eclampsia are by definition normotensive 
and asymptomatic prior to pregnancy, with no known underlying conditions contributing 
to seizure onset, supporting the concept that pregnancy alone may predispose the brain to 
seizure independently of preeclampsia. 
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 It is well-established that fluctuations in neurosteroids occur during the menstrual 
cycle, and to a greater extent during pregnancy, that can affect neuronal excitability [14-
16]. Specifically, increases in progesterone metabolites, including allopregnanolone, act 
as positive allosteric modulators of gamma-aminobutyric acid type A receptors 
(GABAARs), the main inhibitory neurotransmitter receptors in the brain, and decrease 
neuronal excitability [16]. GABAARs consist of several subunits, however, the main 
binding site and therefore site of action of allopregnanolone is on the δ-subunit [17]. δ-
subunit-containing GABAARs (GABAAR-δ) are located extrasynaptically and are 
involved in tonic inhibition throughout the brain [16]. A delicate balance of excitatory 
and inhibitory inputs maintains neuronal excitability of the brain, and alterations in 
excitatory/inhibitory receptor expression can result in a hyperexcitable or hyperinhibited 
state. Neuroactive steroids such as allopregnanolone reduce neuronal excitability 
selectively through actions at GABAAR-δ and cause their downregulation [16,17]. 
Plasticity of the δ-subunit of GABAARs occurs in the brain during pregnancy, and is an 
adaptation that likely functions to maintain a steady state of excitability in the face of 
increased neurosteroids [17,18]. In fact, brain slices from pregnant mice were found to be 
hyperexcitable due to the downregulation of the δ-subunit that was normalized by the 
presence of allopregnanolone [18]. While these in-vitro studies suggest that the brain is 
hyperexcitable during pregnancy, it is less clear if the brain is more susceptible to seizure 
under normal physiological conditions of pregnancy where naturally circulating 
neurosteroids are present.  
One mechanism by which brain excitability may be affected during pregnancy is 
through peripheral inflammation. Pregnancy is considered a state of mild peripheral 
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inflammation and peripheral inflammation has been shown to cause neuroinflammation 
through the activation of microglia, the resident immune cells in the brain [19,20]. When 
microglia become active, they aid in clearance of debris and play a reparative role in the 
brain (M2); however, for unknown reasons they can become cytotoxic (M1) [21]. M1 
microglia secrete proinflammatory cytokines such as tumor necrosis factor alpha (TNFα) 
and increase local neuronal excitability by simultaneously promoting the endocytosis of 
GABAARs and exocytosis of excitatory α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors [20,22]. In fact, neuroinflammation has 
recently been shown to be present in a rat model of preeclampsia that was associated with 
decreased seizure threshold [23]. Whether neuroinflammation is present during normal 
pregnancy is unknown, however, it may be one mechanism by which the pregnant state is 
more susceptible to seizure. We hypothesized that pregnancy is a state of increased 
seizure susceptibility due to decreased expression of GABAAR-δ and/or 
neuroinflammation that acts to lower seizure threshold.  
 Onset of eclampsia may also be related to loss of cerebral blood flow 
autoregulation and decreased cerebrovascular resistance that increases pressure on the 
microcirculation and subsequent vasogenic edema formation [24]. In fact, vasogenic 
edema is present in ~ 90 % of women with eclampsia, as assessed by diffusion weighted 
MRI [25,26]. However, it is difficult to determine if edema is present prior to seizure and 
contributes to the occurrence of eclampsia because seizure itself causes blood-brain 
barrier (BBB) disruption and edema formation [27-30]. Further, vasogenic edema 
formation occurs to a greater extent during pregnancy under pathologic conditions such 
as acute hypertension, suggesting pregnancy predisposes the brain to edema [31,32]. 
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Thus, we hypothesized that the maternal brain is more susceptible to seizure-induced 
vasogenic edema formation than in the nonpregnant state. Understanding if the maternal 
brain is more susceptible to seizure-induced edema may lead to a greater understanding 
of the pathophysiological process of de novo seizure during pregnancy. Further, 
investigating seizure susceptibility during normal pregnancy and underlying mechanisms 
by which pregnancy may affect seizure threshold may shed light on the contribution of 
pregnancy-induced neurophysiological changes to de novo seizure in the absence of 




Animals and ethics statement 
All experiments were conducted using virgin, nonpregnant (Nonpreg) or timed-pregnant 
(Preg) Sprague Dawley rats that were 14-16 weeks old (Charles River, Canada). Pregnant 
rats were used experimentally late in gestation (day 20 of a 22 day gestation), a time 
point when eclampsia occurs most often [12]. All rats were housed singly in the 
University of Vermont Animal Care Facility, an Association for Assessment and 
Accreditation of Laboratory Animal Care International accredited facility. All procedures 
were approved by the Institutional Animal Care and Use Committee and conducted in 
accordance with the National Institute of Health Guide for the Care and Use of 





Measurement of seizure threshold, susceptibility and severity, and brain water content 
Rats that were Nonpreg (n = 9) or Preg (n = 9) were anesthetized initially with isoflurane 
(1 – 3 % in oxygen) for intubation, electrode placement and instrumentation. Animals 
were mechanically ventilated to maintain blood gases and pH within normal 
physiological ranges. Body temperature was monitored with a rectal thermometer and 
maintained with a heating pad at 37 oC throughout the experiment. The dorsal surface of 
the head was shaved to expose the scalp and silver subdermal corkscrew electrodes 
(Ambu, Glen Burnie, MD) were implanted under the scalp and secured in place with 
collodion glue. Electroencephalography (EEG) was recorded unipolarly using a MP150 
acquisition system (BIOPAC System Inc., Goleta, CA) to monitor generalized seizure, as 
previously described [23]. After placement of electrodes, animals were placed in supine 
position for placement of venous and arterial catheters. Femoral arteries were cannulated 
to obtain blood samples for blood gas measurements and continuous measurement of 
arterial blood pressure via a pressure transducer (BIOPAC Systems Inc., Goleta, CA). 
Femoral veins were cannulated for administration of the anesthetic chloral hydrate and 
infusion of the chemoconvulsant pentylenetetrazole (PTZ). PTZ was used because it 
reliably elicits seizure through antagonistic actions at GABAARs. After instrumentation, 
animals were tapered off isoflurane and anesthesia maintained by continuous intravenous 
infusion of chloral hydrate (41.5 mg / mL in Nonpreg, 50 mg / mL in Preg; 30 µL / min) 
and seizure threshold measured as previously described [23]. Chloral hydrate was used 
because it is thought to not depress neural function, and is the preferred anesthetic for 
studies measuring EEG [33,34]. Seizure threshold was calculated as the amount of PTZ 
(mg/kg) required to elicit electrical seizure: Tinfusion * Rinfusion * [PTZ] / bw where Tinfusion 
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is the time of infusion in min, Rinfusion is the rate of infusion in mL/min, [PTZ] is the 
concentration of PTZ in mg/mL, and bw is the body weight in kg. Seizure susceptibility 
scores were also calculated: bw * 10/v, where bw is body weight in grams and v is 
volume of PTZ infused in µL [20]. Baseline blood pressures were taken 30 seconds prior 
to PTZ infusion and at seizure onset. EEG was recorded for 30 minutes post-PTZ 
infusion and seizure severity assessed by counting the number of recurring seizures and 
calculating the percent of the post-infusion period spent in seizure. Two Nonpreg and 
three Preg rats were excluded because blood gases were outside of the physiological 
range. Seizure severity was not assessed in one Preg rat because EEG recordings were 
not available for the entire 30 minutes due to a technical issue with the ground electrode. 
After 30 minutes animals were euthanized under chloral hydrate anesthesia by 
decapitation and brains immediately removed. The posterior cerebral cortex was isolated 
and weighed wet (weightwet), then dried in a laboratory oven at 90 o C for 24 hours and 
re-weighed dry (weightdry). The posterior brain region was chosen as it is a primary 
location of edema in women with eclampsia [35]. Percent water content was determined 
by wet:dry weights using the following formula: (weightwet - weightdry/weightwet) * 100. 
Brain water content of one Nonpreg rat was not measured because the 24-hour drying 
time point was unable to be completed.  
 
Quantification and morphological assessment of microglia 
Separate groups of Nonpreg (n = 6) and Preg (n = 8) rats were euthanized under 
isoflurane anesthesia and brains immediately removed. A 3 mm section (4 – 7 mm 
posterior to bregma) was taken of the posterior cerebral cortex and fixed in 10 % buffered 
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formalin at 4 o C overnight, then transferred to 0.1 M PBS and slices paraffin embedded. 
Immunohistochemical staining for ionized calcium binding adapter molecule 1 (Iba 1; 
Wako, Richmond, VA), a marker for microglia was done using standard procedure as 
described previously [23]. For each brain section, four micrographs of cerebral cortex 
were captured using an Olympus BX50 microscope at 20X magnification. Each Iba1+ cell 
was assessed by its morphology and activation state ranked using a graded scale from 1 
(relatively inactive) to 4 (relatively active) as previously described [23]. To assess 
microglia, two analyses were performed. First, the percentage of cells in each activation 
state was calculated for each micrograph and averaged per group. Second, total number 
of Iba1+ cells were counted per mm2 and averaged for each group. Two evaluators that 
were blinded to group performed all morphological assessments.  
 
GABAAR δ-subunit expression by Western blot 
Separate groups of Nonpreg and Preg animals (n = 3 / group) were euthanized under 
isoflurane anesthesia and brains immediately removed. Cerebral cortex was isolated and 
snap frozen in liquid nitrogen and stored at – 80 o C. Cerebral cortex from either Nonpreg 
or Preg rats were homogenized in COMP1 buffer and centrifuged at 16,000 g at 4 o C for 
20 min. Protein concentration was determined using the bicinchoninic acid, or BCA, 
protein Assay Kit (Pierce Biotechnology, Rockford, IL) with bovine serum albumin as a 
standard. Bromophenol blue and dithiothreitol were added to the supernatant to give a 
final concentration of 0.01 % and 50 mM, respectively, and heated at 95 o C for 10 min. 
40 μg was loaded on a 4 – 20 % Mini-PROTEAN TGX Precast Gel (BioRad, Hercules, 
CA) and ran at 35 mA.  The gel was then wet transferred to a polyvinyl difluoride 
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membrane at 90 V for 45 min.  The membrane was Ponceau-S stained to ensure that 
protein was properly transferred.  The membrane was blocked with 5 % non-fat dried 
milk in TBS-T for 1.5 hrs at room temperature.  The membrane was then rinsed with 
TBS-T and the primary antibody was applied, anti-GABAAR-δ (1:200; Santa Cruz 
Biotechnology, Dallas, TX) overnight at 4 ° C with rocking.  The antibody was removed 
and the membrane rinsed with TBS-T and secondary antibody was applied, anti-Goat 
(1:100,000) (Southern Biotech, Birmingham, AL) for 1 hr at room temperature.  The 
secondary antibody was removed and subsequent TBS-T washes were done.  West Pico 
chemiluminescent substrate (ThermoScientific, Rockford, IL) was applied to the 
membrane and then exposed to film.  β-actin served as a loading control (1:5000, Abcam, 
Cambridge, MA) and all samples were normalized to a Nonpreg control. 
 
Drugs and solutions 
Chloral hydrate and PTZ were purchased from Sigma Aldrich (St Louis, MO) and made 
daily in sterile lactated Ringer’s solution. Western blot solutions were prepared as 
follows: COMP1 buffer contained 60 mM TrisCl, 2 % Sodium Dodecyl Sulfate, 10 % 




Data are presented as mean ± standard error of mean. All comparisons were made 




The effect of pregnancy on seizure threshold, susceptibility and severity 
Figure 1A shows representative EEG tracings during seizure threshold 
measurements from Nonpreg (top tracing) and Preg rats (bottom tracing). The black 
arrowheads indicate when PTZ infusion started and the time of seizure onset. The time to 
seizure onset was longer in Nonpreg rats compared to Preg rats. When seizure threshold 
was calculated, the amount of PTZ (mg/kg) required to elicit electrical seizure was 
significantly lower in Preg compared to Nonpreg rats (Figure 1B).  Further, Preg rats had 
significantly higher seizure susceptibility scores compared to Nonpreg rats (Figure 1C). 
There were no differences in physiological parameters during seizure threshold 
measurements between groups, except that, as expected, body weights were significantly 
higher in Preg compared to Nonpreg rats (Table 1). 
To determine if there were changes in seizure severity during pregnancy, the total 
number of recurrent seizures was counted in the 30 minutes post-infusion time period, 
and the percent of time spent in seizure calculated. Figure 2A shows a representative 
EEG tracing within the 30 minutes post-PTZ infusion recording time period. Indicated on 
the tracing is the rapid onset of a recurrent seizure, followed by the rapid cessation of the 
recurring seizure. There was no change in the number of recurrent seizures in the 30 
minutes post-PTZ infusion between groups (Figure 2B). There were also no differences 






The effect of pregnancy on microglial activation and GABAAR δ-subunit expression 
To determine if normal pregnancy was a state of basal neuroinflammation, we 
used the microglia-specific marker Iba 1 to morphologically assess the activation state of 
microglia in the posterior cerebral cortex from Nonpreg and Preg rats. Figure 3A shows 
representative photomicrographs of Iba 1+ microglia in the posterior cerebral cortices of 
Nonpreg and Preg rats. There was no difference in the total number of microglial cells in 
the posterior cerebral cortex between groups (Figure 3B). Further, there were no changes 
in basal microglial activation during pregnancy with no differences in the percent of cells 
in any activation state between groups (Figure 3C).  
To determine if pregnancy induced changes in protein expression of GABAAR-δ 
in the cerebral cortex of Nonpreg and Preg rats, GABAAR-δ expression was measured 
using Western blot and shown in Figure 4A. GABAAR-δ expression was significantly 
reduced in the cerebral cortex of Preg compared to Nonpreg rats (Figure 4B). 
 
The effect of pregnancy on seizure-induced vasogenic brain edema formation  
Percent water content of the brain was calculated post-seizure in Nonpreg and 
Preg rats to determine if there were differences in seizure-induced vasogenic edema 
formation. Percent water content was significantly higher after seizure in the brains of 





The major finding of this study was that normal pregnancy was a state of 
increased seizure susceptibility, indicated by seizure threshold being significantly lower 
during pregnancy compared to the nonpregnant state. This increase in seizure 
susceptibility did not appear to be due to basal neuroinflammation, as the percent of 
microglia in each activation state was similar between Preg and Nonpreg animals. 
However, there was decreased GABAAR δ-subunit expression in the cerebral cortex of 
Preg compared to Nonpreg rats. The GABAAR-δ are extrasynaptic neurotransmitter 
receptors and involved in tonic inhibition throughout the brain [17]. Thus, it is not 
surprising that a decrease in inhibitory input was associated with increased excitability 
and seizure susceptibility. However, the δ-subunit is considered the main site of action of 
neurosteroids elevated during pregnancy that act as positive allosteric modulators of 
GABAARs [16,17]. Thus, plasticity of the GABAAR-δ is likely a normal adaptation to an 
increase in neuroactive steroids during pregnancy, necessary to maintain the steady state 
of excitability and avoid overinhibition of neuronal networks. Interestingly, despite the 
presence of naturally circulating neurosteroids, pregnant animals remained in a state of 
increased seizure susceptibility, suggesting this downregulation of GABAAR-δ resulted 
in increased cortical excitability. Increased neuronal excitability in response to 
neurosteroids may contribute to the subpopulation of women who experience de novo 
seizure during pregnancies uncomplicated by preeclampsia. Further, the rapid and 
dramatic drop in progesterone and its metabolites that occur immediately after parturition 
may also represent one mechanism by which postpartum eclampsia occurs [36]. 
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Susceptibility to seizure during pregnancy has previously been investigated in the 
context of understanding epilepsy in pregnancy. The finding of a lower seizure threshold 
during pregnancy in the current study would suggest that there would be an increase in 
seizure frequency in pregnant women with epilepsy. However, the effect of pregnancy on 
frequency of seizures in women with epilepsy is difficult to discern and appears variable. 
A review of over 2000 pregnancies in epileptic patients found that ~ 25 % of patients 
experienced a decrease, ~ 25 % an increase, and ~ 50 % experienced no change in seizure 
frequency during pregnancy [37]. This variability in seizure frequency noted may be 
complicated by the absence or presence of anti-epileptic medications during pregnancy. 
One study investigating the effect of antiepileptic drugs on seizure in pregnant mice 
found that electroconvulsive seizure threshold was increased on day 18 of pregnancy 
compared to nonpregnant mice [38]. Another study using amygdaloid kindled rats also 
reported increased threshold to electroconvulsive seizure in pregnant compared to 
nonpregnant animals [39]. The finding that pregnancy increases seizure threshold in these 
previous studies is in contrast to the current study in which seizure threshold was 
significantly lower in Preg compared to Nonpreg rats. One significant difference in the 
present study is that seizure threshold was defined as the onset of electrographic seizure 
and not based on physical manifestations as in the previous studies. Therefore, the 
method of measuring seizure threshold could contribute to these disparate findings. In 
addition, the chemoconvulsant used to induce seizure was also different. In the current 
study, the decrease in seizure threshold in response to PTZ is in accordance with the 
decrease in GABAAR δ-subunit expression, since the mechanism by which PTZ acts as a 
convulsant is through antagonistic actions at GABAARs. Thus, the use of PTZ-induced 
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seizure in the current study allowed investigation into the direct involvement of 
GABAAR plasticity in whole brain excitability during pregnancy. However, whether 
there is plasticity in excitatory receptors in the brain, such as AMPA receptors, during 
pregnancy is currently unknown. To our knowledge this is the first in vivo study 
reporting that normal pregnancy is associated with lowered seizure threshold and 
increased seizure susceptibility using non-kindled rats and EEG to determine seizure 
susceptibility during pregnancy.  
The cause of spontaneous, unexplained seizure in a woman with a seemingly 
normal pregnancy is unknown; however, pregnancy-induced increased seizure 
susceptibility could be a contributing factor. It is also possible that de novo seizure in a 
seemingly healthy pregnant woman represents a form of status epilepticus (SE) of 
idiopathic nature and that eclampsia is idiopathic SE that happens to occur in a woman 
while she is pregnant. In addition, the incidence of eclampsia has declined in developed 
countries with the advancement of prenatal care and the use of seizure prophylactic 
agents such as magnesium sulfate that have reduced the risk of eclampsia by ~ 50% [40]. 
Incidence reports of eclampsia for the United Kingdom found a decrease from 4.9 cases 
of eclampsia per 10,000 pregnancies in 1992 to 2.7/10,000 pregnancies in 2005-06 
[12,41]. Similarly, in Scandinavia the incidence of eclampsia was 5.0/10,000 pregnancies 
between 1998-2000 [42], and in Canada (excluding Quebec) 5.9/10,000 cases between 
2009-2010 [43]. However, in developing countries the incidence of eclampsia is 
considerably higher. For example, in 1990 in South Africa the incidence of eclampsia 
was 60/10,000 pregnancies [44], and 200/10,000 pregnancies at Muhimbili National 
Hospital in Dar es Salaam, Tanzania in 1999-2000 [45]. Population-based epidemiologic 
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studies of SE report incidences of 18.3/100,000 population in Rochester, Minnesota 
between 1965-1984 [46], 13.1/100,000 in Bologna, Italy between 1999-2000 [47], 
15.8/100,000 in Hessen, Germany between 1997-1999 [48], and 10.3/100,000 in French-
speaking Switzerland between 1997-1998 [49]. Interestingly, studies reporting the 
incidence of SE often report that the majority of patients have no history of epilepsy 
[47,48]. Thus, the incidence of eclampsia seems to be magnitudes higher than SE, 
especially in undeveloped countries, and therefore is likely not simply an idiopathic form 
of SE. In fact, these comparisons likely dampen the differences in incidence since 
eclampsia is limited only to women who are of childbearing age. Overall, unexplained de 
novo seizure seems to be more prevalent during pregnancy than in the rest of the 
population, and supports the theory that normal pregnancy increases seizure 
susceptibility. 
Previously we have shown that there are seizure-provoking factors present in 
serum that circulate late in gestation that are not present in the nonpregnant state [43]. 
Using a hippocampal slice culture model to measure excitability using evoked field 
potentials after exposure to serum from pregnant and nonpregnant rats revealed that 
serum from pregnant, but not nonpregnant rats increased slice excitability [50]. This was 
due to serum factors activating microglia and subsequent TNFα secretion increasing 
neuronal excitability [50]. However, under normal conditions, serum constituents do not 
readily gain access to the brain due to the protective nature of the BBB. In addition, the 
pregnant rats from which the hyperexcitable serum was taken did not appear to have 
spontaneous convulsions, suggesting the BBB may be central to seizure prevention 
during normal pregnancy. Together with the findings of the current study that the brain is 
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in a hyperexcitable state during pregnancy, further points to the BBB as a critical factor 
in preventing seizure during pregnancy. We speculate that it is the failure of this crucial 
function of the BBB that underlies de novo seizure during seemingly uncomplicated 
pregnancies, as well as during preeclampsia, by allowing the passage of circulating 
seizure-provoking factors into the hyperexcitable maternal brain.  
The brain has been shown to be more susceptible to vasogenic edema formation 
under certain pathologic conditions during pregnancy, such as acute hypertension 
[31,32]. The current study shows that the maternal brain is also more sensitive to seizure-
induced brain injury, with seizure causing greater vasogenic edema formation than in the 
nonpregnant state. It is important to note that previous studies have revealed no 
differences in brain water content basally between pregnant and nonpregnant rats [31], 
demonstrating that the increase in brain water content found in the present study was an 
effect of seizure. Although edema formation is considered a leading cause of eclampsia 
and is present in ~ 90 % of women with eclampsia [25,26], seizure itself can cause edema 
formation through disruption of the BBB [27-29]. The finding in the current study that 
the brain is more susceptible to seizure-induced vasogenic edema formation during 
pregnancy supports the concept that the brain is more susceptible to injury-induced 
edema formation during pregnancy. Further, this sensitivity to seizure-induced edema 
may help explain vasogenic edema formation that may be present in eclamptic women 
who experienced de novo seizure without an acute elevation in blood pressure.  
There are several potential contributors to pregnancy-induced increase in 
susceptibility to cerebral vasogenic edema formation. Firstly, if pregnancy were 
associated with more severe seizure, there may be greater brain injury and edema 
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formation. However, there were no differences in seizure severity between Preg and 
Nonpreg rats, with the percent of time spent in seizure and number of recurrent seizures 
being similar, making this possibility unlikely. Secondly, seizure-induced acute 
hypertension could account for the increase in vasogenic edema formation during 
pregnancy. However, seizure did not cause a significant change in blood pressure in 
either Preg or Nonpreg rats (data not shown). The lack of effect of seizure onset on blood 
pressure is likely due to the sensitive measure of seizure threshold used in the current 
study that allowed for detection of electrical seizure, as opposed to measuring latency to 
tonic clonic seizure that has been associated with a rapid rise in blood pressure [51]. As 
there was no significant change in blood pressure with the onset of electrical seizure in 
either group, an acute elevation in blood pressure likely did not contribute to the 
increased formation of vasogenic edema in Preg rats. Thirdly, capillary density increases 
in the posterior cerebral cortex during pregnancy [52] that may increase the number of 
sites of BBB disruption during seizure. Further, plasma volume increases ~ 50 % during 
pregnancy resulting in a hemodiluted state that under conditions of BBB disruption such 
as seizure may drive water into the brain due to decreased osmolality [53]. Overall, it 
appears that the maternal brain is more susceptible to vasogenic edema formation during 
conditions that cause BBB disruption, highlighting the importance of seizure prevention 
during pregnancy. 
In summary, this is the first study we are aware of to report that pregnancy is a 
state of increased susceptibility to seizure and seizure-induced cerebral vasogenic edema. 
While the brain appears to be hyperexcitable during pregnancy, this did not appear to be 
due to low-level neuroinflammation, but rather a reduction in GABAAR-δ expression in 
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the cerebral cortex. Understanding pregnancy-related neurophysiological changes may 
clarify mechanisms by which eclamptic seizure occurs during seemingly uncomplicated 
pregnancies when there are failures of other protective mechanisms, such as at the BBB 
or neurosteroid concentrations involved in maintaining steady state excitability, as 
illustrated in Figure 6.  Further, elucidating the contribution of normal pregnancy to 
seizure onset could lead to a greater understanding of pregnancy-specific pathologies 
such as preeclampsia and eclampsia. Our understanding of these conditions may result in 
development of specific screenings to identify pregnant women who are at risk of de 
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Table 1. Physiological parameters of nonpregnant (Nonpreg) and late-pregnant 
(Preg) rats under chloral hydrate anesthesia for seizure threshold measurements. 
 
Nonpreg  
(n = 7) 
Preg  
(n = 6) 
Body Weight (grams) 287 ± 7 377 ± 10 ** 
Body Temp (o C) 36.3 ± 0.2  36.8 ± 0.2 
Arterial PO2 (mm Hg) 114 ± 8 111 ± 7 
Arterial PCO2 (mm Hg) 42.1 ± 1.9  42.8 ± 1.7 







Figure 1. The effect of normal pregnancy on seizure threshold and susceptibility. (A) 
Representative EEG tracings from nonpregnant (Nonpreg) and late-pregnant (Preg) rats 
during timed-infusion of pentylenetetrazol (PTZ). Black arrows indicate when PTZ 
infusion started and the onset of spike-wave discharge indicative of electrical seizure. (B) 
Seizure threshold was significantly lower in Preg rats compared to Nonpreg rats. (C) Preg 
rats scored higher on the seizure susceptibility scale compared to Nonpreg rats. ** p < 






Figure 2. The effect of pregnancy on seizure severity. (A) Representative EEG tracing 
of a recurrent seizure during the 30-minute post-pentylenetetrazol (PTZ) infusion time 
period. Left black arrow indicates seizure onset and right black arrow seizure cessation. 
(B) Number of recurrent seizures in the 30-minute post-PTZ infusion period was similar 
between nonpregnant (Nonpreg) and late-pregnant (Preg) rats. (C) The percent of time 
spent in seizure during the 30-minute post-PTZ time period was similar between Nonpreg 






Figure 3. Basal activation state of microglia in cerebral cortex of nonpregnant 
(Nonpreg) and pregnant (Preg) rats. (A) Representative photomicrographs of Iba 1+ 
microglia in the cerebral cortices of Nonpreg and Preg rats. (B) There was no difference 
in the number of microglia in the cerebral cortices of Nonpreg and Preg rats. (C) The 
percent of Iba 1+ microglial cells in each activation state was similar in the cortices of 






Figure 4. The effect of pregnancy on GABAAR δ-subunit protein expression in the 
cerebral cortex. (A) Representative Western blot showing protein expression of the 
GABAAR δ-subunit in the cerebral cortices of nonpregnant (Nonpreg) and pregnant 
(Preg) rats. (B) δ-subunit protein expression was significantly lower in the cerebral cortex 






Figure 5. The effect of seizure on vasogenic edema formation in nonpregnant 
(Nonpreg) and late-pregnant (Preg) rats. Percent water content of the posterior 
cerebral cortex was significantly higher after seizure in Preg compared to Nonpreg rats. * 






Figure 6. Schematic of the potential contribution of normal pregnancy to eclampsia. 
The maternal brain appears hyperexcitable due to decreased protein expression of the 
GABAAR δ-subunit that increases the potential for spontaneous seizure. However, 
because the majority of women do not have seizure during pregnancy, additional insults 
are required to cause seizure onset that are multifactorial: 1) Imbalanced neurosteroids. 
Hyperexcitability due to downregulation of cortical GABAAR subunits is thought to be 
kept in balance by progesterone and progesterone metabolites; however, seizure can 
occur in response to changes in neurosteroid concentrations, such as postpartum when 
progesterone levels decrease to pre-pregnancy levels. Further, estradiol exerts pro-
convulsive effects by increasing neuronal excitability through activity at excitatory 
ionotropic neurotransmitter receptors and neuronal sodium and potassium channels [54-
56]. Thus, the switch from a progesterone- to an estrogen-dominated state at parturition 
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could facilitate seizure onset during pregnancy.  2) Increased inflammation and/or 
infection.  During pregnancy, neuroinflammation and activation of microglia can occur to 
increase neuronal excitability through local production of inflammatory cytokines (e.g., 
TNFα).  3) Failure or dysregulation of the BBB.  Increased permeability of the BBB can 
occur through elevated mediators such as vasopressin and histamine that are elevated 
during pregnancy and preeclampsia [57,58]. An increase in BBB permeability has several 
effects including passage of circulating seizure-provoking factors into an already 
hyperexcitable maternal brain and movement of water or solutes from blood to brain that 
can disrupt the delicate microenvironment of the brain and cause a charge screening 
effect that depolarizes neurons. Decreased osmolality during pregnancy may result in 
greater vasogenic edema formation under conditions of disrupted BBB. In addition, 
failure of efflux transporters to regulate the entry of steroids, cytokines and chemokines 
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Eclampsia, defined as unexplained seizure in a woman with preeclampsia, is a life-
threatening complication of pregnancy with unclear etiology. Magnesium sulfate 
(MgSO4) is the leading eclamptic seizure prophylactic, yet its mechanism of action 
remains unclear. Here, we hypothesized severe preeclampsia is a state of increased 
seizure susceptibility due to blood-brain barrier (BBB) disruption and neuroinflammation 
that lowers seizure threshold. Further, MgSO4 decreases seizure susceptibility by 
protecting the BBB and preventing neuroinflammation. To model severe preeclampsia, 
placental ischemia (reduced uteroplacental perfusion pressure; RUPP) was combined 
with a high cholesterol diet (HC) to cause maternal endothelial dysfunction. RUPP+HC 
rats developed symptoms associated with severe preeclampsia, including hypertension, 
oxidative stress, endothelial dysfunction and fetal and placental growth restriction. 
Seizure threshold was determined by quantifying the amount of pentylenetetrazole (PTZ; 
mg/kg) required to elicit seizure in RUPP+HC±MgSO4 and compared to normal pregnant 
controls (n=6/group; gestational day 20). RUPP+HC rats were more sensitive to PTZ 
with seizure threshold being ~65% lower vs. control (12.4±1.7 vs. 36.7±3.9 mg/kg PTZ; 
p<0.05) that was reversed by MgSO4 (45.7±8.7 mg/kg PTZ; p<0.05 vs. RUPP+HC). 
BBB permeability to sodium fluorescein, measured in-vivo (n=5-7/group), was increased 
in RUPP+HC vs. control rats, with more tracer passing into the brain (15.9±1.0 vs. 
12.2±0.3 counts/gram x1000; p<0.05) and was unaffected by MgSO4 (15.6±1.0 
counts/gram x1000; p<0.05 vs. controls). In addition, RUPP+HC rats were in a state of 
neuroinflammation, indicated by 35±2% of microglia being active compared to 9±2% in 
normal pregnancy (p<0.01; n=3-8/group). MgSO4 treatment reversed neuroinflammation, 
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reducing microglial activation to 6±2% (p<0.01 vs. RUPP+HC). Overall, RUPP+HC rats 
were in a state of augmented seizure susceptibility potentially due to increased BBB 
permeability and neuroinflammation. MgSO4 treatment reversed this, increasing seizure 
threshold and decreasing neuroinflammation, without affecting BBB permeability. Thus, 
reducing neuroinflammation may be one mechanism by which MgSO4 prevents 





Preeclampsia (PE) is a hypertensive complication of pregnancy that involves 
many organ systems, including the kidney, liver and brain [1]. Some of the most serious 
complications of PE involve neurologic symptoms and include uncontrolled vomiting, 
severe and persistent headache, visual disturbances, unexplained seizure (eclampsia), 
coma and death [1]. Eclampsia is a life-threatening condition with high maternal and fetal 
morbidity and mortality [2,3]. The mechanism by which de novo seizure occurs in 
women with PE is not known, however, studies have shown that the brain is more 
excitable during pregnancy and PE, suggesting a lower seizure threshold that may 
contribute to de novo seizure. For example, network excitability in brain slices of 
pregnant mice was increased compared to virgin animals [4]. Further, a lower seizure 
threshold was reported in a lipopolysaccharide (LPS)-induced rat model of PE compared 
to normal pregnancy [5], suggesting pregnancy and PE may predispose the brain to 
seizure through increased neuronal excitability. However, the mechanism by which 
neuronal excitability is augmented in PE is unknown. 
One of the primary mechanisms by which neuronal excitability can increase is 
through activation of microglia and neuroinflammation [6,7]. Microglial activation under 
conditions of peripheral inflammation has been shown to decrease seizure threshold via a 
promotional effect on neuronal excitability [8]. In addition, increased blood-brain barrier 
(BBB) permeability can result in neuroinflammation by allowing passage of serum 
constituents into the brain that activate microglia [9-12]. A previous study showed that 
circulating factors present during normal pregnancy are hyperexcitable to the brain 
through activation of microglia, and increase network excitability in a hippocampal slice 
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culture model [13]. In addition, circulating factors during PE have been shown to 
increase BBB permeability that could potentially pass into the maternal brain to promote 
neuroinflammation and decrease seizure threshold [14,15]. In the present study, we 
hypothesized that PE produces a state of neuroinflammation that lowers seizure 
threshold. We further hypothesized that BBB disruption during PE leads to microglia 
activation and is a mechanism by which seizure threshold is lowered during PE.  
Magnesium sulfate (MgSO4) is currently the most effective and commonly 
administered drug for eclamptic seizure prophylaxis and reduces the incidence of 
eclampsia by ~ 50 % [16-20]. MgSO4 is administered to women at relatively high doses 
to raise serum levels to between 4.2 – 8.4 mg/dL over 12 - 24 hours [16]. However, 
despite its apparent effectiveness, dangerous side effects are associated with MgSO4 use, 
including the potential for areflexia, respiratory paralysis and cardiac arrest [16]. Further, 
although it is the preferred treatment strategy in women with PE, the exact mechanism by 
which MgSO4 prevents eclampsia is not clear and may be multifaceted. Animal studies 
have provided evidence that MgSO4 has protective actions at the BBB, lowering 
permeability during acute hypertension, and reducing hyperosmolar-induced disruption 
of the BBB [21,22]. We hypothesized that MgSO4 treatment during PE increases seizure 
threshold by preserving the integrity of the BBB and preventing microglial activation, 
thereby decreasing neuroinflammation.  
In the present study, we developed a rat model of severe PE that incorporated 
placental ischemia and maternal endothelial dysfunction that are thought to contribute to 
the pathogenesis of PE [23]. In particular, we sought to model severe PE that 
encompasses both fetal and maternal symptoms and has the greatest risk of life-
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threatening complications [23,24]. This model used the reduced uteroplacental perfusion 
pressure (RUPP) model of placental ischemia [25] combined with a high cholesterol diet 
previously shown to cause maternal endothelial dysfunction [15,26]. Using this model, 
we investigated the effect of severe PE on seizure threshold, BBB permeability in vivo 
and neuroinflammation. Further, rats with severe PE were treated with a clinically 
relevant dose of MgSO4 for 24 hours, and the effect of MgSO4 on these parameters was 




Animals and ethics statement 
All experiments were conducted using timed-pregnant Sprague Dawley rats that were 14-
16 weeks old (Charles River, Canada). All rats were used experimentally and euthanized 
late in gestation (day 20 of a 22 day gestation), as this is when eclampsia occurs most 
often [1]. Rats of the same gestational age were housed in pairs in the University of 
Vermont Animal Care Facility, an Association for Assessment and Accreditation of 
Laboratory Animal Care International accredited facility. All procedures were approved 
by the Institutional Animal Care and Use Committee at the University of Vermont and 
conducted in accordance with the National Institute of Health Guide for the Care and Use 






Rat model of severe PE and assessment of pregnancy outcome 
To model severe PE, we combined the RUPP model of placental ischemia with a high 
cholesterol diet (RUPP+HC) previously shown to cause hyperlipidemia by increasing 
total plasma cholesterol, maternal endothelial dysfunction and increased blood pressure 
[15,26]. Forty-eight pregnant rats were fed a high cholesterol diet (Prolab 3000 rat chow 
with 2 % cholesterol and 0.5 % sodium cholate; Scotts Distributing Inc., Hudson, NH) on 
days 7-20 of gestation. To induce placental ischemia, on day 14 of pregnancy while 
maintained on a high cholesterol diet, a midline abdominal incision was made under 
isoflurane anesthesia and a silver clip (diameter 0.203 mm) placed on the distal aorta, just 
proximal to the iliac bifurcation and distal to the renal and mesenteric arteries. Silver 
clips (diameter 0.10 mm) were placed on the arteries of the uterine arcade before the first 
segmental branch to the uteroplacental unit. This is an established method of reducing 
uteroplacental perfusion pressure by ~ 40 % [25]. Pregnant rats that had a sham surgery 
(n = 4) underwent the same surgical procedure, excluding the placement of silver clips. 
Animals were weighed prior to use and euthanized by decapitation after experimentation 
under anesthesia. Trunk blood was collected and serum stored at – 80 oC until use. 
Uterine horns were examined for total number of pups and any reabsorbed fetuses. To 
assess growth restriction and placental disease, pups and placenta from some RUPP+HC 
rats (n = 5) were removed, weighed individually and compared to control rats (n = 3).  
 
Measurement of conscious, unrestrained arterial blood pressure 
Separate groups of normal late-pregnant (Late-Preg; n = 6) and RUPP+HC rats (n = 6) 
were implanted with indwelling carotid catheters on day 18 of gestation. Under isoflurane 
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anesthesia, the left common carotid artery was exposed and cannulated with saline filled 
V-3 tubing (SCI) which was tunneled to the back of the neck and externalized. On day 19 
of pregnancy, rats were lightly anesthetized with isoflurane (1 - 2 % for 3 - 4 minutes) 
and a pressure transducer (BIOPAC, Inc., Goleta, CA, USA) connected to the indwelling 
carotid catheter. Rats were placed in a rectangular, clear plastic modular chamber (10” x 
7” x 5”) with a metal grid floor, large enough to move freely. Average conscious, 
unrestrained systolic blood pressures were recorded using AcqKnowledge software 
(BIOPAC, Inc., Goleta, CA, USA). One RUPP+HC rat died due to surgical 
complications during catheter implantation and was excluded. 
 
Measurement of circulating markers of endothelial dysfunction and oxidative stress 
Commercially available rat ELISA kits for endothelin-1 (ET-1; R&D Systems, 
Minneapolis, MN, USA) and free 8-isoprostane (Caymen Chemicals, Ann Arbor, MI, 
USA) were used to measure circulating factors in the serum of Late-Preg (n = 6) and 
RUPP+HC (n = 6 – 8) rats. Serum samples were diluted 1:3 for measurements of free 8-
isoprostane otherwise samples were measured undiluted. All samples were measured in 
duplicate.  
 
MgSO4 treatment in RUPP+HC rats 
Eighteen RUPP+HC rats were injected s.c. the morning of day 19 of pregnancy with 270 
mg/kg 1.0 M MgSO4 (RUPP+HC+MgSO4). Four hours later, rats were briefly 
anesthetized with 2 % isoflurane and three 2 mL osmotic minipumps (Alzet, Cupertino, 
CA, USA) primed with 1.0 M MgSO4 were implanted s.c. between the shoulder blades. 
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On day 20 of pregnancy, 1.5 hours prior to surgery and experimentation rats were 
injected with a second bolus of 270 mg/kg 1.0 M MgSO4 s.c. After experimentation, rats 
were euthanized by decapitation under anesthesia and serum collected and stored at – 80 
oC until use. Serum [Mg2+] was measured using a colorimetric assay (BioVision Inc., San 
Francisco, CA, USA) according to the manufactures’ instructions and compared to 
RUPP+HC rats that did not receive treatment with MgSO4 (n = 4 / group).  
 
Measurement of seizure threshold, susceptibility and severity, and brain water content 
Separate groups of Late-Preg (n = 10), RUPP+HC (n = 6) and RUPP+HC+MgSO4 (n = 
6) were anesthetized initially with isoflurane (1 – 3 % in oxygen) for intubation, electrode 
placement and instrumentation. Animals were mechanically ventilated to maintain blood 
gases and pH within normal physiological ranges. Body temperature was monitored with 
a rectal thermometer and maintained with a heating pad at 37 oC throughout the 
experiment. The dorsal surface of the head was shaved to expose the scalp and silver 
subdermal corkscrew electrodes (Ambu, Glen Burnie, MD, USA) were implanted under 
the scalp and secured in place with collodion glue. Electroencephalography (EEG) was 
recorded unipolarly using a MP150 acquisition system (BIOPAC System Inc., Goleta, 
CA, USA) to monitor generalized seizure. The recording electrode was placed over the 
right parieto-occipital cortex (5 ± 0.16 mm lateral and 7 ± 0.16 mm posterior to bregma) 
[27], a reference electrode was placed in the soft tissue of the snout and a ground 
electrode placed posterior to the right ear. Signals were amplified and filtered (low 
frequency filter, 0.1 Hz; high frequency filter 35.0 Hz) and sampled at 1.0 kHz. After 
placement of electrodes, the animal was placed in supine position for placement of 
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venous and arterial catheters. Femoral arteries were cannulated to obtain blood samples 
for blood gas measurements and continuous measurement of arterial blood pressure via a 
pressure transducer (BIOPAC Systems Inc., Goleta, CA, USA). As placement of a silver 
clip on the distal aorta in rats with RUPP made monitoring blood pressure in the femoral 
artery inaccurate, blood pressures were measured in the axillary artery, as done 
previously [28]. Femoral veins were cannulated for administration of the anesthetic 
chloral hydrate and infusion of the chemoconvulsant pentylenetetrazole (PTZ). PTZ was 
chosen because it reliably elicits seizure by its antagonistic action at the main inhibitory 
receptors in the brain, gamma-aminobutyric acid (GABA) type A receptors [29]. After 
instrumentation, animals were tapered off isoflurane and anesthesia maintained by 
continuous intravenous infusion of chloral hydrate (50 mg/mL; 30 µL/min). Chloral 
hydrate was used because it is thought to not depress neural function, and is the preferred 
anesthetic for studies measuring EEG [30,31]. Seizure was induced by a timed infusion 
of PTZ (10 mg/mL; 1 mL / min) that was stopped at the first onset of spikewave 
discharges. Seizure threshold was calculated as the amount of PTZ (mg/kg) required to 
elicit electrical seizure: Tinfusion * Rinfusion * [PTZ] / BW where Tinfusion is the time of 
infusion in min, Rinfusion is the rate of infusion in mL/min, [PTZ] is the concentration of 
PTZ in mg/mL, and BW is the body weight in kg. Seizure susceptibility scores were also 
calculated: bw * 10/v where bw is body weight in grams and v is volume of PTZ infused 
in µL.[8] Baseline blood pressures were taken 30 seconds prior to PTZ infusion and at 
seizure onset. EEG was recorded for 30 minutes post-PTZ infusion and seizure severity 
assessed by counting the number of recurring seizures and calculating the percent of the 
post-infusion period spent in seizure. After 30 minutes animals were euthanized under 
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chloral hydrate anesthesia by decapitation and brains immediately removed. The 
posterior cerebral cortex was isolated and weighed wet (weightwet), then dried in a 
laboratory oven at 90 oC for 24 hours and re-weighed dry (weightdry). Percent water 
content was determined by wet:dry weights using the following formula: (weightwet - 
weightdry/weightwet) * 100. The posterior cortex was chosen for measurements as this is a 
primary brain region affected in women with PE and eclampsia [32]. Four Late-Preg rats 
were excluded because blood gases were outside of the physiological range. 
 
Measurement of in vivo BBB permeability 
Permeability of the BBB was measured in Late-Preg (n = 6), RUPP+HC (n = 5) and 
RUPP+HC+MgSO4 (n = 8) using previously described methods with modifications [33]. 
Briefly, animals were anesthetized and instrumented similarly as during seizure threshold 
measurements, excluding EEG electrode placement and substituting the catheter for PTZ 
with fluorescent tracers. While under chloral hydrate anesthesia, fluorescent tracers were 
infused into the femoral vein (0.5 mL/min for 2.25 min) and allowed to circulate for 10 
minutes. Sodium fluorescein (0.1 %; mol wt 476 Da; Stokes-Einstein radius ~ 0.45 nm) 
and 70-kDa Texas red dextran (0.5 mg/mL; Stokes-Einstein radius ~ 7.0 nm) in lactated 
Ringer’s solution and heparin were used to distinguish size selectivity to small and large 
solutes, respectively. A thoracotomy was performed, a needle inserted into the left 
ventricle of the heart and the right atrium cut to allow for drainage of blood and tracers. 
Using an infusion pump, the circulation was flushed with 60 mL lactated Ringer’s 
solution (5.0 mL/min) until the circulation was clear of blood. Animals were decapitated, 
the brain removed and the posterior cerebral cortex isolated and weighed. Each brain 
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section was homogenized in 5.0 mL 0.1 M PBS, 5.0 mL 50 % trichloroacetic acid (TCA) 
added, vortexed for 1 min, and centrifuged at 4 o C for 10 min at 4500 rpm (Sorvall 
Legend X1R, Thermo Scientific, Waltham, MA, USA. The supernatant was removed and 
re-centrifuged. The fluorescence of the supernatant was determined at excitation and 
emission wavelengths of 460 and 515 nm for sodium fluorescein and 595 and 615 nm for 
Texas red dextran. Background emissions of 50:50 lactated Ringer’s and 50 % TCA were 
subtracted and samples normalized to brain weight to compare fluorescence as 
counts/gram of brain tissue. One Late-Preg rat and one RUPP+HC+MgSO4 rat were 
excluded due to surgical complications. 
 
Quantification and morphological assessment of microglia 
Separate groups of Late-Preg (n = 8), RUPP+HC (n = 3) and RUPP+HC+MgSO4 (n = 4) 
rats were euthanized under isoflurane anesthesia and brains immediately removed. A 3 
mm coronal section (4 – 7 mm posterior to bregma) of the posterior cerebral cortex was 
taken and fixed in 10 % buffered formalin at 4 o C overnight, then transferred to 0.1 M 
PBS and paraffin embedded. Immunohistochemical staining for ionized calcium-binding 
adapter molecule 1 (Iba1; Wako, Richmond, VA), a marker for microglia, was done 
using standard procedures. Briefly, tissue was sectioned at 4 μm on a Leica 2030 paraffin 
microtome. Slides were allowed to air dry overnight at room temperature and then baked 
for one hour at 60 o C. Following deparaffinization and rehydration, the sections 
underwent antigen retrieval with DAKO Target Retrieval Solution, pH 6.0 in 50 % 
glycerol at 95 o C for 20 min. Sections were treated with 1 % bovine serum albumin, 10 
% normal goat serum and 0.1 % Triton X-100. The tissue was incubated overnight at 
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room temperature with Iba1 antibody (1 μg/mL) and one hour in Cyanine 3 dye (1:100).  
For each brain section, four micrographs of cerebral cortex were captured using an 
Olympus BX50 microscope at 20X magnification. Each Iba1+ cell was assessed by its 
morphology and activation state ranked using a graded scale from 1 (relatively inactive) 
to 4 (relatively active). Cells with highly ramified, long processes with a scattered, 
irregularly shaped cell body were ranked in state 1. Cells with an asymmetrical cell body 
and many long, defined processes were ranked in state 2. Cell bodies that were more 
rounded with several shorter, thicker processes were ranked 3, and large, round 
amoeboid-like cell bodies with few to no processes were ranked in state 4 [34]. To assess 
microglia, two analyses were performed. First, the percentage of cells in each activation 
state was calculated for each micrograph and averaged per group. Second, total number 
of Iba1+ cells were counted per mm2 and averaged for each group. A group of sham-
operated rats were assessed for microglial activation to confirm the surgery alone did not 
activate microglia. Two evaluators that were blinded to group performed all 
morphological assessments. 
 
Measurement of cerebral blood flow autoregulation and brain water content 
Separate groups of Preg (n = 6) and RUPP+HC (n = 10) rats were anesthetized initially 
with isoflurane (1 - 3 % in oxygen) for intubation and instrumentation, after which 
anesthesia was maintained with a bolus intravenous injection of chloral hydrate (200 
mg/kg into femoral vein). Animals were mechanically ventilated to maintain blood gases 
and pH within normal physiological ranges. Body temperature was monitored with a 
rectal thermometer and maintained with a heating pad at 37 oC throughout the 
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experiment. Relative cerebral blood flow (rCBF) was measured transcranially in the 
posterior cerebral cortex using laser Doppler flowmetry.  The left side of the 
medioposterior skull was exposed and the bone thinned. A laser Doppler probe (Perimed, 
Ardmore, PA, USA) was affixed 2 mm lateral to the sagittal suture and 1 mm anterior to 
the lambdoid suture to measure rCBF in the posterior cerebral artery territory. Femoral 
arteries were cannulated to obtain blood samples for blood gas measurements and 
measurement of arterial blood pressure via a pressure transducer (Living Systems 
Instrumentation, Inc., Burlington, VT, USA). Femoral veins were cannulated for 
administration of chloral hydrate and acute infusion of phenylephrine. To measure CBF 
autoregulation, phenylephrine was infused intravenously at an increasing rate of 4 - 48 
µg/min, and blood pressure and rCBF measured simultaneously, as previously described 
[35]. After experimentation, while under anesthesia, rats were euthanized by decapitation, 
brains immediately removed and percent water content measured by wet:dry weights. 
One RUPP+HC rat was excluded because of technical issues with placement of the laser 
Doppler probe. The percent increase in CBF of one RUPP+HC rat was greater than two 
standard deviations from the mean, and therefore excluded as a statistical outlier. 
Animals were not randomized due to the use of timed-pregnant rats. 
 
Drugs and solutions 
MgSO4, phenylephrine, chloral hydrate, PTZ, sodium fluorescein and TCA were 
purchased from Sigma Aldrich (St Louis, MO, USA) and all were made daily in sterile 
lactated Ringer’s solution except MgSO4, which was ready-to-use. Texas red dextran was 
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purchased from Invitrogen (Life Technologies, Grand Island, NY, USA) and made daily 
in sterile lactated Ringer’s solution. 
 
Statistical analyses 
Data are presented as mean ± standard error of mean. Physiological parameters were 
compared between Late-Preg and RUPP+HC rats using analysis of variance (ANOVA). 
Pup and placental weights were compared using ANOVA with the n-value being total 
pups and placentas in each group. Differences in circulating levels of ET-1 and free 8-
isoprostane were also compared using ANOVA. Percent change in rCBF was compared 
between Late-Preg and RUPP+HC rats at pressures between 100 and 180 mmHg using 
ANOVA. Comparisons of physiological parameters, seizure threshold, susceptibility, 
severity, BBB permeability, % water content and microglial activation between Late-
Preg, RUPP+HC and RUPP+HC+MgSO4 rats were done using a one-way ANOVA with 
a Bonferroni’s post-hoc test to correct for multiple comparisons. Differences were 




Severe PE caused hypertension, oxidative stress, endothelial dysfunction, and fetal and 
placental growth restriction 
Table 1 shows physiological parameters of Late-Preg and RUPP+HC rats. RUPP+HC 
rats weighed significantly less on day 20 of gestation compared to Late-Preg rats. This 
decrease in maternal body weight was not due to significant pup loss or fetal 
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reabsorptions, as the number of pups and reabsorbed fetuses were not statistically 
different between groups. However, RUPP+HC caused both fetal and placental growth 
restriction, as shown by significant reductions in pup and placental weights. Further, rats 
with severe PE had increased systolic blood pressure compared to Late-Preg rats. When 
serum markers of oxidative stress and endothelial dysfunction were compared, severe PE 
was associated with significantly higher levels of circulating free 8-isoprostane compared 
to control rats: 369 ± 25 pg/mL for RUPP+HC vs. 281 ± 8 pg/mL for Late-Preg; p < 
0.01 and ET-1: 0.99 ± 0.25 pg/mL for RUPP+HC vs. 0.46 ± 0.06 pg/mL for Late-Preg; p 
< 0.05.  
 
Severe PE was associated with decreased seizure threshold and increased seizure 
susceptibility 
To determine if severe PE was a state associated with increased neuronal excitability, 
seizure threshold was measured in vivo in RUPP+HC and Late-Preg rats by timed 
infusion of PTZ and simultaneous EEG recording. Figure 1A shows a representative EEG 
tracing in a Late-Preg rat during PTZ infusion that had spike wave discharges indicative 
of seizure onset after 2.4 min of infusion.  Seizure threshold was significantly lower in 
RUPP+HC rats, requiring less PTZ to elicit electrical seizure than in Late-Preg controls 
(Figure 1B). Further, severe PE was associated with a higher seizure susceptibility score 
than in Late-Preg controls, suggesting that RUPP+HC rats are in a state of increased 
neuronal excitability (Figure 1C). Comparison of recurring seizures and percentage of 
time spent seizing revealed no differences between RUPP+HC and Late-Preg rats (Table 
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2), indicating that although rats with severe PE were more susceptible to seizure than 
controls, seizure severity was similar between these groups.  
 
MgSO4 treatment reversed seizure susceptibility in rats with severe PE 
Treatment of RUPP+HC rats with MgSO4 raised serum Mg2+ levels into the target 
therapeutic range that was significantly higher than RUPP+HC rats that did not receive 
treatment (5.2 ± 0.5 mg/dL for treated vs. 1.2 ± 0.1 mg/dL for untreated; p < 0.01). 
MgSO4 treatment did not affect physiological parameters or pregnancy outcome, as 
maternal body weight (389.2 ± 8.9 grams; p > 0.05 vs. untreated), number of pups (11.5 
± 1.2; p > 0.05) and fetal reabsorptions (1.8 ± 0.9; p > 0.05) were similar to RUPP+HC 
rats (see Table 1). Severe PE rats that received MgSO4 had significantly higher seizure 
threshold compared to rats with severe PE that did not receive treatment (Figure 1B). 
Further, MgSO4 reversed the increase in seizure susceptibility, lowering susceptibility 
scores back to control levels (Figure 1C). Despite these apparent protective effects, 
MgSO4 did not affect seizure severity, as there were no changes in either number of 
recurrent seizures or percent of time spent seizing with MgSO4 treatment (Table 2). There 
were no differences in any physiological parameters under anesthesia during seizure 
threshold measurements between groups (Table 3). 
 
Severe PE rats with and without MgSO4 had decreased seizure-induced cerebral 
vasogenic edema formation 
Cerebral vasogenic edema is present in ~ 90 % of women with eclampsia [36]. Further, 
the maternal brain has been shown to be more susceptible to vasogenic edema formation 
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than the nonpregnant state under pathologic conditions including acute hypertension and 
in response to seizure [37,38]. However, whether the brain during severe PE is more 
susceptible to seizure-induced vasogenic edema has yet to be investigated, and the effect 
of MgSO4 treatment under such conditions remains unknown. In the current study, 
seizure-induced vasogenic edema formation was significantly lower in RUPP+HC rats 
compared to Late-Preg controls, and remained unaffected by MgSO4 treatment (Figure 
2). 
 
Severe PE increased BBB permeability in vivo that was unaffected by MgSO4 treatment  
BBB permeability to sodium fluorescein, the small ~ 470 Da solute, was increased in 
RUPP+HC rats compared to Late-Preg rats, with significantly more tracer passing from 
the cerebral circulation into the brain parenchyma in rats with severe PE (Figure 3A). 
There was no difference in permeability of the BBB to Texas red dextran, a larger 70 kDa 
tracer, between Late-Preg and RUPP+HC rats (Figure 3B). MgSO4 treatment 
administered to rats with severe PE did not affect BBB permeability, as permeability to 
sodium fluorescein remained higher in RUPP+HC+MgSO4 rats than Late-Preg controls 
(Figure 3A), with no change in permeability to Texas red (Figure 3B). 
 
Severe PE increased neuroinflammation that was reversed by MgSO4 treatment  
Figure 4A illustrates the dynamic morphological changes that occur as quiescent 
microglia transition to an activated state and was used as a graded scale to assess 
microglial activation.  Figure 4B shows representative photomicrographs of Iba1+ 
microglia from the posterior cerebral cortex of Late-Preg, RUPP+HC and 
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RUPP+HC+MgSO4 rats. The total number of microglia was modestly increased in rats 
with severe PE regardless of MgSO4 treatment, but was not statistically different than 
Late-Preg controls (Figure 4C). There was a significantly higher percent of cells in fully 
activated state 4 in rats with severe PE compared to controls, that was coupled by a 
reduction in the percent of cells in activation state 2 (Figure 4D). These findings indicate 
the presence of neuroinflammation in rats with severe PE. Treatment of RUPP+HC rats 
with MgSO4 decreased the percent of activated microglia, shifting back to a relatively 
quiescent and inactive pattern similar to Late-Preg controls, with the majority of 
microglial cells residing in a relatively inactive state. Sham operated rats had similar 
microglial activation as Late-Preg control rats (data not shown).  
 
CBF autoregulation and brain water content in Severe PE 
An underlying feature of neurological complications during severe PE is thought to be 
impairment of CBF autoregulation [39]. To compare CBF autoregulation between Late-
Preg and RUPP+HC rats, rCBF vs. pressure curves were generated. Figure 5A shows that 
as arterial blood pressure increased, the change in rCBF was similar between Late-Preg 
rats and rats with severe PE and stayed below 20 % until 150 mmHg (Figure 5A). To 
investigate if RUPP+HC rats were more susceptible than Late-Preg rats to hypertension-
induced cerebral edema, percent water content of the brain was measured after 
measurement of CBF autoregulation. There was no difference in brain water content after 






When eclamptic seizure occurs in women with early-onset severe PE there is 
approximately a 50 % maternal mortality rate [3]. This suggests that the maternal brain is 
adversely affected in severe PE and at a greater risk of damage. The mechanism(s) by 
which eclampsia occurs is not clearly understood, but may involve a pathologic process 
involving BBB dysfunction, neuroinflammation and hyperexcitability of the brain. Here, 
we modeled severe PE by introducing placental ischemia in a setting of maternal 
endothelial dysfunction due to hyperlipidemia. RUPP+HC rats had increased blood 
pressure and were in a state of oxidative stress and endothelial dysfunction, as indicated 
by elevated circulating levels of free 8-isoprostane and ET-1. Further, rats with severe PE 
had fetal and placental growth restriction that was not associated with a change in number 
of pups or fetal reabsorptions. This is similar to women with early-onset severe PE that 
have intrauterine growth restriction and placental disease [40]. Importantly, rats with 
severe PE were in a state of increased seizure susceptibility, with seizure threshold being 
significantly lower than normal pregnant controls. Seizure susceptibility in rats with 
severe PE was associated with increased BBB permeability to small solutes and 
microglial activation. However, there was no change in seizure severity between Late-
Preg and RUPP+HC rats, indicating that regulatory mechanisms limiting prolonged 
seizure activity were similar to the control state, despite neuroinflammation in rats with 
severe PE. Thus, the brain seems to be at a greater risk of seizure due to breakdown of the 
BBB and associated neuroinflammation in this rat model of severe PE.  
Neuroinflammation, demonstrated in the current study by activated microglia, can 
increase neuronal excitability through microglial secretion of pro-inflammatory cytokines 
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such as tumor necrosis factor alpha (TNFα) [8,13]. TNFα causes trafficking of excitatory 
receptors to the neuronal cell surface and simultaneous internalization of inhibitory 
receptors, resulting in a net increase in neuronal excitability [8,41,42]. Thus, it is possible 
that in this model of severe PE, lower seizure threshold and increased seizure 
susceptibility were a consequence of neuroinflammation because they also had marked 
microglial activation. In the current study, severe PE rats treated with MgSO4 had 
significantly less microglial activation that correlated with increased seizure threshold. In 
fact, MgSO4 treatment returned neuroinflammation and seizure susceptibility to the level 
of normal pregnant controls. However, the effect of MgSO4 appeared to be a direct effect 
on microglial activation, as opposed to limiting BBB permeability. MgSO4 has been 
shown to limit LPS-induced microglial secretion of pro-inflammatory cytokines in cell 
culture through inhibition of L-type calcium channels and subsequent reduction in 
downstream signaling of nuclear factor kappa B (NF-κB), a transcription factor involved 
in inflammatory pathways [43-45]. However, to our knowledge, this is the first study 
showing that MgSO4 treatment increases seizure threshold in severe PE via a quiescent 
effect on activated microglia in vivo. This is in agreement with a recent study showing 
MgSO4 treatment increased seizure threshold in a LPS model of PE, however, the 
mechanism by which this occurred was not investigated [5].  
Overall the effect of MgSO4 treatment on seizure threshold appeared to be due to 
reducing neuroinflammation, and not a protective effect at the BBB. In the present study, 
rats with severe PE had selectively increased BBB permeability to small, but not large 
solutes. Increased permeability to sodium fluorescein but not 70 kDa Texas red dextran 
suggests size-selectivity of the increased permeability and indicates modest tight junction 
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disruption [46,47]. However, as MgSO4 is thought to decrease BBB permeability through 
a calcium-antagonistic action on tight junction permeability [16,21,22,48], it was 
surprising that there was no effect of MgSO4 on BBB permeability in rats with severe PE. 
Instead, the increase in BBB permeability to sodium fluorescein may indicate an increase 
in transcellular permeability that may be calcium-independent, which could further 
explain the lack of effect of MgSO4 treatment on severe PE-associated BBB 
permeability. 
The lack of increase in permeability to large solutes is in contrast to two recent 
studies using the RUPP model without high cholesterol treatment. Both studies report 
increased BBB permeability to Evan’s Blue in RUPP compared to pregnant control rats 
[49,50]. One explanation of these contrasting results is the different methodology used. 
Evan’s Blue binds to albumin that changes during pregnancy and PE [51-54]. Thus, the 
use of 70 kDa Texas red dextran that does not bind to albumin likely provides more 
reliable results. Further, the two studies reporting increased BBB permeability to Evan’s 
Blue in RUPP rats allowed the tracer to circulate for a longer duration of time: 3 – 24 
hours versus 10 minutes in the current study [49,50]. These longer time frames likely 
provide more variable results due to differences in clearance by cerebrospinal fluid or 
other tissues, including placenta [55-57]. Regardless, in the present study, RUPP+HC rats 
had selectively increased BBB permeability that may contribute to lowering seizure 
threshold by allowing passage of serum constituents into the brain that activated 
microglia and created a neuroinflammatory state.  
Cerebral edema formation is considered a leading cause of the neurological 
symptoms that occur in severe PE, including eclamptic seizure [58-60]. In fact, 
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approximately 90 % of women with eclampsia have vasogenic cerebral edema formation 
as indicated by diffusion-weighted MRI [36]. Seizure itself leads to BBB disruption, 
making it difficult to determine if edema is the cause of or a consequence of eclamptic 
seizure [10,61]. A recent study using PTZ to induce seizure in normal pregnant rats found 
that the maternal brain was more susceptible to seizure-induced vasogenic edema 
formation than the nonpregnant state [38]. This may be an effect of increased plasma 
volume during pregnancy that, under conditions of BBB disruption such as seizure, may 
drive water into the brain. In the current study, however, brain water content after seizure 
was significantly lower in RUPP+HC rats compared to Late-Preg rats, with no effect of 
MgSO4 treatment. Plasma volume contraction is known to occur in women with PE that 
may underlie the decreased vasogenic edema formation in severe PE rats [62]. This 
would also support the concept that increased plasma volume contributes to increased 
seizure-induced edema. Further, plasma volume contraction could also explain the 
significant reduction in maternal body weight that occurred in rats with severe PE. 
Although the brain does not seem to be more susceptible to seizure-induced vasogenic 
edema formation in severe PE, the cerebral circulation appears to be compromised, 
indicated by increased BBB permeability and neuroinflammation that could increase the 
risk of brain injury during eclampsia. 
The cerebral circulation is thought to have a central role in neurologic 
complications associated with PE [3]. In fact, cerebrovascular events such as edema and 
hemorrhage account for ~ 40 % of maternal deaths [3]. Development of neurologic 
symptoms in women with PE is thought to involve the impairment of CBF autoregulation 
that is associated with decreased cerebrovascular resistance, hyperperfusion of the brain 
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and vasogenic edema formation [32,39]. Studies that have assessed dynamic CBF 
autoregulation in women with PE using transcranial Doppler (TCD) to measure changes 
in CBF velocity in the middle cerebral artery in response to hemodynamic fluctuations 
have found that CBF autoregulation appears to be intact in PE [39,63,64].  The findings in 
the current study showing intact CBF autoregulation in rats with severe PE supports these 
previous findings in humans. Further, as autoregulation remained intact in RUPP+HC 
rats, it was not surprising that there was no difference in brain water content after 
autoregulation measurements between groups. However, a recent study investigating 
CBF autoregulation in rats with RUPP without a high cholesterol diet report that 
autoregulation was impaired [50]. While it is unlikely that the addition of a high 
cholesterol diet in the current study restored autoregulation, it is more likely that 
methodological differences account for this discrepancy. Specifically, the current study 
assessed CBF autoregulation in the posterior cerebral cortex where as Warrington et al. 
investigated autoregulation in the anterior brain region [50]. Thus, it is possible that 
regional differences exist due to the primary blood supply differing between regions that 
may explain the conflicting findings between these two studies. Further, in the current 
study all catheters for continuous arterial blood pressure measurement and drug delivery 
were placed in distal systemic arteries such as the femoral arteries/veins to avoid 
disrupting blood flow to the brain. Warrington et al. used a carotid catheter to 
continuously monitor blood pressure while simultaneously recording CBF and cannulated 
one jugular vein for drug infusion [50]. As the carotid arteries and jugular veins are 
important for hemodynamics and CBF, their cannulation may account for the 
discrepancies in the effectiveness of CBF autoregulation between these studies.  
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Regardless, the current study suggests that CBF autoregulation in the posterior cerebral 
cortex in rats with severe PE is similar to Late-Preg control rats. Thus it is not likely that 
impaired CBF autoregulation contributes to decreased seizure threshold in rats with 
severe PE. 
 In summary, PE is a heterogeneous disorder that seems to manifest along a 
spectrum of severity and symptoms [1,65]. It remains unclear why some women with PE 
develop neurologic symptoms such as seizure, and others do not. That eclamptic seizure 
is more often fatal in women with severe PE stresses the importance of gaining a clear 
understanding of the disease processes leading to seizure onset. This study provides 
insight into the etiology of eclamptic seizure in severe PE, as it seems to involve a 
pathologic process of compromised BBB function and subsequent neuroinflammation, 
resulting in increased seizure susceptibility. By reducing neuroinflammation, MgSO4 
effectively increased seizure threshold, without affecting BBB permeability. Overall, 
preventing eclampsia, particularly during severe PE, is important in preventing maternal 
and fetal morbidity and mortality worldwide. Further, understanding the mechanism by 
which MgSO4 functions as a seizure prophylactic in PE may lead to more targeted 
therapies and avoid unnecessary risks associated with MgSO4 treatment.  
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Table 1. Physiological parameters in models of normal pregnancy (Late-Preg) and 
severe preeclampsia (RUPP+HC). 
 Late-Preg (n) RUPP+HC (n) 
Body Weight (grams) 460.0 ± 10.0 (3) 371.0 ± 21.2 (5) * 
# Pups 14.7 ± 1.2 (3) 11.2 ± 3.4 (5) 
# Reabsorptions 1.7 ± 0.9 (3) 3.0 ± 2.5 (5) 
Pup Weight (grams) 2.5 ± 0.03 (44) 2.2 ± 0.02 (56) ** 
Placental Weight (grams) 0.46 ± 0.01 (44) 0.42 ± 0.01 (56) ** 
Blood Pressure (mmHg) 114 ± 1 (6) 138 ± 3 (4) ** 
* p < 0.05; ** p < 0.01 vs. Late-Preg by ANOVA 
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Table 2. Assessment of seizure severity in late-pregnant (Late-Preg) rats, rats with 
severe preeclampsia (RUPP+HC), and severe preeclamptic rats treated with 
magnesium sulfate (RUPP+HC+MgSO4). 
 # Recurrent Seizures % of Time in Seizure 
Late-Preg (n = 6) 12 ± 3 85 ± 7 
RUPP+HC (n = 6) 13 ± 4 86 ± 5 




Table 3. Physiological parameters of late-pregnant (Late-Preg) rats, rats with severe 
preeclampsia (RUPP+HC), and severe preeclamptic rats treated with magnesium 




(n = 6) 
RUPP+HC  
(n = 6) 
RUPP+HC+MgSO4  
(n = 6) 
Body Temp (o C) 36.8 ± 0.2 36.4 ± 0.1 36.5 ± 0.1 
Arterial PO2 (mmHg) 111 ± 7 121 ± 6 116 ± 10 
Arterial PCO2 
(mmHg) 





Figure 1. Effect of severe preeclampsia and magnesium sulfate (MgSO4) treatment 
on seizure threshold and susceptibility. (A) Representative EEG tracing during timed-
infusion of pentylenetetrazole (PTZ). Black arrows indicate when PTZ infusion begun 
and the onset of spike-wave discharges, or seizure onset. (B) Seizure threshold was 
significantly lower in rats with severe preeclampsia (RUPP+HC), and treatment with 
MgSO4 (RUPP+HC+MgSO4) significantly increased seizure threshold back to late-
pregnant (Late-Preg) control levels. (C) Rats with severe PE had significantly higher 
seizure susceptibility scores compared to Late-Preg controls that were reversed in 
RUPP+HC+MgSO4 rats. * p < 0.05 vs. Late-Preg; ^ p < 0.01 vs. RUPP+HC+MgSO4; ** 





Figure 2. Effect of severe preeclampsia and magnesium sulfate (MgSO4) on seizure-
induced vasogenic edema formation. Percent water content of the posterior cerebral 
cortex was significantly lower after seizure in rats with severe preeclampsia (RUPP+HC) 
compared to late-pregnant (Late-Preg) control rats. Treatment of severe preeclamptic rats 
with MgSO4 (RUPP+HC+MgSO4) did not affect brain water content after seizure. * p < 






Figure 3. Effect of severe preeclampsia and magnesium sulfate (MgSO4) on in vivo 
blood-brain barrier (BBB) permeability to different sized solutes. (A) BBB 
permeability to sodium fluorescein was increased in rats with severe preeclampsia 
(RUPP+HC) in the posterior cerebral cortex compared to late-pregnant (Late-Preg) 
control rats. MgSO4 treatment in rats with severe preeclampsia (RUPP+HC+MgSO4) had 
no effect on BBB permeability to sodium fluorescein. (B) Permeability of the BBB to 70 
kDa Texas red dextran was similar between Late-Preg and RUPP+HC rats with and 





Figure 4. Effect of severe preeclampsia and magnesium sulfate (MgSO4) treatment 
on microglial activation. (A) Illustration of morphological changes occurring as 
microglia progress from their inactive state 1, marked by long ramified processes to their 
active state 4, indicated by a large, amoeboid-like shape. (B) Representative 
photomicrographs of microglial cells stained for ionized calcium-binding adapter 
molecule 1 (Iba1) in the posterior cerebral cortices of late-pregnant (Late-Preg) rats, rats 
with severe preeclampsia (RUPP+HC) and rats with severe preeclampsia treated with 
MgSO4 (RUPP+HC+MgSO4). (C) The number of Iba1+ microglia was similar between 
groups. (D) The percentage of microglia in active state 4 was significantly higher in 
RUPP+HC rats compared to Late-Preg controls. Treatment of RUPP+HC rats with 
MgSO4 decreased the percentage of cells that were active and was similar to Late-Preg 
controls. ** p < 0.01 vs. Late-Preg and RUPP+HC+MgSO4 by one-way ANOVA and 





Figure 5. Effect of severe preeclampsia on cerebral blood flow (CBF) autoregulation 
and vasogenic edema formation. (A) Relative CBF (rCBF) increased similarly between 
late-pregnant (Late-Preg) and rats with severe preeclampsia (RUPP+HC) as arterial blood 
pressure was increased between 100 mmHg to 180 mmHg demonstrating intact 
autoregulation of CBF that was not different between groups. (B) Percent water content 
of the posterior cerebral cortex after CBF autoregulation measurements was similar 





CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
Eclampsia is considered a form of hypertensive encephalopathy during which an 
acute hypertensive episode leads to loss of vascular resistance of cerebral arteries, 
autoregulatory breakthrough, and increased hydrostatic pressure on the microcirculation, 
BBB disruption, and vasogenic edema formation (Lassen and Agnoli, 1972; Easton, 
1998). However, women have eclamptic seizure during seemingly uncomplicated 
pregnancies at normal blood pressures and in the absence of preeclampsia (Douglas and 
Redman, 1994; Katz et al., 2000). Further, preeclamptic and eclamptic women are, by 
definition, normotensive prior to pregnancy. This may suggest that the pressure at which 
autoregulatory breakthrough occurs is shifted to lower pressure during pregnancy. 
However, previous studies in pregnant rats and findings in this dissertation suggest that 
the CBF autoregulatory curve is actually extended in the pregnant state, making the 
maternal brain better prepared to maintain CBF in the face of both acute hypotensive and 
hypertensive episodes (Cipolla et al., 2012a).  Further, CBF autoregulation appears to be 
similar during preeclampsia and normal pregnancy. The findings that edema is present in 
over 90% of eclamptic women has supported that eclampsia is a form of hypertensive 
encephalopathy (Zeeman et al., 2004; Brewer et al., 2013); however, the maternal brain is 
more susceptible to vasogenic edema formation in response to acute hypertension with 
and without autoregulatory breakthrough (Euser and Cipolla, 2007; Cipolla et al., 2012a). 
Further, the brain appears to be hyperexcitable during normal pregnancy, and to a greater 
degree in preeclampsia. Thus, eclamptic seizure may occur due to vasogenic edema 
formation in the hyperexcitable maternal brain, potentially due to mechanisms involving 
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disrupted BBB function and increased permeability, rather than impairment of CBF 
autoregulation. In some women, eclampsia most likely occurs due to autoregulatory 
breakthrough similarly to hypertensive encephalopathy, however, the onset of eclamptic 
seizure seems to be more convoluted, and perhaps should not be considered a form for 
hypertensive encephalopathy. 
The role of vasogenic edema formation in eclamptic seizure onset remains 
difficult to determine, as seizure itself leads to BBB disruption and edema formation 
(Oztas et al., 2003; Oby and Janigro, 2006). It is further complicated by the finding that 
the maternal brain is more susceptible to seizure-induced vasogenic edema, suggesting 
that vasogenic edema during eclampsia may be a result of the convulsions, rather than a 
cause, or, perhaps, a combination of both. However, this increase in seizure-induced 
edema was only present in normal pregnant rats. Vasogenic edema formation was 
significantly reduced in response to seizure in rats with preeclampsia compared to normal 
pregnancy, suggesting that preeclampsia may either prevent or reverse the increase in 
capillary density or plasma volume that appear to contribute to the susceptibility of the 
brain to vasogenic edema during pregnancy under conditions that promote BBB 
disruption. Regardless, the role of vasogenic edema formation in seizure onset during 
pregnancy needs to be further investigated. Further, the effect of preeclampsia on 
cerebrovascular adaptations to normal pregnancy needs to be investigated, as that may 
further elucidate roles of the cerebral circulation in eclamptic seizure onset.  
The protective extension of the CBF autoregulatory curve during pregnancy 
appears to involve changes in nitric oxide synthase (NOS). The nitric oxide (NO)-
dependent enhancement of vasodilation of cerebral pial arteries reported in this 
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dissertation and the pregnancy-induced outward remodeling of penetrating arterioles 
likely contribute to the leftward shift by increasing dilation of cerebral arteries in 
response to decreased intravascular pressure, thereby maintaining CBF at lower pressures 
(Cipolla et al., 2011). However, the systemic administration of a NOS inhibitor did not 
affect the lower limit, suggesting that perhaps there are compensatory mechanisms to 
maintain CBF, such as neuronal sources of NOS. Although in this study there was no 
change in mRNA expression of endothelial NOS in the cerebral arteries investigated, 
another study reported that endothelial NOS mRNA expression was decreased in the 
posterior cerebral cortex compared to the nonpregnant state (Cipolla et al., 2012a). The 
leftward shift of the lower limit may be due to increased activity of endothelial NOS in 
response to decreased intraluminal pressure, despite the decrease in expression. Further, 
NO production has been shown to contribute to the loss of vascular resistance that occurs 
in response to extreme increases in pressure, leading to forced dilatation of cerebral 
arteries and autoregulatory breakthrough (Talman and Nitschke Dragon, 2007). In fact, 
NOS inhibition shifts the upper limit of the CBF autoregulatory curve to higher pressures 
(Euser and Cipolla, 2007). Thus, the decrease in endothelial NOS expression in the 
posterior cerebral cortex during pregnancy could contribute to the rightward shift of the 
upper limit measured in pregnancy (Cipolla et al., 2012a). Overall, it appears that 
fluctuations in arterial pressure may have a differential effect on NOS and NO production 
in order to have protective effects at both the upper and lower limits of the CBF 
autoregulatory curve during pregnancy; however, whether the same mechanism exists in 
preeclampsia needs to be further investigated.  
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CBF autoregulation being similar between rats with preeclampsia and normal 
pregnant rats is particularly interesting, given the prominent role of NOS that has 
emerged in the extension of the autoregulatory curve, and that preeclampsia is a state 
marked by decreased bioavailability of NO. Systemically, oxidative stress and increased 
reactive oxygen species decrease the bioavailability of NO during preeclampsia (Lowe, 
2000). However, what may be occurring in the brain during preeclampsia regarding 
changes in endothelial, neuronal or inducible NOS expression and NO production, or 
cerebrovascular function in general, remains relatively unknown. That NOS inhibition 
shifts the upper limit of the autoregulatory curve to higher pressure would suggest that if 
preeclampsia were a state of decreased NOS expression and NO bioavailability, than the 
limit may be shifted even further. However, this does not appear to be the case. 
Importantly, pregnancy prevents and reverses the protective cerebrovascular remodeling 
that occurs in response to chronic hypertension that has been shown to shift the upper 
limit of CBF autoregulation to higher pressure (Paulson et al., 1990; Cipolla et al., 2006; 
Aukes et al., 2007; Cipolla et al., 2008). Thus, that autoregulation was similar between 
pregnant and chronically hypertensive preeclamptic rats may actually indicate less 
effective autoregulation in rats with preeclampsia. Further investigation into the function 
of cerebral arteries during experimental preeclampsia would be useful to gain a better 
understanding of the role the cerebrovasculature may play in the potential for brain injury 
and eclampsia. 
Preeclampsia appears to be a state of greater seizure susceptibility than normal 
pregnancy, which makes sense in the context that the majority of women with eclampsia 
are preeclamptic (Douglas and Redman, 1994). Regardless, normal pregnancy contributes 
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to the potential for eclampsia, not only by increasing the excitability of the brain, but also 
by the seizure-provoking factors that circulate late in gestation (Cipolla et al., 2012b). 
Under pathologic states when the BBB may be compromised due to infection, failure of 
efflux transporters, or acute hypertension, such hyperexcitable factors would likely gain 
access to the hyperexcitable maternal brain, and lead to seizure onset. Similarly, during 
preeclampsia where a level of basal BBB disruption appears to be present, the secondary 
insult necessary to initiate seizure onset is likely minor compared to the normal pregnant 
state. Thus, a therapeutic medication that acts as a neuroprotectant through targeting 
either the compromised BBB, hyperexcitable neurons, or activated microglia would 
likely be necessary and sufficient for seizure prevention during preeclampsia.  
There is in vivo evidence that MgSO4 exerts protective effects at the BBB (Kaya 
et al., 2001; Esen et al., 2003; Kaya et al., 2004; Esen et al., 2005; Euser et al., 2008) and 
an anticonvulsant effect on NMDA receptor-containing cortical neurons (Hallak et al., 
1992; Hallak et al., 1994). Further, findings from this dissertation provide evidence that 
MgSO4 acts as a seizure prophylactic through quiescent effects on activated microglia, 
thereby reducing neuroinflammation and raising seizure threshold. This is likely due to 
the calcium-antagonistic effects of MgSO4, preventing the secretion of pro-inflammatory 
cytokines through inhibition of L-type calcium channels and subsequent activation of the 
NF-κB signaling cascade (Gao et al., 2013). By inhibiting the secretion of pro-
inflammatory cytokines that have been shown to increase neuronal excitability 
(Stellwagen et al., 2005; Riazi et al., 2008), MgSO4 restores seizure threshold to the level 
of normal pregnancy. Whether there are further effects of MgSO4 on the excitability of 
NMDA receptor-containing neurons that also contributes to the restoration of seizure 
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threshold is unclear at this time. However, through the use of a GABAAR-specific 
chemoconvulsant, there does not appear to be an effect at NMDA receptors. If there was 
an effect at NMDA receptors, one might expect seizure threshold to be even higher with 
MgSO4 treatment than pregnant controls. That seizure threshold is similar to pregnant 
control levels suggests that it is mainly changes in the GABAAR system that is affecting 
seizure threshold during pregnancy and preeclampsia. Current literature on the effects of 
microglial-secreted pro-inflammatory cytokines such as TNFα indicate increased 
excitability is due to the simultaneous increase in trafficking of AMPA receptors to 
neuronal cell membranes coupled with increased endocytosis of GABAAR away from the 
cell membrane (Stellwagen et al., 2005). This mechanism of increased excitability does 
not seem to involve a role for NMDA receptors. However, direct investigation of seizure 
threshold using a specific NMDA receptor antagonist in preeclamptic rats with and 
without MgSO4 treatment could lead to a better understanding of potential central 
anticonvulsant effects of MgSO4 treatment in seizure prevention during preeclampsia. 
Normal pregnancy and preeclampsia appear to be the setting of a perfect storm, 
with hyperexcitable factors circulating and the brain in a hyperexcitable state. There is 
evidence that actions of MgSO4 have protective effects at several sites that may be 
involved in the pathogenesis of eclampsia, including a “tightening” effect at the BBB, a 
quiescent effect on microglial, and an anticonvulsant effect at NMDA receptors. This 
multifaceted action likely contributes to the effectiveness of MgSO4 as a seizure 
prophylactic, especially given the heterogeneity of disease processes involved in the 
pathogenesis preeclampsia and eclampsia. It is unlikely that every woman with 
preeclampsia that develops eclampsia has the same insult that results in seizure onset. 
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Thus, by targeting several areas of potential disruption through which seizure may be 
initiated, MgSO4 effectively prevents seizure in women all along the spectrum of disease. 
This may be the reason why MgSO4 is more effective in seizure prevention during 
preeclampsia than any anticonvulsant medication that only manipulates neuronal activity. 
This dissertation had several limitations that should be taken into account. 
Specifically, seizure threshold was determined as the amount of PTZ required to induce 
generalized seizure. Generalized seizure can accurately be monitored via subcutaneous 
EEG electrodes and, as eclampsia is generalized tonic-clonic seizure, is an appropriate 
measure to begin to understand the excitability of the maternal brain that may contribute 
to eclampsia. However, it may have also been useful to measure focal seizure using more 
sensitive electrode placement such as cortical or implanted hippocampal electrodes. 
Further, PTZ was used as the chemoconvulsant in this study due to its antagonistic 
actions at GABAARs that allowed direct investigation of pregnancy-induced changes in 
the inhibitory system within the brain; however, the use of a chemoconvulsant that targets 
excitatory glutamatergic receptors, such as AMPA or kainic acid, may provide insight 
into pregnancy-induced plasticity of the excitatory system. It is possible that the apparent 
decrease in tonic inhibition due to downregulation of the GABAAR-δ is compensated for 
by a decrease in excitatory receptor expression that would only be unmasked by the use 
of a convulsant specific to the excitatory system. In a similar regard, only cortical protein 
expression of one subunit, GABAAR-δ, was investigated via Western blot in this project. 
It is possible that pregnancy-induced plasticity of the γ-subunit (GABAAR-γ) that is 
synaptically located and involved in phasic inhibition may compensate for the decrease in 
expression of GABAAR-δ. However, studies report that GABAAR-γ expression also 
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decreases over the course of gestation (Maguire and Mody, 2009), making it more likely 
that this pregnancy-induced decrease in GABAAR-γ augments hyperexcitability as 
opposed to compensating for the decrease in GABAAR-δ to maintain appropriate 
inhibition. Finally, the seizure model used in this dissertation was not a model of 
spontaneous seizure, and therefore, not a model of eclampsia. However, this dissertation 
sought to understand changes in brain excitability during pregnancy and preeclampsia 
that could potentiate seizure and contribute to eclampsia. Thus, seizure was induced to 
detect changes in seizure threshold and susceptibility. The findings in this dissertation 
shed new light on excitability changes during normal pregnancy and preeclampsia and 
potential underlying mechanisms by which that hyperexcitability may be occurring; 
however, we still do not have a clear understanding of eclamptic seizure onset.  
This dissertation provided insight into mechanisms of seizure during pregnancy 
and preeclampsia; however, it also opened the door for further investigation into the 
pathogenesis of eclampsia during both seemingly healthy pregnancies and pregnancies 
complicated by preeclampsia. Future studies investigating the role of the BBB in seizure 
prevention during normal pregnancy would be useful in gaining a better understanding of 
not only the adaptation of the BBB to normal pregnancy, but potential mechanisms of 
disrupted barrier function that may become central to seizure onset. Specifically, studies 
bypassing the BBB and delivering seizure-provoking serum directly to the brain and 
monitoring for spontaneous seizure in late-pregnant rats would be critical proof-of-
principle experiments that the BBB definitively contributes to seizure prevention during 
pregnancy. Further, investigation into gestational regulation of both expression and 
activity of efflux transporters including Pgp and Mrp1 in cerebral microvessels would 
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allow a greater understanding of the adaptation of the BBB to increased circulating 
factors occurring during pregnancy. In addition, in vivo studies manipulating the activity 
of efflux transporters at the BBB through pharmacological inhibition of Pgp and 
Mrp1with simultaneous EEG recording during normal pregnancy would provide insight 
into the role of these specific transporters in seizure prevention during normal pregnancy. 
The BBB during preeclampsia should also be investigated to determine the pathologic 
process leading to increased BBB permeability that occurs in rats with experimental 
preeclampsia. Additional size-selectivity studies would be useful to determine the extent 
of BBB disruption, including further investigation into the type of BBB disruption that is 
occurring (e.g. increased paracellular vs. transcellular transport) in rats with experimental 
preeclampsia. Further studies investigating whether there is an effect of circulating 
factors during preeclampsia on efflux transporters at the BBB that may decrease their 
activity and result in decreased barrier function remains unclear, but could also be 
investigated using the experimental model of preeclampsia developed in this dissertation. 
These future studies could potentially lead to enhanced screening procedures to identify 
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